Financial Metrics

HCA HCA Healthcare, Inc.

Range: 2016-01-01 to 2026-04-29

Export Quarterly CSV Export Annual CSV

Chart Range:

% Change:

Annual View:

Financial Statements

Grouped by statement

Income Statement

Metrics: 6

Revenue

Q: 15 | A: 7

Quarterly

Annual

Show Data Rows

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2021-03-31	13977000000.0	—	USD	10-Q	2022-05-03
Quarterly	2021-06-30	14435000000.0	+3.3%	USD	10-Q	2022-08-01
Quarterly	2021-09-30	15276000000.0	+5.8%	USD	10-Q	2022-11-01
Quarterly	2022-03-31	14945000000.0	-2.2%	USD	10-Q	2023-04-27
Quarterly	2022-06-30	14820000000.0	-0.8%	USD	10-Q	2023-08-02
Quarterly	2022-09-30	14971000000.0	+1.0%	USD	10-Q	2023-10-26
Quarterly	2023-03-31	15591000000.0	+4.1%	USD	10-Q	2024-05-02
Quarterly	2023-06-30	15861000000.0	+1.7%	USD	10-Q	2024-07-29
Quarterly	2023-09-30	16213000000.0	+2.2%	USD	10-Q	2024-10-31
Quarterly	2024-03-31	17339000000.0	+6.9%	USD	10-Q	2025-05-01
Quarterly	2024-06-30	17492000000.0	+0.9%	USD	10-Q	2025-08-04
Quarterly	2024-09-30	17487000000.0	-0.0%	USD	10-Q	2025-10-30
Quarterly	2025-03-31	18321000000.0	+4.8%	USD	10-Q	2025-05-01
Quarterly	2025-06-30	18605000000.0	+1.6%	USD	10-Q	2025-08-04
Quarterly	2025-09-30	19161000000.0	+3.0%	USD	10-Q	2025-10-30
Annual	2019-12-31	51336000000.0	—	USD	10-K	2022-02-18
Annual	2020-12-31	51533000000.0	+0.4%	USD	10-K	2023-02-17
Annual	2021-12-31	58752000000.0	+14.0%	USD	10-K	2024-02-16
Annual	2022-12-31	60233000000.0	+2.5%	USD	10-K	2025-02-14
Annual	2023-12-31	64968000000.0	+7.9%	USD	10-K	2026-02-10
Annual	2024-12-31	70603000000.0	+8.7%	USD	10-K	2026-02-10
Annual	2025-12-31	75600000000.0	+7.1%	USD	10-K	2026-02-10

Gross Profit

Q: 0 | A: 0

Quarterly

Annual

Show Data Rows

Frequency	Period End	Value	% Chg	Unit	Form	Filed

Operating Income

Q: 0 | A: 0

Quarterly

Annual

Show Data Rows

Frequency	Period End	Value	% Chg	Unit	Form	Filed

Net Income

Q: 30 | A: 10

Quarterly

Annual

Show Data Rows

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	811000000.0	—	USD	10-Q	2017-05-09
Quarterly	2016-06-30	791000000.0	-2.5%	USD	10-Q	2017-08-04
Quarterly	2016-09-30	745000000.0	-5.8%	USD	10-Q	2017-11-07
Quarterly	2017-03-31	777000000.0	+4.3%	USD	10-Q	2018-05-08
Quarterly	2017-06-30	795000000.0	+2.3%	USD	10-Q	2018-08-03
Quarterly	2017-09-30	530000000.0	-33.3%	USD	10-Q	2018-11-06
Quarterly	2018-03-31	1282000000.0	+141.9%	USD	10-Q	2019-05-03
Quarterly	2018-06-30	966000000.0	-24.6%	USD	10-Q	2019-08-02
Quarterly	2018-09-30	896000000.0	-7.2%	USD	10-Q	2019-11-01
Quarterly	2019-03-31	1181000000.0	+31.8%	USD	10-Q	2020-05-06
Quarterly	2019-06-30	927000000.0	-21.5%	USD	10-Q	2020-07-30
Quarterly	2019-09-30	764000000.0	-17.6%	USD	10-Q	2020-10-29
Quarterly	2020-03-31	698000000.0	-8.6%	USD	10-Q	2021-04-30
Quarterly	2020-06-30	1216000000.0	+74.2%	USD	10-Q	2021-08-02
Quarterly	2020-09-30	779000000.0	-35.9%	USD	10-Q	2021-11-01
Quarterly	2021-03-31	1580000000.0	+102.8%	USD	10-Q	2022-05-03
Quarterly	2021-06-30	1664000000.0	+5.3%	USD	10-Q	2022-08-01
Quarterly	2021-09-30	2472000000.0	+48.6%	USD	10-Q	2022-11-01
Quarterly	2022-03-31	1465000000.0	-40.7%	USD	10-Q	2023-04-27
Quarterly	2022-06-30	1379000000.0	-5.9%	USD	10-Q	2023-08-02
Quarterly	2022-09-30	1344000000.0	-2.5%	USD	10-Q	2023-10-26
Quarterly	2023-03-31	1543000000.0	+14.8%	USD	10-Q	2024-05-02
Quarterly	2023-06-30	1412000000.0	-8.5%	USD	10-Q	2024-07-29
Quarterly	2023-09-30	1275000000.0	-9.7%	USD	10-Q	2024-10-31
Quarterly	2024-03-31	1802000000.0	+41.3%	USD	10-Q	2025-05-01
Quarterly	2024-06-30	1687000000.0	-6.4%	USD	10-Q	2025-08-04
Quarterly	2024-09-30	1482000000.0	-12.2%	USD	10-Q	2025-10-30
Quarterly	2025-03-31	1825000000.0	+23.1%	USD	10-Q	2025-05-01
Quarterly	2025-06-30	1891000000.0	+3.6%	USD	10-Q	2025-08-04
Quarterly	2025-09-30	1903000000.0	+0.6%	USD	10-Q	2025-10-30
Annual	2016-12-31	3432000000.0	—	USD	10-K	2019-02-21
Annual	2017-12-31	2743000000.0	-20.1%	USD	10-K	2020-02-20
Annual	2018-12-31	4389000000.0	+60.0%	USD	10-K	2021-02-19
Annual	2019-12-31	4145000000.0	-5.6%	USD	10-K	2022-02-18
Annual	2020-12-31	4387000000.0	+5.8%	USD	10-K	2023-02-17
Annual	2021-12-31	7721000000.0	+76.0%	USD	10-K	2024-02-16
Annual	2022-12-31	6834000000.0	-11.5%	USD	10-K	2025-02-14
Annual	2023-12-31	6091000000.0	-10.9%	USD	10-K	2026-02-10
Annual	2024-12-31	6657000000.0	+9.3%	USD	10-K	2026-02-10
Annual	2025-12-31	7782000000.0	+16.9%	USD	10-K	2026-02-10

EPS Basic

Q: 30 | A: 10

Quarterly

Annual

Show Data Rows

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	1.75	—	USD/shares	10-Q	2017-05-09
Quarterly	2016-06-30	1.7	-2.9%	USD/shares	10-Q	2017-08-04
Quarterly	2016-09-30	1.63	-4.1%	USD/shares	10-Q	2017-11-07
Quarterly	2017-03-31	1.78	+9.2%	USD/shares	10-Q	2018-05-08
Quarterly	2017-06-30	1.79	+0.6%	USD/shares	10-Q	2018-08-03
Quarterly	2017-09-30	1.18	-34.1%	USD/shares	10-Q	2018-11-06
Quarterly	2018-03-31	3.26	+176.3%	USD/shares	10-Q	2019-05-03
Quarterly	2018-06-30	2.35	-27.9%	USD/shares	10-Q	2019-08-02
Quarterly	2018-09-30	2.2	-6.4%	USD/shares	10-Q	2019-11-01
Quarterly	2019-03-31	3.03	+37.7%	USD/shares	10-Q	2020-05-06
Quarterly	2019-06-30	2.29	-24.4%	USD/shares	10-Q	2020-07-30
Quarterly	2019-09-30	1.8	-21.4%	USD/shares	10-Q	2020-10-29
Quarterly	2020-03-31	1.72	-4.4%	USD/shares	10-Q	2021-04-30
Quarterly	2020-06-30	3.2	+86.0%	USD/shares	10-Q	2021-08-02
Quarterly	2020-09-30	1.97	-38.4%	USD/shares	10-Q	2021-11-01
Quarterly	2021-03-31	4.21	+113.7%	USD/shares	10-Q	2022-05-03
Quarterly	2021-06-30	4.42	+5.0%	USD/shares	10-Q	2022-08-01
Quarterly	2021-09-30	7.13	+61.3%	USD/shares	10-Q	2022-11-01
Quarterly	2022-03-31	4.21	-41.0%	USD/shares	10-Q	2023-04-27
Quarterly	2022-06-30	3.95	-6.2%	USD/shares	10-Q	2023-08-02
Quarterly	2022-09-30	3.97	+0.5%	USD/shares	10-Q	2023-10-26
Quarterly	2023-03-31	4.92	+23.9%	USD/shares	10-Q	2024-05-02
Quarterly	2023-06-30	4.35	-11.6%	USD/shares	10-Q	2024-07-29
Quarterly	2023-09-30	3.98	-8.5%	USD/shares	10-Q	2024-10-31
Quarterly	2024-03-31	6.01	+51.0%	USD/shares	10-Q	2025-05-01
Quarterly	2024-06-30	5.6	-6.8%	USD/shares	10-Q	2025-08-04
Quarterly	2024-09-30	4.94	-11.8%	USD/shares	10-Q	2025-10-30
Quarterly	2025-03-31	6.52	+32.0%	USD/shares	10-Q	2025-05-01
Quarterly	2025-06-30	6.91	+6.0%	USD/shares	10-Q	2025-08-04
Quarterly	2025-09-30	7.05	+2.0%	USD/shares	10-Q	2025-10-30
Annual	2016-12-31	7.53	—	USD/shares	10-K	2019-02-21
Annual	2017-12-31	6.12	-18.7%	USD/shares	10-K	2020-02-20
Annual	2018-12-31	10.9	+78.1%	USD/shares	10-K	2021-02-19
Annual	2019-12-31	10.27	-5.8%	USD/shares	10-K	2022-02-18
Annual	2020-12-31	11.1	+8.1%	USD/shares	10-K	2023-02-17
Annual	2021-12-31	21.52	+93.9%	USD/shares	10-K	2024-02-16
Annual	2022-12-31	19.43	-9.7%	USD/shares	10-K	2025-02-14
Annual	2023-12-31	19.25	-0.9%	USD/shares	10-K	2026-02-10
Annual	2024-12-31	22.27	+15.7%	USD/shares	10-K	2026-02-10
Annual	2025-12-31	28.7	+28.9%	USD/shares	10-K	2026-02-10

EPS Diluted

Q: 30 | A: 10

Quarterly

Annual

Show Data Rows

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	1.69	—	USD/shares	10-Q	2017-05-09
Quarterly	2016-06-30	1.65	-2.4%	USD/shares	10-Q	2017-08-04
Quarterly	2016-09-30	1.59	-3.6%	USD/shares	10-Q	2017-11-07
Quarterly	2017-03-31	1.74	+9.4%	USD/shares	10-Q	2018-05-08
Quarterly	2017-06-30	1.75	+0.6%	USD/shares	10-Q	2018-08-03
Quarterly	2017-09-30	1.15	-34.3%	USD/shares	10-Q	2018-11-06
Quarterly	2018-03-31	3.18	+176.5%	USD/shares	10-Q	2019-05-03
Quarterly	2018-06-30	2.31	-27.4%	USD/shares	10-Q	2019-08-02
Quarterly	2018-09-30	2.15	-6.9%	USD/shares	10-Q	2019-11-01
Quarterly	2019-03-31	2.97	+38.1%	USD/shares	10-Q	2020-05-06
Quarterly	2019-06-30	2.25	-24.2%	USD/shares	10-Q	2020-07-30
Quarterly	2019-09-30	1.76	-21.8%	USD/shares	10-Q	2020-10-29
Quarterly	2020-03-31	1.69	-4.0%	USD/shares	10-Q	2021-04-30
Quarterly	2020-06-30	3.16	+87.0%	USD/shares	10-Q	2021-08-02
Quarterly	2020-09-30	1.95	-38.3%	USD/shares	10-Q	2021-11-01
Quarterly	2021-03-31	4.14	+112.3%	USD/shares	10-Q	2022-05-03
Quarterly	2021-06-30	4.36	+5.3%	USD/shares	10-Q	2022-08-01
Quarterly	2021-09-30	7.0	+60.6%	USD/shares	10-Q	2022-11-01
Quarterly	2022-03-31	4.14	-40.9%	USD/shares	10-Q	2023-04-27
Quarterly	2022-06-30	3.9	-5.8%	USD/shares	10-Q	2023-08-02
Quarterly	2022-09-30	3.91	+0.3%	USD/shares	10-Q	2023-10-26
Quarterly	2023-03-31	4.85	+24.0%	USD/shares	10-Q	2024-05-02
Quarterly	2023-06-30	4.29	-11.5%	USD/shares	10-Q	2024-07-29
Quarterly	2023-09-30	3.91	-8.9%	USD/shares	10-Q	2024-10-31
Quarterly	2024-03-31	5.93	+51.7%	USD/shares	10-Q	2025-05-01
Quarterly	2024-06-30	5.53	-6.7%	USD/shares	10-Q	2025-08-04
Quarterly	2024-09-30	4.88	-11.8%	USD/shares	10-Q	2025-10-30
Quarterly	2025-03-31	6.45	+32.2%	USD/shares	10-Q	2025-05-01
Quarterly	2025-06-30	6.83	+5.9%	USD/shares	10-Q	2025-08-04
Quarterly	2025-09-30	6.96	+1.9%	USD/shares	10-Q	2025-10-30
Annual	2016-12-31	7.3	—	USD/shares	10-K	2019-02-21
Annual	2017-12-31	5.95	-18.5%	USD/shares	10-K	2020-02-20
Annual	2018-12-31	10.66	+79.2%	USD/shares	10-K	2021-02-19
Annual	2019-12-31	10.07	-5.5%	USD/shares	10-K	2022-02-18
Annual	2020-12-31	10.93	+8.5%	USD/shares	10-K	2023-02-17
Annual	2021-12-31	21.16	+93.6%	USD/shares	10-K	2024-02-16
Annual	2022-12-31	19.15	-9.5%	USD/shares	10-K	2025-02-14
Annual	2023-12-31	18.97	-0.9%	USD/shares	10-K	2026-02-10
Annual	2024-12-31	22.0	+16.0%	USD/shares	10-K	2026-02-10
Annual	2025-12-31	28.33	+28.8%	USD/shares	10-K	2026-02-10

Balance Sheet

Metrics: 9

Cash and Equivalents

Q: 39 | A: 10

Quarterly

Annual

Show Data Rows

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	852000000.0	—	USD	10-Q	2017-05-09
Quarterly	2016-06-30	691000000.0	-18.9%	USD	10-Q	2017-08-04
Quarterly	2016-09-30	677000000.0	-2.0%	USD	10-Q	2017-11-07
Quarterly	2016-12-31	646000000.0	-4.6%	USD	10-Q	2018-05-08
Quarterly	2017-03-31	753000000.0	+16.6%	USD	10-Q	2018-05-08
Quarterly	2017-06-30	705000000.0	-6.4%	USD	10-Q	2017-08-04
Quarterly	2017-09-30	718000000.0	+1.8%	USD	10-Q	2017-11-07
Quarterly	2017-12-31	732000000.0	+1.9%	USD	10-Q	2018-11-06
Quarterly	2018-03-31	1086000000.0	+48.4%	USD	10-Q	2018-05-08
Quarterly	2018-06-30	868000000.0	-20.1%	USD	10-Q	2018-08-03
Quarterly	2018-09-30	578000000.0	-33.4%	USD	10-Q	2018-11-06
Quarterly	2018-12-31	502000000.0	-13.1%	USD	10-Q	2019-11-01
Quarterly	2019-03-31	531000000.0	+5.8%	USD	10-Q	2019-05-03
Quarterly	2019-06-30	2430000000.0	+357.6%	USD	10-Q	2019-08-02
Quarterly	2019-09-30	559000000.0	-77.0%	USD	10-Q	2019-11-01
Quarterly	2019-12-31	621000000.0	+11.1%	USD	10-Q	2020-10-29
Quarterly	2020-03-31	731000000.0	+17.7%	USD	10-Q	2020-05-06
Quarterly	2020-06-30	4638000000.0	+534.5%	USD	10-Q	2020-07-30
Quarterly	2020-09-30	6588000000.0	+42.0%	USD	10-Q	2020-10-29
Quarterly	2020-12-31	1793000000.0	-72.8%	USD	10-Q	2021-11-01
Quarterly	2021-03-31	1030000000.0	-42.6%	USD	10-Q	2021-04-30
Quarterly	2021-06-30	1120000000.0	+8.7%	USD	10-Q	2021-08-02
Quarterly	2021-09-30	1027000000.0	-8.3%	USD	10-Q	2021-11-01
Quarterly	2021-12-31	1451000000.0	+41.3%	USD	10-Q	2022-11-01
Quarterly	2022-03-31	2371000000.0	+63.4%	USD	10-Q	2022-05-03
Quarterly	2022-06-30	858000000.0	-63.8%	USD	10-Q	2022-08-01
Quarterly	2022-09-30	999000000.0	+16.4%	USD	10-Q	2022-11-01
Quarterly	2022-12-31	908000000.0	-9.1%	USD	10-Q	2023-10-26
Quarterly	2023-03-31	842000000.0	-7.3%	USD	10-Q	2023-04-27
Quarterly	2023-06-30	862000000.0	+2.4%	USD	10-Q	2023-08-02
Quarterly	2023-09-30	891000000.0	+3.4%	USD	10-Q	2023-10-26
Quarterly	2023-12-31	935000000.0	+4.9%	USD	10-Q	2024-10-31
Quarterly	2024-03-31	1284000000.0	+37.3%	USD	10-Q	2024-05-02
Quarterly	2024-06-30	831000000.0	-35.3%	USD	10-Q	2024-07-29
Quarterly	2024-09-30	2888000000.0	+247.5%	USD	10-Q	2024-10-31
Quarterly	2024-12-31	1933000000.0	-33.1%	USD	10-Q	2025-10-30
Quarterly	2025-03-31	1060000000.0	-45.2%	USD	10-Q	2025-05-01
Quarterly	2025-06-30	939000000.0	-11.4%	USD	10-Q	2025-08-04
Quarterly	2025-09-30	997000000.0	+6.2%	USD	10-Q	2025-10-30
Annual	2016-12-31	646000000.0	—	USD	10-K	2018-02-23
Annual	2017-12-31	732000000.0	+13.3%	USD	10-K	2019-02-21
Annual	2018-12-31	502000000.0	-31.4%	USD	10-K	2020-02-20
Annual	2019-12-31	621000000.0	+23.7%	USD	10-K	2021-02-19
Annual	2020-12-31	1793000000.0	+188.7%	USD	10-K	2022-02-18
Annual	2021-12-31	1451000000.0	-19.1%	USD	10-K	2023-02-17
Annual	2022-12-31	908000000.0	-37.4%	USD	10-K	2024-02-16
Annual	2023-12-31	935000000.0	+3.0%	USD	10-K	2025-02-14
Annual	2024-12-31	1933000000.0	+106.7%	USD	10-K	2026-02-10
Annual	2025-12-31	1040000000.0	-46.2%	USD	10-K	2026-02-10

Accounts Receivable

Q: 39 | A: 10

Quarterly

Annual

Show Data Rows

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	5880000000.0	—	USD	10-Q	2016-05-06
Quarterly	2016-06-30	5669000000.0	-3.6%	USD	10-Q	2016-08-04
Quarterly	2016-09-30	5503000000.0	-2.9%	USD	10-Q	2016-11-03
Quarterly	2016-12-31	5826000000.0	+5.9%	USD	10-Q	2017-11-07
Quarterly	2017-03-31	5664000000.0	-2.8%	USD	10-Q	2017-05-09
Quarterly	2017-06-30	5782000000.0	+2.1%	USD	10-Q	2017-08-04
Quarterly	2017-09-30	5980000000.0	+3.4%	USD	10-Q	2017-11-07
Quarterly	2017-12-31	6501000000.0	+8.7%	USD	10-Q	2018-11-06
Quarterly	2018-03-31	6332000000.0	-2.6%	USD	10-Q	2018-05-08
Quarterly	2018-06-30	6592000000.0	+4.1%	USD	10-Q	2018-08-03
Quarterly	2018-09-30	6532000000.0	-0.9%	USD	10-Q	2018-11-06
Quarterly	2018-12-31	6789000000.0	+3.9%	USD	10-Q	2019-11-01
Quarterly	2019-03-31	7420000000.0	+9.3%	USD	10-Q	2019-05-03
Quarterly	2019-06-30	7219000000.0	-2.7%	USD	10-Q	2019-08-02
Quarterly	2019-09-30	7131000000.0	-1.2%	USD	10-Q	2019-11-01
Quarterly	2019-12-31	7380000000.0	+3.5%	USD	10-Q	2020-10-29
Quarterly	2020-03-31	6890000000.0	-6.6%	USD	10-Q	2020-05-06
Quarterly	2020-06-30	6139000000.0	-10.9%	USD	10-Q	2020-07-30
Quarterly	2020-09-30	6433000000.0	+4.8%	USD	10-Q	2020-10-29
Quarterly	2020-12-31	7051000000.0	+9.6%	USD	10-Q	2021-11-01
Quarterly	2021-03-31	7424000000.0	+5.3%	USD	10-Q	2021-04-30
Quarterly	2021-06-30	7636000000.0	+2.9%	USD	10-Q	2021-08-02
Quarterly	2021-09-30	8433000000.0	+10.4%	USD	10-Q	2021-11-01
Quarterly	2021-12-31	8095000000.0	-4.0%	USD	10-Q	2022-11-01
Quarterly	2022-03-31	8520000000.0	+5.3%	USD	10-Q	2022-05-03
Quarterly	2022-06-30	8628000000.0	+1.3%	USD	10-Q	2022-08-01
Quarterly	2022-09-30	8552000000.0	-0.9%	USD	10-Q	2022-11-01
Quarterly	2022-12-31	8891000000.0	+4.0%	USD	10-Q	2023-10-26
Quarterly	2023-03-31	8657000000.0	-2.6%	USD	10-Q	2023-04-27
Quarterly	2023-06-30	8713000000.0	+0.6%	USD	10-Q	2023-08-02
Quarterly	2023-09-30	9182000000.0	+5.4%	USD	10-Q	2023-10-26
Quarterly	2023-12-31	9958000000.0	+8.5%	USD	10-Q	2024-10-31
Quarterly	2024-03-31	10044000000.0	+0.9%	USD	10-Q	2024-05-02
Quarterly	2024-06-30	10239000000.0	+1.9%	USD	10-Q	2024-07-29
Quarterly	2024-09-30	9915000000.0	-3.2%	USD	10-Q	2024-10-31
Quarterly	2024-12-31	10751000000.0	+8.4%	USD	10-Q	2025-10-30
Quarterly	2025-03-31	11088000000.0	+3.1%	USD	10-Q	2025-05-01
Quarterly	2025-06-30	10459000000.0	-5.7%	USD	10-Q	2025-08-04
Quarterly	2025-09-30	10428000000.0	-0.3%	USD	10-Q	2025-10-30
Annual	2016-12-31	5826000000.0	—	USD	10-K	2018-02-23
Annual	2017-12-31	6501000000.0	+11.6%	USD	10-K	2019-02-21
Annual	2018-12-31	6789000000.0	+4.4%	USD	10-K	2020-02-20
Annual	2019-12-31	7380000000.0	+8.7%	USD	10-K	2021-02-19
Annual	2020-12-31	7051000000.0	-4.5%	USD	10-K	2022-02-18
Annual	2021-12-31	8095000000.0	+14.8%	USD	10-K	2023-02-17
Annual	2022-12-31	8891000000.0	+9.8%	USD	10-K	2024-02-16
Annual	2023-12-31	9958000000.0	+12.0%	USD	10-K	2025-02-14
Annual	2024-12-31	10751000000.0	+8.0%	USD	10-K	2026-02-10
Annual	2025-12-31	10867000000.0	+1.1%	USD	10-K	2026-02-10

Inventory

Q: 39 | A: 10

Quarterly

Annual

Show Data Rows

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	1415000000.0	—	USD	10-Q	2016-05-06
Quarterly	2016-06-30	1481000000.0	+4.7%	USD	10-Q	2016-08-04
Quarterly	2016-09-30	1503000000.0	+1.5%	USD	10-Q	2016-11-03
Quarterly	2016-12-31	1503000000.0	+0.0%	USD	10-Q	2017-11-07
Quarterly	2017-03-31	1501000000.0	-0.1%	USD	10-Q	2017-05-09
Quarterly	2017-06-30	1544000000.0	+2.9%	USD	10-Q	2017-08-04
Quarterly	2017-09-30	1546000000.0	+0.1%	USD	10-Q	2017-11-07
Quarterly	2017-12-31	1573000000.0	+1.7%	USD	10-Q	2018-11-06
Quarterly	2018-03-31	1677000000.0	+6.6%	USD	10-Q	2018-05-08
Quarterly	2018-06-30	1636000000.0	-2.4%	USD	10-Q	2018-08-03
Quarterly	2018-09-30	1634000000.0	-0.1%	USD	10-Q	2018-11-06
Quarterly	2018-12-31	1732000000.0	+6.0%	USD	10-Q	2019-11-01
Quarterly	2019-03-31	1778000000.0	+2.7%	USD	10-Q	2019-05-03
Quarterly	2019-06-30	1826000000.0	+2.7%	USD	10-Q	2019-08-02
Quarterly	2019-09-30	1769000000.0	-3.1%	USD	10-Q	2019-11-01
Quarterly	2019-12-31	1849000000.0	+4.5%	USD	10-Q	2020-10-29
Quarterly	2020-03-31	1953000000.0	+5.6%	USD	10-Q	2020-05-06
Quarterly	2020-06-30	1834000000.0	-6.1%	USD	10-Q	2020-07-30
Quarterly	2020-09-30	1950000000.0	+6.3%	USD	10-Q	2020-10-29
Quarterly	2020-12-31	2025000000.0	+3.8%	USD	10-Q	2021-11-01
Quarterly	2021-03-31	2068000000.0	+2.1%	USD	10-Q	2021-04-30
Quarterly	2021-06-30	2027000000.0	-2.0%	USD	10-Q	2021-08-02
Quarterly	2021-09-30	2019000000.0	-0.4%	USD	10-Q	2021-11-01
Quarterly	2021-12-31	1986000000.0	-1.6%	USD	10-Q	2022-11-01
Quarterly	2022-03-31	2003000000.0	+0.9%	USD	10-Q	2022-05-03
Quarterly	2022-06-30	2043000000.0	+2.0%	USD	10-Q	2022-08-01
Quarterly	2022-09-30	2009000000.0	-1.7%	USD	10-Q	2022-11-01
Quarterly	2022-12-31	2068000000.0	+2.9%	USD	10-Q	2023-10-26
Quarterly	2023-03-31	2085000000.0	+0.8%	USD	10-Q	2023-04-27
Quarterly	2023-06-30	2050000000.0	-1.7%	USD	10-Q	2023-08-02
Quarterly	2023-09-30	2030000000.0	-1.0%	USD	10-Q	2023-10-26
Quarterly	2023-12-31	2021000000.0	-0.4%	USD	10-Q	2024-10-31
Quarterly	2024-03-31	1903000000.0	-5.8%	USD	10-Q	2024-05-02
Quarterly	2024-06-30	1800000000.0	-5.4%	USD	10-Q	2024-07-29
Quarterly	2024-09-30	1776000000.0	-1.3%	USD	10-Q	2024-10-31
Quarterly	2024-12-31	1738000000.0	-2.1%	USD	10-Q	2025-10-30
Quarterly	2025-03-31	1794000000.0	+3.2%	USD	10-Q	2025-05-01
Quarterly	2025-06-30	1792000000.0	-0.1%	USD	10-Q	2025-08-04
Quarterly	2025-09-30	1734000000.0	-3.2%	USD	10-Q	2025-10-30
Annual	2016-12-31	1503000000.0	—	USD	10-K	2018-02-23
Annual	2017-12-31	1573000000.0	+4.7%	USD	10-K	2019-02-21
Annual	2018-12-31	1732000000.0	+10.1%	USD	10-K	2020-02-20
Annual	2019-12-31	1849000000.0	+6.8%	USD	10-K	2021-02-19
Annual	2020-12-31	2025000000.0	+9.5%	USD	10-K	2022-02-18
Annual	2021-12-31	1986000000.0	-1.9%	USD	10-K	2023-02-17
Annual	2022-12-31	2068000000.0	+4.1%	USD	10-K	2024-02-16
Annual	2023-12-31	2021000000.0	-2.3%	USD	10-K	2025-02-14
Annual	2024-12-31	1738000000.0	-14.0%	USD	10-K	2026-02-10
Annual	2025-12-31	1652000000.0	-4.9%	USD	10-K	2026-02-10

Current Assets

Q: 39 | A: 10

Quarterly

Annual

Show Data Rows

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	9201000000.0	—	USD	10-Q	2016-05-06
Quarterly	2016-06-30	9095000000.0	-1.2%	USD	10-Q	2016-08-04
Quarterly	2016-09-30	8843000000.0	-2.8%	USD	10-Q	2016-11-03
Quarterly	2016-12-31	9086000000.0	+2.7%	USD	10-Q	2017-11-07
Quarterly	2017-03-31	9037000000.0	-0.5%	USD	10-Q	2017-05-09
Quarterly	2017-06-30	9337000000.0	+3.3%	USD	10-Q	2017-08-04
Quarterly	2017-09-30	9448000000.0	+1.2%	USD	10-Q	2017-11-07
Quarterly	2017-12-31	9977000000.0	+5.6%	USD	10-Q	2018-11-06
Quarterly	2018-03-31	10391000000.0	+4.1%	USD	10-Q	2018-05-08
Quarterly	2018-06-30	10394000000.0	+0.0%	USD	10-Q	2018-08-03
Quarterly	2018-09-30	10010000000.0	-3.7%	USD	10-Q	2018-11-06
Quarterly	2018-12-31	10213000000.0	+2.0%	USD	10-Q	2019-11-01
Quarterly	2019-03-31	11108000000.0	+8.8%	USD	10-Q	2019-05-03
Quarterly	2019-06-30	12869000000.0	+15.9%	USD	10-Q	2019-08-02
Quarterly	2019-09-30	10769000000.0	-16.3%	USD	10-Q	2019-11-01
Quarterly	2019-12-31	11196000000.0	+4.0%	USD	10-Q	2020-10-29
Quarterly	2020-03-31	11016000000.0	-1.6%	USD	10-Q	2020-05-06
Quarterly	2020-06-30	14031000000.0	+27.4%	USD	10-Q	2020-07-30
Quarterly	2020-09-30	16266000000.0	+15.9%	USD	10-Q	2020-10-29
Quarterly	2020-12-31	12333000000.0	-24.2%	USD	10-Q	2021-11-01
Quarterly	2021-03-31	12036000000.0	-2.4%	USD	10-Q	2021-04-30
Quarterly	2021-06-30	12475000000.0	+3.6%	USD	10-Q	2021-08-02
Quarterly	2021-09-30	13248000000.0	+6.2%	USD	10-Q	2021-11-01
Quarterly	2021-12-31	13542000000.0	+2.2%	USD	10-Q	2022-11-01
Quarterly	2022-03-31	15006000000.0	+10.8%	USD	10-Q	2022-05-03
Quarterly	2022-06-30	13937000000.0	-7.1%	USD	10-Q	2022-08-01
Quarterly	2022-09-30	13481000000.0	-3.3%	USD	10-Q	2022-11-01
Quarterly	2022-12-31	13643000000.0	+1.2%	USD	10-Q	2023-10-26
Quarterly	2023-03-31	13541000000.0	-0.7%	USD	10-Q	2023-04-27
Quarterly	2023-06-30	13888000000.0	+2.6%	USD	10-Q	2023-08-02
Quarterly	2023-09-30	14294000000.0	+2.9%	USD	10-Q	2023-10-26
Quarterly	2023-12-31	14927000000.0	+4.4%	USD	10-Q	2024-10-31
Quarterly	2024-03-31	15282000000.0	+2.4%	USD	10-Q	2024-05-02
Quarterly	2024-06-30	15173000000.0	-0.7%	USD	10-Q	2024-07-29
Quarterly	2024-09-30	16662000000.0	+9.8%	USD	10-Q	2024-10-31
Quarterly	2024-12-31	16414000000.0	-1.5%	USD	10-Q	2025-10-30
Quarterly	2025-03-31	16258000000.0	-1.0%	USD	10-Q	2025-05-01
Quarterly	2025-06-30	15563000000.0	-4.3%	USD	10-Q	2025-08-04
Quarterly	2025-09-30	15285000000.0	-1.8%	USD	10-Q	2025-10-30
Annual	2016-12-31	9086000000.0	—	USD	10-K	2018-02-23
Annual	2017-12-31	9977000000.0	+9.8%	USD	10-K	2019-02-21
Annual	2018-12-31	10213000000.0	+2.4%	USD	10-K	2020-02-20
Annual	2019-12-31	11196000000.0	+9.6%	USD	10-K	2021-02-19
Annual	2020-12-31	12333000000.0	+10.2%	USD	10-K	2022-02-18
Annual	2021-12-31	13542000000.0	+9.8%	USD	10-K	2023-02-17
Annual	2022-12-31	13643000000.0	+0.7%	USD	10-K	2024-02-16
Annual	2023-12-31	14927000000.0	+9.4%	USD	10-K	2025-02-14
Annual	2024-12-31	16414000000.0	+10.0%	USD	10-K	2026-02-10
Annual	2025-12-31	15783000000.0	-3.8%	USD	10-K	2026-02-10

Total Assets

Q: 39 | A: 10

Quarterly

Annual

Show Data Rows

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	32776000000.0	—	USD	10-Q	2016-05-06
Quarterly	2016-06-30	33205000000.0	+1.3%	USD	10-Q	2016-08-04
Quarterly	2016-09-30	33127000000.0	-0.2%	USD	10-Q	2016-11-03
Quarterly	2016-12-31	33758000000.0	+1.9%	USD	10-Q	2017-11-07
Quarterly	2017-03-31	33795000000.0	+0.1%	USD	10-Q	2017-05-09
Quarterly	2017-06-30	34566000000.0	+2.3%	USD	10-Q	2017-08-04
Quarterly	2017-09-30	35731000000.0	+3.4%	USD	10-Q	2017-11-07
Quarterly	2017-12-31	36593000000.0	+2.4%	USD	10-Q	2018-11-06
Quarterly	2018-03-31	37299000000.0	+1.9%	USD	10-Q	2018-05-08
Quarterly	2018-06-30	37742000000.0	+1.2%	USD	10-Q	2018-08-03
Quarterly	2018-09-30	38044000000.0	+0.8%	USD	10-Q	2018-11-06
Quarterly	2018-12-31	39207000000.0	+3.1%	USD	10-Q	2019-11-01
Quarterly	2019-03-31	43379000000.0	+10.6%	USD	10-Q	2019-05-03
Quarterly	2019-06-30	45449000000.0	+4.8%	USD	10-Q	2019-08-02
Quarterly	2019-09-30	43912000000.0	-3.4%	USD	10-Q	2019-11-01
Quarterly	2019-12-31	45058000000.0	+2.6%	USD	10-Q	2020-10-29
Quarterly	2020-03-31	45421000000.0	+0.8%	USD	10-Q	2020-05-06
Quarterly	2020-06-30	48709000000.0	+7.2%	USD	10-Q	2020-07-30
Quarterly	2020-09-30	51016000000.0	+4.7%	USD	10-Q	2020-10-29
Quarterly	2020-12-31	47490000000.0	-6.9%	USD	10-Q	2021-11-01
Quarterly	2021-03-31	47277000000.0	-0.4%	USD	10-Q	2021-04-30
Quarterly	2021-06-30	48164000000.0	+1.9%	USD	10-Q	2021-08-02
Quarterly	2021-09-30	49562000000.0	+2.9%	USD	10-Q	2021-11-01
Quarterly	2021-12-31	50742000000.0	+2.4%	USD	10-Q	2022-11-01
Quarterly	2022-03-31	52208000000.0	+2.9%	USD	10-Q	2022-05-03
Quarterly	2022-06-30	51584000000.0	-1.2%	USD	10-Q	2022-08-01
Quarterly	2022-09-30	51484000000.0	-0.2%	USD	10-Q	2022-11-01
Quarterly	2022-12-31	52438000000.0	+1.9%	USD	10-Q	2023-10-26
Quarterly	2023-03-31	52711000000.0	+0.5%	USD	10-Q	2023-04-27
Quarterly	2023-06-30	53594000000.0	+1.7%	USD	10-Q	2023-08-02
Quarterly	2023-09-30	54589000000.0	+1.9%	USD	10-Q	2023-10-26
Quarterly	2023-12-31	56211000000.0	+3.0%	USD	10-Q	2024-10-31
Quarterly	2024-03-31	56962000000.0	+1.3%	USD	10-Q	2024-05-02
Quarterly	2024-06-30	57379000000.0	+0.7%	USD	10-Q	2024-07-29
Quarterly	2024-09-30	59459000000.0	+3.6%	USD	10-Q	2024-10-31
Quarterly	2024-12-31	59513000000.0	+0.1%	USD	10-Q	2025-10-30
Quarterly	2025-03-31	59798000000.0	+0.5%	USD	10-Q	2025-05-01
Quarterly	2025-06-30	59536000000.0	-0.4%	USD	10-Q	2025-08-04
Quarterly	2025-09-30	59747000000.0	+0.4%	USD	10-Q	2025-10-30
Annual	2016-12-31	33758000000.0	—	USD	10-K	2019-02-21
Annual	2017-12-31	36593000000.0	+8.4%	USD	10-K	2020-02-20
Annual	2018-12-31	39207000000.0	+7.1%	USD	10-K	2021-02-19
Annual	2019-12-31	45058000000.0	+14.9%	USD	10-K	2022-02-18
Annual	2020-12-31	47490000000.0	+5.4%	USD	10-K	2023-02-17
Annual	2021-12-31	50742000000.0	+6.8%	USD	10-K	2024-02-16
Annual	2022-12-31	52438000000.0	+3.3%	USD	10-K	2025-02-14
Annual	2023-12-31	56211000000.0	+7.2%	USD	10-K	2026-02-10
Annual	2024-12-31	59513000000.0	+5.9%	USD	10-K	2026-02-10
Annual	2025-12-31	60720000000.0	+2.0%	USD	10-K	2026-02-10

Current Liabilities

Q: 39 | A: 10

Quarterly

Annual

Show Data Rows

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	5398000000.0	—	USD	10-Q	2016-05-06
Quarterly	2016-06-30	5396000000.0	-0.0%	USD	10-Q	2016-08-04
Quarterly	2016-09-30	5155000000.0	-4.5%	USD	10-Q	2016-11-03
Quarterly	2016-12-31	5834000000.0	+13.2%	USD	10-Q	2017-11-07
Quarterly	2017-03-31	5463000000.0	-6.4%	USD	10-Q	2017-05-09
Quarterly	2017-06-30	5771000000.0	+5.6%	USD	10-Q	2017-08-04
Quarterly	2017-09-30	5611000000.0	-2.8%	USD	10-Q	2017-11-07
Quarterly	2017-12-31	6158000000.0	+9.7%	USD	10-Q	2018-11-06
Quarterly	2018-03-31	7478000000.0	+21.4%	USD	10-Q	2018-05-08
Quarterly	2018-06-30	7625000000.0	+2.0%	USD	10-Q	2018-08-03
Quarterly	2018-09-30	6231000000.0	-18.3%	USD	10-Q	2018-11-06
Quarterly	2018-12-31	7569000000.0	+21.5%	USD	10-Q	2019-11-01
Quarterly	2019-03-31	10531000000.0	+39.1%	USD	10-Q	2019-05-03
Quarterly	2019-06-30	8961000000.0	-14.9%	USD	10-Q	2019-08-02
Quarterly	2019-09-30	7124000000.0	-20.5%	USD	10-Q	2019-11-01
Quarterly	2019-12-31	7757000000.0	+8.9%	USD	10-Q	2020-10-29
Quarterly	2020-03-31	7019000000.0	-9.5%	USD	10-Q	2020-05-06
Quarterly	2020-06-30	12856000000.0	+83.2%	USD	10-Q	2020-07-30
Quarterly	2020-09-30	14379000000.0	+11.8%	USD	10-Q	2020-10-29
Quarterly	2020-12-31	8704000000.0	-39.5%	USD	10-Q	2021-11-01
Quarterly	2021-03-31	8642000000.0	-0.7%	USD	10-Q	2021-04-30
Quarterly	2021-06-30	8615000000.0	-0.3%	USD	10-Q	2021-08-02
Quarterly	2021-09-30	9624000000.0	+11.7%	USD	10-Q	2021-11-01
Quarterly	2021-12-31	9582000000.0	-0.4%	USD	10-Q	2022-11-01
Quarterly	2022-03-31	10518000000.0	+9.8%	USD	10-Q	2022-05-03
Quarterly	2022-06-30	8999000000.0	-14.4%	USD	10-Q	2022-08-01
Quarterly	2022-09-30	9784000000.0	+8.7%	USD	10-Q	2022-11-01
Quarterly	2022-12-31	9902000000.0	+1.2%	USD	10-Q	2023-10-26
Quarterly	2023-03-31	11028000000.0	+11.4%	USD	10-Q	2023-04-27
Quarterly	2023-06-30	11545000000.0	+4.7%	USD	10-Q	2023-08-02
Quarterly	2023-09-30	12407000000.0	+7.5%	USD	10-Q	2023-10-26
Quarterly	2023-12-31	12655000000.0	+2.0%	USD	10-Q	2024-10-31
Quarterly	2024-03-31	13141000000.0	+3.8%	USD	10-Q	2024-05-02
Quarterly	2024-06-30	14301000000.0	+8.8%	USD	10-Q	2024-07-29
Quarterly	2024-09-30	14900000000.0	+4.2%	USD	10-Q	2024-10-31
Quarterly	2024-12-31	15177000000.0	+1.9%	USD	10-Q	2025-10-30
Quarterly	2025-03-31	13631000000.0	-10.2%	USD	10-Q	2025-05-01
Quarterly	2025-06-30	15939000000.0	+16.9%	USD	10-Q	2025-08-04
Quarterly	2025-09-30	17896000000.0	+12.3%	USD	10-Q	2025-10-30
Annual	2016-12-31	5834000000.0	—	USD	10-K	2018-02-23
Annual	2017-12-31	6158000000.0	+5.6%	USD	10-K	2019-02-21
Annual	2018-12-31	7569000000.0	+22.9%	USD	10-K	2020-02-20
Annual	2019-12-31	7757000000.0	+2.5%	USD	10-K	2021-02-19
Annual	2020-12-31	8704000000.0	+12.2%	USD	10-K	2022-02-18
Annual	2021-12-31	9582000000.0	+10.1%	USD	10-K	2023-02-17
Annual	2022-12-31	9902000000.0	+3.3%	USD	10-K	2024-02-16
Annual	2023-12-31	12655000000.0	+27.8%	USD	10-K	2025-02-14
Annual	2024-12-31	15177000000.0	+19.9%	USD	10-K	2026-02-10
Annual	2025-12-31	16350000000.0	+7.7%	USD	10-K	2026-02-10

Total Liabilities

Q: 15 | A: 4

Quarterly

Annual

Show Data Rows

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	38775000000.0	—	USD	10-Q	2016-05-06
Quarterly	2016-06-30	39703000000.0	+2.4%	USD	10-Q	2016-08-04
Quarterly	2016-09-30	39290000000.0	-1.0%	USD	10-Q	2016-11-03
Quarterly	2016-12-31	39391000000.0	+0.3%	USD	10-Q	2017-11-07
Quarterly	2017-03-31	39152000000.0	-0.6%	USD	10-Q	2017-05-09
Quarterly	2017-06-30	39645000000.0	+1.3%	USD	10-Q	2017-08-04
Quarterly	2017-09-30	40797000000.0	+2.9%	USD	10-Q	2017-11-07
Quarterly	2017-12-31	41588000000.0	+1.9%	USD	10-Q	2018-11-06
Quarterly	2018-03-31	41733000000.0	+0.3%	USD	10-Q	2018-05-08
Quarterly	2018-06-30	41867000000.0	+0.3%	USD	10-Q	2018-08-03
Quarterly	2018-09-30	41774000000.0	-0.2%	USD	10-Q	2018-11-06
Quarterly	2018-12-31	42125000000.0	+0.8%	USD	10-Q	2019-11-01
Quarterly	2019-03-31	45634000000.0	+8.3%	USD	10-Q	2019-05-03
Quarterly	2019-06-30	47219000000.0	+3.5%	USD	10-Q	2019-08-02
Quarterly	2019-09-30	45359000000.0	-3.9%	USD	10-Q	2019-11-01
Annual	2016-12-31	39391000000.0	—	USD	10-K	2018-02-23
Annual	2017-12-31	41588000000.0	+5.6%	USD	10-K	2019-02-21
Annual	2018-12-31	42125000000.0	+1.3%	USD	10-K	2020-02-20
Annual	2019-12-31	45623000000.0	+8.3%	USD	10-K	2020-02-20

Stockholders' Equity

Q: 39 | A: 10

Quarterly

Annual

Show Data Rows

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	-5999000000.0	—	USD	10-Q	2016-05-06
Quarterly	2016-06-30	-6498000000.0	-8.3%	USD	10-Q	2016-08-04
Quarterly	2016-09-30	-6163000000.0	+5.2%	USD	10-Q	2016-11-03
Quarterly	2016-12-31	-5633000000.0	+8.6%	USD	10-Q	2018-11-06
Quarterly	2017-03-31	-5357000000.0	+4.9%	USD	10-Q	2018-11-06
Quarterly	2017-06-30	-5079000000.0	+5.2%	USD	10-Q	2018-11-06
Quarterly	2017-09-30	-5066000000.0	+0.3%	USD	10-Q	2018-11-06
Quarterly	2017-12-31	-4995000000.0	+1.4%	USD	10-Q	2019-11-01
Quarterly	2018-03-31	-4434000000.0	+11.2%	USD	10-Q	2019-11-01
Quarterly	2018-06-30	-4125000000.0	+7.0%	USD	10-Q	2019-11-01
Quarterly	2018-09-30	-3730000000.0	+9.6%	USD	10-Q	2019-11-01
Quarterly	2018-12-31	-2918000000.0	+21.8%	USD	10-Q	2020-10-29
Quarterly	2019-03-31	-2255000000.0	+22.7%	USD	10-Q	2020-10-29
Quarterly	2019-06-30	-1770000000.0	+21.5%	USD	10-Q	2020-10-29
Quarterly	2019-09-30	-1447000000.0	+18.2%	USD	10-Q	2020-10-29
Quarterly	2019-12-31	-565000000.0	+61.0%	USD	10-Q	2021-11-01
Quarterly	2020-03-31	-703000000.0	-24.4%	USD	10-Q	2021-11-01
Quarterly	2020-06-30	568000000.0	+180.8%	USD	10-Q	2021-11-01
Quarterly	2020-09-30	1299000000.0	+128.7%	USD	10-Q	2021-11-01
Quarterly	2020-12-31	2892000000.0	+122.6%	USD	10-Q	2022-11-01
Quarterly	2021-03-31	2482000000.0	-14.2%	USD	10-Q	2022-11-01
Quarterly	2021-06-30	1790000000.0	-27.9%	USD	10-Q	2022-11-01
Quarterly	2021-09-30	1825000000.0	+2.0%	USD	10-Q	2022-11-01
Quarterly	2021-12-31	1489000000.0	-18.4%	USD	10-Q	2023-10-26
Quarterly	2022-03-31	414000000.0	-72.2%	USD	10-Q	2023-10-26
Quarterly	2022-06-30	-1142000000.0	-375.8%	USD	10-Q	2023-10-26
Quarterly	2022-09-30	-778000000.0	+31.9%	USD	10-Q	2023-10-26
Quarterly	2022-12-31	-73000000.0	+90.6%	USD	10-Q	2024-10-31
Quarterly	2023-03-31	232000000.0	+417.8%	USD	10-Q	2024-10-31
Quarterly	2023-06-30	461000000.0	+98.7%	USD	10-Q	2024-10-31
Quarterly	2023-09-30	357000000.0	-22.6%	USD	10-Q	2024-10-31
Quarterly	2023-12-31	1060000000.0	+196.9%	USD	10-Q	2025-10-30
Quarterly	2024-03-31	1270000000.0	+19.8%	USD	10-Q	2025-10-30
Quarterly	2024-06-30	1339000000.0	+5.4%	USD	10-Q	2025-10-30
Quarterly	2024-09-30	786000000.0	-41.3%	USD	10-Q	2025-10-30
Quarterly	2024-12-31	555000000.0	-29.4%	USD	10-Q	2025-10-30
Quarterly	2025-03-31	-438000000.0	-178.9%	USD	10-Q	2025-10-30
Quarterly	2025-06-30	-1238000000.0	-182.6%	USD	10-Q	2025-10-30
Quarterly	2025-09-30	-2159000000.0	-74.4%	USD	10-Q	2025-10-30
Annual	2016-12-31	-5633000000.0	—	USD	10-K	2020-02-20
Annual	2017-12-31	-4995000000.0	+11.3%	USD	10-K	2021-02-19
Annual	2018-12-31	-2918000000.0	+41.6%	USD	10-K	2022-02-18
Annual	2019-12-31	-565000000.0	+80.6%	USD	10-K	2023-02-17
Annual	2020-12-31	2892000000.0	+611.9%	USD	10-K	2024-02-16
Annual	2021-12-31	1489000000.0	-48.5%	USD	10-K	2025-02-14
Annual	2022-12-31	-73000000.0	-104.9%	USD	10-K	2026-02-10
Annual	2023-12-31	1060000000.0	+1552.1%	USD	10-K	2026-02-10
Annual	2024-12-31	555000000.0	-47.6%	USD	10-K	2026-02-10
Annual	2025-12-31	-2771000000.0	-599.3%	USD	10-K	2026-02-10

Long-Term Debt

Q: 39 | A: 10

Quarterly

Annual

Show Data Rows

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	30554000000.0	—	USD	10-Q	2016-05-06
Quarterly	2016-06-30	31452000000.0	+2.9%	USD	10-Q	2016-08-04
Quarterly	2016-09-30	31441000000.0	-0.0%	USD	10-Q	2016-11-03
Quarterly	2016-12-31	31376000000.0	-0.2%	USD	10-Q	2017-11-07
Quarterly	2017-03-31	31514000000.0	+0.4%	USD	10-Q	2017-05-09
Quarterly	2017-06-30	31661000000.0	+0.5%	USD	10-Q	2017-08-04
Quarterly	2017-09-30	32953000000.0	+4.1%	USD	10-Q	2017-11-07
Quarterly	2017-12-31	33058000000.0	+0.3%	USD	10-Q	2018-11-06
Quarterly	2018-03-31	33291000000.0	+0.7%	USD	10-Q	2018-05-08
Quarterly	2018-06-30	33192000000.0	-0.3%	USD	10-Q	2018-08-03
Quarterly	2018-09-30	33107000000.0	-0.3%	USD	10-Q	2018-11-06
Quarterly	2018-12-31	32821000000.0	-0.9%	USD	10-Q	2019-11-01
Quarterly	2019-03-31	34815000000.0	+6.1%	USD	10-Q	2019-05-03
Quarterly	2019-06-30	36193000000.0	+4.0%	USD	10-Q	2019-08-02
Quarterly	2019-09-30	34245000000.0	-5.4%	USD	10-Q	2019-11-01
Quarterly	2019-12-31	33722000000.0	-1.5%	USD	10-Q	2020-10-29
Quarterly	2020-03-31	34861000000.0	+3.4%	USD	10-Q	2020-05-06
Quarterly	2020-06-30	30942000000.0	-11.2%	USD	10-Q	2020-07-30
Quarterly	2020-09-30	30964000000.0	+0.1%	USD	10-Q	2020-10-29
Quarterly	2020-12-31	31004000000.0	+0.1%	USD	10-Q	2021-11-01
Quarterly	2021-03-31	31072000000.0	+0.2%	USD	10-Q	2021-04-30
Quarterly	2021-06-30	32572000000.0	+4.8%	USD	10-Q	2021-08-02
Quarterly	2021-09-30	32299000000.0	-0.8%	USD	10-Q	2021-11-01
Quarterly	2021-12-31	34579000000.0	+7.1%	USD	10-Q	2022-11-01
Quarterly	2022-03-31	37696000000.0	+9.0%	USD	10-Q	2022-05-03
Quarterly	2022-06-30	38903000000.0	+3.2%	USD	10-Q	2022-08-01
Quarterly	2022-09-30	37710000000.0	-3.1%	USD	10-Q	2022-11-01
Quarterly	2022-12-31	38084000000.0	+1.0%	USD	10-Q	2023-10-26
Quarterly	2023-03-31	38856000000.0	+2.0%	USD	10-Q	2023-04-27
Quarterly	2023-06-30	38932000000.0	+0.2%	USD	10-Q	2023-08-02
Quarterly	2023-09-30	39346000000.0	+1.1%	USD	10-Q	2023-10-26
Quarterly	2023-12-31	39593000000.0	+0.6%	USD	10-Q	2024-10-31
Quarterly	2024-03-31	40191000000.0	+1.5%	USD	10-Q	2024-05-02
Quarterly	2024-06-30	40880000000.0	+1.7%	USD	10-Q	2024-07-29
Quarterly	2024-09-30	42965000000.0	+5.1%	USD	10-Q	2024-10-31
Quarterly	2024-12-31	43031000000.0	+0.2%	USD	10-Q	2025-10-30
Quarterly	2025-03-31	44576000000.0	+3.6%	USD	10-Q	2025-05-01
Quarterly	2025-06-30	42705000000.0	-4.2%	USD	10-Q	2025-08-04
Quarterly	2025-09-30	42601000000.0	-0.2%	USD	10-Q	2025-10-30
Annual	2016-12-31	31376000000.0	—	USD	10-K	2018-02-23
Annual	2017-12-31	33058000000.0	+5.4%	USD	10-K	2019-02-21
Annual	2018-12-31	32821000000.0	-0.7%	USD	10-K	2020-02-20
Annual	2019-12-31	33722000000.0	+2.7%	USD	10-K	2021-02-19
Annual	2020-12-31	31004000000.0	-8.1%	USD	10-K	2022-02-18
Annual	2021-12-31	34579000000.0	+11.5%	USD	10-K	2023-02-17
Annual	2022-12-31	38084000000.0	+10.1%	USD	10-K	2024-02-16
Annual	2023-12-31	39593000000.0	+4.0%	USD	10-K	2025-02-14
Annual	2024-12-31	43031000000.0	+8.7%	USD	10-K	2026-02-10
Annual	2025-12-31	44285000000.0	+2.9%	USD	10-K	2026-02-10

Cash Flow

Metrics: 4

Operating Cash Flow

Q: 26 | A: 10

Quarterly

Annual

Show Data Rows

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2017-06-30	2684000000.0	—	USD	10-Q	2018-08-03
Quarterly	2017-09-30	3692000000.0	+37.6%	USD	10-Q	2018-11-06
Quarterly	2018-03-31	1283000000.0	-65.2%	USD	10-Q	2019-05-03
Quarterly	2018-06-30	2865000000.0	+123.3%	USD	10-Q	2019-08-02
Quarterly	2018-09-30	4586000000.0	+60.1%	USD	10-Q	2019-11-01
Quarterly	2019-03-31	974000000.0	-78.8%	USD	10-Q	2020-05-06
Quarterly	2019-06-30	2971000000.0	+205.0%	USD	10-Q	2020-07-30
Quarterly	2019-09-30	5097000000.0	+71.6%	USD	10-Q	2020-10-29
Quarterly	2020-03-31	1375000000.0	-73.0%	USD	10-Q	2021-04-30
Quarterly	2020-06-30	10098000000.0	+634.4%	USD	10-Q	2021-08-02
Quarterly	2020-09-30	12815000000.0	+26.9%	USD	10-Q	2021-11-01
Quarterly	2021-03-31	1988000000.0	-84.5%	USD	10-Q	2022-05-03
Quarterly	2021-06-30	4239000000.0	+113.2%	USD	10-Q	2022-08-01
Quarterly	2021-09-30	6516000000.0	+53.7%	USD	10-Q	2022-11-01
Quarterly	2022-03-31	1345000000.0	-79.4%	USD	10-Q	2023-04-27
Quarterly	2022-06-30	2975000000.0	+121.2%	USD	10-Q	2023-08-02
Quarterly	2022-09-30	5995000000.0	+101.5%	USD	10-Q	2023-10-26
Quarterly	2023-03-31	1803000000.0	-69.9%	USD	10-Q	2024-05-02
Quarterly	2023-06-30	4278000000.0	+137.3%	USD	10-Q	2024-07-29
Quarterly	2023-09-30	6757000000.0	+57.9%	USD	10-Q	2024-10-31
Quarterly	2024-03-31	2469000000.0	-63.5%	USD	10-Q	2025-05-01
Quarterly	2024-06-30	4440000000.0	+79.8%	USD	10-Q	2025-08-04
Quarterly	2024-09-30	7955000000.0	+79.2%	USD	10-Q	2025-10-30
Quarterly	2025-03-31	1651000000.0	-79.2%	USD	10-Q	2025-05-01
Quarterly	2025-06-30	5861000000.0	+255.0%	USD	10-Q	2025-08-04
Quarterly	2025-09-30	10277000000.0	+75.3%	USD	10-Q	2025-10-30
Annual	2016-12-31	5653000000.0	—	USD	10-K	2019-02-21
Annual	2017-12-31	5426000000.0	-4.0%	USD	10-K	2020-02-20
Annual	2018-12-31	6761000000.0	+24.6%	USD	10-K	2021-02-19
Annual	2019-12-31	7602000000.0	+12.4%	USD	10-K	2022-02-18
Annual	2020-12-31	9232000000.0	+21.4%	USD	10-K	2023-02-17
Annual	2021-12-31	8959000000.0	-3.0%	USD	10-K	2024-02-16
Annual	2022-12-31	8522000000.0	-4.9%	USD	10-K	2025-02-14
Annual	2023-12-31	9431000000.0	+10.7%	USD	10-K	2026-02-10
Annual	2024-12-31	10514000000.0	+11.5%	USD	10-K	2026-02-10
Annual	2025-12-31	12636000000.0	+20.2%	USD	10-K	2026-02-10

Investing Cash Flow

Q: 26 | A: 10

Quarterly

Annual

Show Data Rows

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2017-06-30	-1591000000.0	—	USD	10-Q	2018-08-03
Quarterly	2017-09-30	-3172000000.0	-99.4%	USD	10-Q	2018-11-06
Quarterly	2018-03-31	-335000000.0	+89.4%	USD	10-Q	2019-05-03
Quarterly	2018-06-30	-1315000000.0	-292.5%	USD	10-Q	2019-08-02
Quarterly	2018-09-30	-2615000000.0	-98.9%	USD	10-Q	2019-11-01
Quarterly	2019-03-31	-2165000000.0	+17.2%	USD	10-Q	2020-05-06
Quarterly	2019-06-30	-3113000000.0	-43.8%	USD	10-Q	2020-07-30
Quarterly	2019-09-30	-4375000000.0	-40.5%	USD	10-Q	2020-10-29
Quarterly	2020-03-31	-1145000000.0	+73.8%	USD	10-Q	2021-04-30
Quarterly	2020-06-30	-1953000000.0	-70.6%	USD	10-Q	2021-08-02
Quarterly	2020-09-30	-2483000000.0	-27.1%	USD	10-Q	2021-11-01
Quarterly	2021-03-31	-649000000.0	+73.9%	USD	10-Q	2022-05-03
Quarterly	2021-06-30	-1569000000.0	-141.8%	USD	10-Q	2022-08-01
Quarterly	2021-09-30	-929000000.0	+40.8%	USD	10-Q	2022-11-01
Quarterly	2022-03-31	-845000000.0	+9.0%	USD	10-Q	2023-04-27
Quarterly	2022-06-30	-2050000000.0	-142.6%	USD	10-Q	2023-08-02
Quarterly	2022-09-30	-2596000000.0	-26.6%	USD	10-Q	2023-10-26
Quarterly	2023-03-31	-1151000000.0	+55.7%	USD	10-Q	2024-05-02
Quarterly	2023-06-30	-2408000000.0	-109.2%	USD	10-Q	2024-07-29
Quarterly	2023-09-30	-3720000000.0	-54.5%	USD	10-Q	2024-10-31
Quarterly	2024-03-31	-903000000.0	+75.7%	USD	10-Q	2025-05-01
Quarterly	2024-06-30	-2235000000.0	-147.5%	USD	10-Q	2025-08-04
Quarterly	2024-09-30	-3587000000.0	-60.5%	USD	10-Q	2025-10-30
Quarterly	2025-03-31	-1032000000.0	+71.2%	USD	10-Q	2025-05-01
Quarterly	2025-06-30	-2283000000.0	-121.2%	USD	10-Q	2025-08-04
Quarterly	2025-09-30	-3671000000.0	-60.8%	USD	10-Q	2025-10-30
Annual	2016-12-31	-3240000000.0	—	USD	10-K	2019-02-21
Annual	2017-12-31	-4279000000.0	-32.1%	USD	10-K	2020-02-20
Annual	2018-12-31	-3901000000.0	+8.8%	USD	10-K	2021-02-19
Annual	2019-12-31	-5720000000.0	-46.6%	USD	10-K	2022-02-18
Annual	2020-12-31	-3393000000.0	+40.7%	USD	10-K	2023-02-17
Annual	2021-12-31	-2643000000.0	+22.1%	USD	10-K	2024-02-16
Annual	2022-12-31	-3389000000.0	-28.2%	USD	10-K	2025-02-14
Annual	2023-12-31	-5317000000.0	-56.9%	USD	10-K	2026-02-10
Annual	2024-12-31	-4933000000.0	+7.2%	USD	10-K	2026-02-10
Annual	2025-12-31	-4988000000.0	-1.1%	USD	10-K	2026-02-10

Financing Cash Flow

Q: 26 | A: 10

Quarterly

Annual

Show Data Rows

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2017-06-30	-1034000000.0	—	USD	10-Q	2018-08-03
Quarterly	2017-09-30	-448000000.0	+56.7%	USD	10-Q	2018-11-06
Quarterly	2018-03-31	-611000000.0	-36.4%	USD	10-Q	2019-05-03
Quarterly	2018-06-30	-1408000000.0	-130.4%	USD	10-Q	2019-08-02
Quarterly	2018-09-30	-2114000000.0	-50.1%	USD	10-Q	2019-11-01
Quarterly	2019-03-31	1216000000.0	+157.5%	USD	10-Q	2020-05-06
Quarterly	2019-06-30	2070000000.0	+70.2%	USD	10-Q	2020-07-30
Quarterly	2019-09-30	-661000000.0	-131.9%	USD	10-Q	2020-10-29
Quarterly	2020-03-31	-109000000.0	+83.5%	USD	10-Q	2021-04-30
Quarterly	2020-06-30	-4116000000.0	-3676.1%	USD	10-Q	2021-08-02
Quarterly	2020-09-30	-4361000000.0	-6.0%	USD	10-Q	2021-11-01
Quarterly	2021-03-31	-2104000000.0	+51.8%	USD	10-Q	2022-05-03
Quarterly	2021-06-30	-3346000000.0	-59.0%	USD	10-Q	2022-08-01
Quarterly	2021-09-30	-6349000000.0	-89.7%	USD	10-Q	2022-11-01
Quarterly	2022-03-31	425000000.0	+106.7%	USD	10-Q	2023-04-27
Quarterly	2022-06-30	-1501000000.0	-453.2%	USD	10-Q	2023-08-02
Quarterly	2022-09-30	-3818000000.0	-154.4%	USD	10-Q	2023-10-26
Quarterly	2023-03-31	-725000000.0	+81.0%	USD	10-Q	2024-05-02
Quarterly	2023-06-30	-1923000000.0	-165.2%	USD	10-Q	2024-07-29
Quarterly	2023-09-30	-3055000000.0	-58.9%	USD	10-Q	2024-10-31
Quarterly	2024-03-31	-1216000000.0	+60.2%	USD	10-Q	2025-05-01
Quarterly	2024-06-30	-2309000000.0	-89.9%	USD	10-Q	2025-08-04
Quarterly	2024-09-30	-2419000000.0	-4.8%	USD	10-Q	2025-10-30
Quarterly	2025-03-31	-1495000000.0	+38.2%	USD	10-Q	2025-05-01
Quarterly	2025-06-30	-4584000000.0	-206.6%	USD	10-Q	2025-08-04
Quarterly	2025-09-30	-7551000000.0	-64.7%	USD	10-Q	2025-10-30
Annual	2016-12-31	-2508000000.0	—	USD	10-K	2019-02-21
Annual	2017-12-31	-1061000000.0	+57.7%	USD	10-K	2020-02-20
Annual	2018-12-31	-3075000000.0	-189.8%	USD	10-K	2021-02-19
Annual	2019-12-31	-1771000000.0	+42.4%	USD	10-K	2022-02-18
Annual	2020-12-31	-4677000000.0	-164.1%	USD	10-K	2023-02-17
Annual	2021-12-31	-6655000000.0	-42.3%	USD	10-K	2024-02-16
Annual	2022-12-31	-5656000000.0	+15.0%	USD	10-K	2025-02-14
Annual	2023-12-31	-4094000000.0	+27.6%	USD	10-K	2026-02-10
Annual	2024-12-31	-4582000000.0	-11.9%	USD	10-K	2026-02-10
Annual	2025-12-31	-8550000000.0	-86.6%	USD	10-K	2026-02-10

Capital Expenditures

Q: 30 | A: 10

Quarterly

Annual

Show Data Rows

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	509000000.0	—	USD	10-Q	2017-05-09
Quarterly	2016-06-30	1172000000.0	+130.3%	USD	10-Q	2017-08-04
Quarterly	2016-09-30	1884000000.0	+60.8%	USD	10-Q	2017-11-07
Quarterly	2017-03-31	571000000.0	-69.7%	USD	10-Q	2018-05-08
Quarterly	2017-06-30	1304000000.0	+128.4%	USD	10-Q	2018-08-03
Quarterly	2017-09-30	2033000000.0	+55.9%	USD	10-Q	2018-11-06
Quarterly	2018-03-31	694000000.0	-65.9%	USD	10-Q	2019-05-03
Quarterly	2018-06-30	1574000000.0	+126.8%	USD	10-Q	2019-08-02
Quarterly	2018-09-30	2420000000.0	+53.7%	USD	10-Q	2019-11-01
Quarterly	2019-03-31	781000000.0	-67.7%	USD	10-Q	2020-05-06
Quarterly	2019-06-30	1745000000.0	+123.4%	USD	10-Q	2020-07-30
Quarterly	2019-09-30	2884000000.0	+65.3%	USD	10-Q	2020-10-29
Quarterly	2020-03-31	853000000.0	-70.4%	USD	10-Q	2021-04-30
Quarterly	2020-06-30	1598000000.0	+87.3%	USD	10-Q	2021-08-02
Quarterly	2020-09-30	2087000000.0	+30.6%	USD	10-Q	2021-11-01
Quarterly	2021-03-31	654000000.0	-68.7%	USD	10-Q	2022-05-03
Quarterly	2021-06-30	1496000000.0	+128.7%	USD	10-Q	2022-08-01
Quarterly	2021-09-30	2385000000.0	+59.4%	USD	10-Q	2022-11-01
Quarterly	2022-03-31	861000000.0	-63.9%	USD	10-Q	2023-04-27
Quarterly	2022-06-30	1941000000.0	+125.4%	USD	10-Q	2023-08-02
Quarterly	2022-09-30	3072000000.0	+58.3%	USD	10-Q	2023-10-26
Quarterly	2023-03-31	1197000000.0	-61.0%	USD	10-Q	2024-05-02
Quarterly	2023-06-30	2438000000.0	+103.7%	USD	10-Q	2024-07-29
Quarterly	2023-09-30	3585000000.0	+47.0%	USD	10-Q	2024-10-31
Quarterly	2024-03-31	1118000000.0	-68.8%	USD	10-Q	2025-05-01
Quarterly	2024-06-30	2399000000.0	+114.6%	USD	10-Q	2025-08-04
Quarterly	2024-09-30	3590000000.0	+49.6%	USD	10-Q	2025-10-30
Quarterly	2025-03-31	991000000.0	-72.4%	USD	10-Q	2025-05-01
Quarterly	2025-06-30	2167000000.0	+118.7%	USD	10-Q	2025-08-04
Quarterly	2025-09-30	3455000000.0	+59.4%	USD	10-Q	2025-10-30
Annual	2016-12-31	2760000000.0	—	USD	10-K	2019-02-21
Annual	2017-12-31	3015000000.0	+9.2%	USD	10-K	2020-02-20
Annual	2018-12-31	3573000000.0	+18.5%	USD	10-K	2021-02-19
Annual	2019-12-31	4158000000.0	+16.4%	USD	10-K	2022-02-18
Annual	2020-12-31	2835000000.0	-31.8%	USD	10-K	2023-02-17
Annual	2021-12-31	3577000000.0	+26.2%	USD	10-K	2024-02-16
Annual	2022-12-31	4395000000.0	+22.9%	USD	10-K	2025-02-14
Annual	2023-12-31	4744000000.0	+7.9%	USD	10-K	2026-02-10
Annual	2024-12-31	4875000000.0	+2.8%	USD	10-K	2026-02-10
Annual	2025-12-31	4944000000.0	+1.4%	USD	10-K	2026-02-10

Share Data

Metrics: 4

Shares Outstanding

Q: 39 | A: 10

Quarterly

Annual

Show Data Rows

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	393650000.0	—	shares	10-Q	2016-05-06
Quarterly	2016-06-30	380061600.0	-3.5%	shares	10-Q	2016-08-04
Quarterly	2016-09-30	376140800.0	-1.0%	shares	10-Q	2016-11-03
Quarterly	2016-12-31	370535900.0	-1.5%	shares	10-Q	2017-11-07
Quarterly	2017-03-31	368694700.0	-0.5%	shares	10-Q	2017-05-09
Quarterly	2017-06-30	362895000.0	-1.6%	shares	10-Q	2017-08-04
Quarterly	2017-09-30	356979800.0	-1.6%	shares	10-Q	2017-11-07
Quarterly	2017-12-31	350091600.0	-1.9%	shares	10-Q	2018-11-06
Quarterly	2018-03-31	350987500.0	+0.3%	shares	10-Q	2018-05-08
Quarterly	2018-06-30	346760200.0	-1.2%	shares	10-Q	2018-08-03
Quarterly	2018-09-30	345085800.0	-0.5%	shares	10-Q	2018-11-06
Quarterly	2018-12-31	342895200.0	-0.6%	shares	10-Q	2019-11-01
Quarterly	2019-03-31	343030500.0	+0.0%	shares	10-Q	2019-05-03
Quarterly	2019-06-30	341516800.0	-0.4%	shares	10-Q	2019-08-02
Quarterly	2019-09-30	340053100.0	-0.4%	shares	10-Q	2019-11-01
Quarterly	2019-12-31	338445600.0	-0.5%	shares	10-Q	2020-10-29
Quarterly	2020-03-31	337607500.0	-0.2%	shares	10-Q	2020-05-06
Quarterly	2020-06-30	337960400.0	+0.1%	shares	10-Q	2020-07-30
Quarterly	2020-09-30	338370500.0	+0.1%	shares	10-Q	2020-10-29
Quarterly	2020-12-31	339425600.0	+0.3%	shares	10-Q	2021-11-01
Quarterly	2021-03-31	333714500.0	-1.7%	shares	10-Q	2021-04-30
Quarterly	2021-06-30	322824800.0	-3.3%	shares	10-Q	2021-08-02
Quarterly	2021-09-30	313502400.0	-2.9%	shares	10-Q	2021-11-01
Quarterly	2021-12-31	305476800.0	-2.6%	shares	10-Q	2022-11-01
Quarterly	2022-03-31	298980900.0	-2.1%	shares	10-Q	2022-05-03
Quarterly	2022-06-30	287004400.0	-4.0%	shares	10-Q	2022-08-01
Quarterly	2022-09-30	283903500.0	-1.1%	shares	10-Q	2022-11-01
Quarterly	2022-12-31	277378300.0	-2.3%	shares	10-Q	2023-10-26
Quarterly	2023-03-31	275939900.0	-0.5%	shares	10-Q	2023-04-27
Quarterly	2023-06-30	272931700.0	-1.1%	shares	10-Q	2023-08-02
Quarterly	2023-09-30	268967300.0	-1.5%	shares	10-Q	2023-10-26
Quarterly	2023-12-31	265537300.0	-1.3%	shares	10-Q	2024-10-31
Quarterly	2024-03-31	263215800.0	-0.9%	shares	10-Q	2024-05-02
Quarterly	2024-06-30	259237600.0	-1.5%	shares	10-Q	2024-07-29
Quarterly	2024-09-30	254517700.0	-1.8%	shares	10-Q	2024-10-31
Quarterly	2024-12-31	249981400.0	-1.8%	shares	10-Q	2025-10-30
Quarterly	2025-03-31	242955400.0	-2.8%	shares	10-Q	2025-05-01
Quarterly	2025-06-30	236143900.0	-2.8%	shares	10-Q	2025-08-04
Quarterly	2025-09-30	229845100.0	-2.7%	shares	10-Q	2025-10-30
Annual	2016-12-31	370535900.0	—	shares	10-K	2018-02-23
Annual	2017-12-31	350091600.0	-5.5%	shares	10-K	2019-02-21
Annual	2018-12-31	342895200.0	-2.1%	shares	10-K	2020-02-20
Annual	2019-12-31	338445600.0	-1.3%	shares	10-K	2021-02-19
Annual	2020-12-31	339425600.0	+0.3%	shares	10-K	2022-02-18
Annual	2021-12-31	305476800.0	-10.0%	shares	10-K	2023-02-17
Annual	2022-12-31	277378300.0	-9.2%	shares	10-K	2024-02-16
Annual	2023-12-31	265537300.0	-4.3%	shares	10-K	2025-02-14
Annual	2024-12-31	249981400.0	-5.9%	shares	10-K	2026-02-10
Annual	2025-12-31	224605100.0	-10.2%	shares	10-K	2026-02-10

Shares Issued

Q: 0 | A: 0

Quarterly

Annual

Show Data Rows

Frequency	Period End	Value	% Chg	Unit	Form	Filed

Weighted Avg Shares Basic

Q: 30 | A: 10

Quarterly

Annual

Show Data Rows

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	396397000.0	—	shares	10-Q	2017-05-09
Quarterly	2016-06-30	386406000.0	-2.5%	shares	10-Q	2017-08-04
Quarterly	2016-09-30	378199000.0	-2.1%	shares	10-Q	2017-11-07
Quarterly	2017-03-31	370289000.0	-2.1%	shares	10-Q	2018-05-08
Quarterly	2017-06-30	365847000.0	-1.2%	shares	10-Q	2018-08-03
Quarterly	2017-09-30	360170000.0	-1.6%	shares	10-Q	2018-11-06
Quarterly	2018-03-31	350850000.0	-2.6%	shares	10-Q	2019-05-03
Quarterly	2018-06-30	348615000.0	-0.6%	shares	10-Q	2019-08-02
Quarterly	2018-09-30	345823000.0	-0.8%	shares	10-Q	2019-11-01
Quarterly	2019-03-31	342876000.0	-0.9%	shares	10-Q	2020-05-06
Quarterly	2019-06-30	342170000.0	-0.2%	shares	10-Q	2020-07-30
Quarterly	2019-09-30	340789000.0	-0.4%	shares	10-Q	2020-10-29
Quarterly	2020-03-31	338242000.0	-0.7%	shares	10-Q	2021-04-30
Quarterly	2020-06-30	337760000.0	-0.1%	shares	10-Q	2021-08-02
Quarterly	2020-09-30	338168000.0	+0.1%	shares	10-Q	2021-11-01
Quarterly	2021-03-31	338123000.0	-0.0%	shares	10-Q	2022-05-03
Quarterly	2021-06-30	328171000.0	-2.9%	shares	10-Q	2022-08-01
Quarterly	2021-09-30	318072000.0	-3.1%	shares	10-Q	2022-11-01
Quarterly	2022-03-31	302446000.0	-4.9%	shares	10-Q	2023-04-27
Quarterly	2022-06-30	292527000.0	-3.3%	shares	10-Q	2023-08-02
Quarterly	2022-09-30	285958000.0	-2.2%	shares	10-Q	2023-10-26
Quarterly	2023-03-31	276910000.0	-3.2%	shares	10-Q	2024-05-02
Quarterly	2023-06-30	274494000.0	-0.9%	shares	10-Q	2024-07-29
Quarterly	2023-09-30	271173000.0	-1.2%	shares	10-Q	2024-10-31
Quarterly	2024-03-31	264435000.0	-2.5%	shares	10-Q	2025-05-01
Quarterly	2024-06-30	261156000.0	-1.2%	shares	10-Q	2025-08-04
Quarterly	2024-09-30	256763000.0	-1.7%	shares	10-Q	2025-10-30
Quarterly	2025-03-31	246936000.0	-3.8%	shares	10-Q	2025-05-01
Quarterly	2025-06-30	239173000.0	-3.1%	shares	10-Q	2025-08-04
Quarterly	2025-09-30	232891000.0	-2.6%	shares	10-Q	2025-10-30
Annual	2016-12-31	383591000.0	—	shares	10-K	2019-02-21
Annual	2017-12-31	362305000.0	-5.5%	shares	10-K	2020-02-20
Annual	2018-12-31	347297000.0	-4.1%	shares	10-K	2021-02-19
Annual	2019-12-31	341210000.0	-1.8%	shares	10-K	2022-02-18
Annual	2020-12-31	338274000.0	-0.9%	shares	10-K	2023-02-17
Annual	2021-12-31	323315000.0	-4.4%	shares	10-K	2024-02-16
Annual	2022-12-31	290348000.0	-10.2%	shares	10-K	2025-02-14
Annual	2023-12-31	272404000.0	-6.2%	shares	10-K	2026-02-10
Annual	2024-12-31	258603000.0	-5.1%	shares	10-K	2026-02-10
Annual	2025-12-31	236413000.0	-8.6%	shares	10-K	2026-02-10

Weighted Avg Shares Diluted

Q: 30 | A: 10

Quarterly

Annual

Show Data Rows

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	410575000.0	—	shares	10-Q	2017-05-09
Quarterly	2016-06-30	398659000.0	-2.9%	shares	10-Q	2017-08-04
Quarterly	2016-09-30	389592000.0	-2.3%	shares	10-Q	2017-11-07
Quarterly	2017-03-31	379980000.0	-2.5%	shares	10-Q	2018-05-08
Quarterly	2017-06-30	375338000.0	-1.2%	shares	10-Q	2018-08-03
Quarterly	2017-09-30	369834000.0	-1.5%	shares	10-Q	2018-11-06
Quarterly	2018-03-31	359749000.0	-2.7%	shares	10-Q	2019-05-03
Quarterly	2018-06-30	355039000.0	-1.3%	shares	10-Q	2019-08-02
Quarterly	2018-09-30	353639000.0	-0.4%	shares	10-Q	2019-11-01
Quarterly	2019-03-31	350316000.0	-0.9%	shares	10-Q	2020-05-06
Quarterly	2019-06-30	348373000.0	-0.6%	shares	10-Q	2020-07-30
Quarterly	2019-09-30	347487000.0	-0.3%	shares	10-Q	2020-10-29
Quarterly	2020-03-31	344096000.0	-1.0%	shares	10-Q	2021-04-30
Quarterly	2020-06-30	341599000.0	-0.7%	shares	10-Q	2021-08-02
Quarterly	2020-09-30	343346000.0	+0.5%	shares	10-Q	2021-11-01
Quarterly	2021-03-31	343321000.0	-0.0%	shares	10-Q	2022-05-03
Quarterly	2021-06-30	332613000.0	-3.1%	shares	10-Q	2022-08-01
Quarterly	2021-09-30	324029000.0	-2.6%	shares	10-Q	2022-11-01
Quarterly	2022-03-31	307374000.0	-5.1%	shares	10-Q	2023-04-27
Quarterly	2022-06-30	296061000.0	-3.7%	shares	10-Q	2023-08-02
Quarterly	2022-09-30	289852000.0	-2.1%	shares	10-Q	2023-10-26
Quarterly	2023-03-31	280961000.0	-3.1%	shares	10-Q	2024-05-02
Quarterly	2023-06-30	278198000.0	-1.0%	shares	10-Q	2024-07-29
Quarterly	2023-09-30	275424000.0	-1.0%	shares	10-Q	2024-10-31
Quarterly	2024-03-31	268016000.0	-2.7%	shares	10-Q	2025-05-01
Quarterly	2024-06-30	264071000.0	-1.5%	shares	10-Q	2025-08-04
Quarterly	2024-09-30	259917000.0	-1.6%	shares	10-Q	2025-10-30
Quarterly	2025-03-31	249440000.0	-4.0%	shares	10-Q	2025-05-01
Quarterly	2025-06-30	241911000.0	-3.0%	shares	10-Q	2025-08-04
Quarterly	2025-09-30	236181000.0	-2.4%	shares	10-Q	2025-10-30
Annual	2016-12-31	395851000.0	—	shares	10-K	2019-02-21
Annual	2017-12-31	372221000.0	-6.0%	shares	10-K	2020-02-20
Annual	2018-12-31	355303000.0	-4.5%	shares	10-K	2021-02-19
Annual	2019-12-31	348226000.0	-2.0%	shares	10-K	2022-02-18
Annual	2020-12-31	343605000.0	-1.3%	shares	10-K	2023-02-17
Annual	2021-12-31	328752000.0	-4.3%	shares	10-K	2024-02-16
Annual	2022-12-31	294666000.0	-10.4%	shares	10-K	2025-02-14
Annual	2023-12-31	276412000.0	-6.2%	shares	10-K	2026-02-10
Annual	2024-12-31	261806000.0	-5.3%	shares	10-K	2026-02-10
Annual	2025-12-31	239495000.0	-8.5%	shares	10-K	2026-02-10

Credit and Bond Coverage

Company-level

Long-Term Debt (latest annual)

44,285,000,000

Total Liabilities (latest annual)

45,623,000,000

Current Liabilities (latest annual)

16,350,000,000

Metrics

Metrics: 7

Asset Turnover

Efficiency Q: 15 | A: 7

Quarterly

Annual

Show Data Rows

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2021-03-31	0.2956	—	ratio	10-Q	2022-05-03
Quarterly	2021-06-30	0.2997	+1.4%	ratio	10-Q	2022-08-01
Quarterly	2021-09-30	0.3082	+2.8%	ratio	10-Q	2022-11-01
Quarterly	2022-03-31	0.2863	-7.1%	ratio	10-Q	2023-04-27
Quarterly	2022-06-30	0.2873	+0.4%	ratio	10-Q	2023-08-02
Quarterly	2022-09-30	0.2908	+1.2%	ratio	10-Q	2023-10-26
Quarterly	2023-03-31	0.2958	+1.7%	ratio	10-Q	2024-05-02
Quarterly	2023-06-30	0.2959	+0.1%	ratio	10-Q	2024-07-29
Quarterly	2023-09-30	0.2970	+0.4%	ratio	10-Q	2024-10-31
Quarterly	2024-03-31	0.3044	+2.5%	ratio	10-Q	2025-05-01
Quarterly	2024-06-30	0.3049	+0.1%	ratio	10-Q	2025-08-04
Quarterly	2024-09-30	0.2941	-3.5%	ratio	10-Q	2025-10-30
Quarterly	2025-03-31	0.3064	+4.2%	ratio	10-Q	2025-05-01
Quarterly	2025-06-30	0.3125	+2.0%	ratio	10-Q	2025-08-04
Quarterly	2025-09-30	0.3207	+2.6%	ratio	10-Q	2025-10-30
Annual	2019-12-31	1.1393	—	ratio	10-K	2022-02-18
Annual	2020-12-31	1.0851	-4.8%	ratio	10-K	2023-02-17
Annual	2021-12-31	1.1579	+6.7%	ratio	10-K	2024-02-16
Annual	2022-12-31	1.1487	-0.8%	ratio	10-K	2025-02-14
Annual	2023-12-31	1.1558	+0.6%	ratio	10-K	2026-02-10
Annual	2024-12-31	1.1863	+2.6%	ratio	10-K	2026-02-10
Annual	2025-12-31	1.2451	+4.9%	ratio	10-K	2026-02-10

Current Ratio

Liquidity Q: 39 | A: 10

Quarterly

Annual

Show Data Rows

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	1.7045	—	ratio	10-Q	2016-05-06
Quarterly	2016-06-30	1.6855	-1.1%	ratio	10-Q	2016-08-04
Quarterly	2016-09-30	1.7154	+1.8%	ratio	10-Q	2016-11-03
Quarterly	2016-12-31	1.5574	-9.2%	ratio	10-Q	2017-11-07
Quarterly	2017-03-31	1.6542	+6.2%	ratio	10-Q	2017-05-09
Quarterly	2017-06-30	1.6179	-2.2%	ratio	10-Q	2017-08-04
Quarterly	2017-09-30	1.6838	+4.1%	ratio	10-Q	2017-11-07
Quarterly	2017-12-31	1.6202	-3.8%	ratio	10-Q	2018-11-06
Quarterly	2018-03-31	1.3895	-14.2%	ratio	10-Q	2018-05-08
Quarterly	2018-06-30	1.3631	-1.9%	ratio	10-Q	2018-08-03
Quarterly	2018-09-30	1.6065	+17.9%	ratio	10-Q	2018-11-06
Quarterly	2018-12-31	1.3493	-16.0%	ratio	10-Q	2019-11-01
Quarterly	2019-03-31	1.0548	-21.8%	ratio	10-Q	2019-05-03
Quarterly	2019-06-30	1.4361	+36.2%	ratio	10-Q	2019-08-02
Quarterly	2019-09-30	1.5117	+5.3%	ratio	10-Q	2019-11-01
Quarterly	2019-12-31	1.4433	-4.5%	ratio	10-Q	2020-10-29
Quarterly	2020-03-31	1.5695	+8.7%	ratio	10-Q	2020-05-06
Quarterly	2020-06-30	1.0914	-30.5%	ratio	10-Q	2020-07-30
Quarterly	2020-09-30	1.1312	+3.7%	ratio	10-Q	2020-10-29
Quarterly	2020-12-31	1.4169	+25.3%	ratio	10-Q	2021-11-01
Quarterly	2021-03-31	1.3927	-1.7%	ratio	10-Q	2021-04-30
Quarterly	2021-06-30	1.4481	+4.0%	ratio	10-Q	2021-08-02
Quarterly	2021-09-30	1.3766	-4.9%	ratio	10-Q	2021-11-01
Quarterly	2021-12-31	1.4133	+2.7%	ratio	10-Q	2022-11-01
Quarterly	2022-03-31	1.4267	+0.9%	ratio	10-Q	2022-05-03
Quarterly	2022-06-30	1.5487	+8.6%	ratio	10-Q	2022-08-01
Quarterly	2022-09-30	1.3779	-11.0%	ratio	10-Q	2022-11-01
Quarterly	2022-12-31	1.3778	-0.0%	ratio	10-Q	2023-10-26
Quarterly	2023-03-31	1.2279	-10.9%	ratio	10-Q	2023-04-27
Quarterly	2023-06-30	1.2029	-2.0%	ratio	10-Q	2023-08-02
Quarterly	2023-09-30	1.1521	-4.2%	ratio	10-Q	2023-10-26
Quarterly	2023-12-31	1.1795	+2.4%	ratio	10-Q	2024-10-31
Quarterly	2024-03-31	1.1629	-1.4%	ratio	10-Q	2024-05-02
Quarterly	2024-06-30	1.0610	-8.8%	ratio	10-Q	2024-07-29
Quarterly	2024-09-30	1.1183	+5.4%	ratio	10-Q	2024-10-31
Quarterly	2024-12-31	1.0815	-3.3%	ratio	10-Q	2025-10-30
Quarterly	2025-03-31	1.1927	+10.3%	ratio	10-Q	2025-05-01
Quarterly	2025-06-30	0.9764	-18.1%	ratio	10-Q	2025-08-04
Quarterly	2025-09-30	0.8541	-12.5%	ratio	10-Q	2025-10-30
Annual	2016-12-31	1.5574	—	ratio	10-K	2018-02-23
Annual	2017-12-31	1.6202	+4.0%	ratio	10-K	2019-02-21
Annual	2018-12-31	1.3493	-16.7%	ratio	10-K	2020-02-20
Annual	2019-12-31	1.4433	+7.0%	ratio	10-K	2021-02-19
Annual	2020-12-31	1.4169	-1.8%	ratio	10-K	2022-02-18
Annual	2021-12-31	1.4133	-0.3%	ratio	10-K	2023-02-17
Annual	2022-12-31	1.3778	-2.5%	ratio	10-K	2024-02-16
Annual	2023-12-31	1.1795	-14.4%	ratio	10-K	2025-02-14
Annual	2024-12-31	1.0815	-8.3%	ratio	10-K	2026-02-10
Annual	2025-12-31	0.9653	-10.7%	ratio	10-K	2026-02-10

Debt to Equity

Leverage Q: 15 | A: 4

Quarterly

Annual

Show Data Rows

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	-6.4636	—	ratio	10-Q	2016-05-06
Quarterly	2016-06-30	-6.1100	+5.5%	ratio	10-Q	2016-08-04
Quarterly	2016-09-30	-6.3751	-4.3%	ratio	10-Q	2016-11-03
Quarterly	2016-12-31	-6.9929	-9.7%	ratio	10-Q	2017-11-07
Quarterly	2017-03-31	-7.3086	-4.5%	ratio	10-Q	2017-05-09
Quarterly	2017-06-30	-7.8057	-6.8%	ratio	10-Q	2017-08-04
Quarterly	2017-09-30	-8.0531	-3.2%	ratio	10-Q	2017-11-07
Quarterly	2017-12-31	-8.3259	-3.4%	ratio	10-Q	2018-11-06
Quarterly	2018-03-31	-9.4120	-13.0%	ratio	10-Q	2018-05-08
Quarterly	2018-06-30	-10.1496	-7.8%	ratio	10-Q	2018-08-03
Quarterly	2018-09-30	-11.1995	-10.3%	ratio	10-Q	2018-11-06
Quarterly	2018-12-31	-14.4363	-28.9%	ratio	10-Q	2019-11-01
Quarterly	2019-03-31	-20.2368	-40.2%	ratio	10-Q	2019-05-03
Quarterly	2019-06-30	-26.6774	-31.8%	ratio	10-Q	2019-08-02
Quarterly	2019-09-30	-31.3469	-17.5%	ratio	10-Q	2019-11-01
Annual	2016-12-31	-6.9929	—	ratio	10-K	2018-02-23
Annual	2017-12-31	-8.3259	-19.1%	ratio	10-K	2019-02-21
Annual	2018-12-31	-14.4363	-73.4%	ratio	10-K	2020-02-20
Annual	2019-12-31	-80.7487	-459.3%	ratio	10-K	2020-02-20

Net Margin

Profitability Q: 15 | A: 7

Quarterly

Annual

Show Data Rows

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2021-03-31	0.1130	—	ratio	10-Q	2022-05-03
Quarterly	2021-06-30	0.1153	+2.0%	ratio	10-Q	2022-08-01
Quarterly	2021-09-30	0.1618	+40.4%	ratio	10-Q	2022-11-01
Quarterly	2022-03-31	0.0980	-39.4%	ratio	10-Q	2023-04-27
Quarterly	2022-06-30	0.0930	-5.1%	ratio	10-Q	2023-08-02
Quarterly	2022-09-30	0.0898	-3.5%	ratio	10-Q	2023-10-26
Quarterly	2023-03-31	0.0990	+10.2%	ratio	10-Q	2024-05-02
Quarterly	2023-06-30	0.0890	-10.0%	ratio	10-Q	2024-07-29
Quarterly	2023-09-30	0.0786	-11.7%	ratio	10-Q	2024-10-31
Quarterly	2024-03-31	0.1039	+32.2%	ratio	10-Q	2025-05-01
Quarterly	2024-06-30	0.0964	-7.2%	ratio	10-Q	2025-08-04
Quarterly	2024-09-30	0.0847	-12.1%	ratio	10-Q	2025-10-30
Quarterly	2025-03-31	0.0996	+17.5%	ratio	10-Q	2025-05-01
Quarterly	2025-06-30	0.1016	+2.0%	ratio	10-Q	2025-08-04
Quarterly	2025-09-30	0.0993	-2.3%	ratio	10-Q	2025-10-30
Annual	2019-12-31	0.0807	—	ratio	10-K	2022-02-18
Annual	2020-12-31	0.0851	+5.4%	ratio	10-K	2023-02-17
Annual	2021-12-31	0.1314	+54.4%	ratio	10-K	2024-02-16
Annual	2022-12-31	0.1135	-13.7%	ratio	10-K	2025-02-14
Annual	2023-12-31	0.0938	-17.4%	ratio	10-K	2026-02-10
Annual	2024-12-31	0.0943	+0.6%	ratio	10-K	2026-02-10
Annual	2025-12-31	0.1029	+9.2%	ratio	10-K	2026-02-10

Quick Ratio

Liquidity Q: 39 | A: 10

Quarterly

Annual

Show Data Rows

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	0.1578	—	ratio	10-Q	2017-05-09
Quarterly	2016-06-30	0.1281	-18.9%	ratio	10-Q	2017-08-04
Quarterly	2016-09-30	0.1313	+2.6%	ratio	10-Q	2017-11-07
Quarterly	2016-12-31	0.1107	-15.7%	ratio	10-Q	2018-05-08
Quarterly	2017-03-31	0.1378	+24.5%	ratio	10-Q	2018-05-08
Quarterly	2017-06-30	0.1222	-11.4%	ratio	10-Q	2017-08-04
Quarterly	2017-09-30	0.1280	+4.7%	ratio	10-Q	2017-11-07
Quarterly	2017-12-31	0.1189	-7.1%	ratio	10-Q	2018-11-06
Quarterly	2018-03-31	0.1452	+22.2%	ratio	10-Q	2018-05-08
Quarterly	2018-06-30	0.1138	-21.6%	ratio	10-Q	2018-08-03
Quarterly	2018-09-30	0.0928	-18.5%	ratio	10-Q	2018-11-06
Quarterly	2018-12-31	0.0663	-28.5%	ratio	10-Q	2019-11-01
Quarterly	2019-03-31	0.0504	-24.0%	ratio	10-Q	2019-05-03
Quarterly	2019-06-30	0.2712	+437.8%	ratio	10-Q	2019-08-02
Quarterly	2019-09-30	0.0785	-71.1%	ratio	10-Q	2019-11-01
Quarterly	2019-12-31	0.0801	+2.0%	ratio	10-Q	2020-10-29
Quarterly	2020-03-31	0.1041	+30.1%	ratio	10-Q	2020-05-06
Quarterly	2020-06-30	0.3608	+246.4%	ratio	10-Q	2020-07-30
Quarterly	2020-09-30	0.4582	+27.0%	ratio	10-Q	2020-10-29
Quarterly	2020-12-31	0.2060	-55.0%	ratio	10-Q	2021-11-01
Quarterly	2021-03-31	0.1192	-42.1%	ratio	10-Q	2021-04-30
Quarterly	2021-06-30	0.1300	+9.1%	ratio	10-Q	2021-08-02
Quarterly	2021-09-30	0.1067	-17.9%	ratio	10-Q	2021-11-01
Quarterly	2021-12-31	0.1514	+41.9%	ratio	10-Q	2022-11-01
Quarterly	2022-03-31	0.2254	+48.9%	ratio	10-Q	2022-05-03
Quarterly	2022-06-30	0.0953	-57.7%	ratio	10-Q	2022-08-01
Quarterly	2022-09-30	0.1021	+7.1%	ratio	10-Q	2022-11-01
Quarterly	2022-12-31	0.0917	-10.2%	ratio	10-Q	2023-10-26
Quarterly	2023-03-31	0.0764	-16.7%	ratio	10-Q	2023-04-27
Quarterly	2023-06-30	0.0747	-2.2%	ratio	10-Q	2023-08-02
Quarterly	2023-09-30	0.0718	-3.8%	ratio	10-Q	2023-10-26
Quarterly	2023-12-31	0.0739	+2.9%	ratio	10-Q	2024-10-31
Quarterly	2024-03-31	0.0977	+32.2%	ratio	10-Q	2024-05-02
Quarterly	2024-06-30	0.0581	-40.5%	ratio	10-Q	2024-07-29
Quarterly	2024-09-30	0.1938	+233.6%	ratio	10-Q	2024-10-31
Quarterly	2024-12-31	0.1274	-34.3%	ratio	10-Q	2025-10-30
Quarterly	2025-03-31	0.0778	-38.9%	ratio	10-Q	2025-05-01
Quarterly	2025-06-30	0.0589	-24.2%	ratio	10-Q	2025-08-04
Quarterly	2025-09-30	0.0557	-5.4%	ratio	10-Q	2025-10-30
Annual	2016-12-31	0.1107	—	ratio	10-K	2018-02-23
Annual	2017-12-31	0.1189	+7.4%	ratio	10-K	2019-02-21
Annual	2018-12-31	0.0663	-44.2%	ratio	10-K	2020-02-20
Annual	2019-12-31	0.0801	+20.7%	ratio	10-K	2021-02-19
Annual	2020-12-31	0.2060	+157.3%	ratio	10-K	2022-02-18
Annual	2021-12-31	0.1514	-26.5%	ratio	10-K	2023-02-17
Annual	2022-12-31	0.0917	-39.4%	ratio	10-K	2024-02-16
Annual	2023-12-31	0.0739	-19.4%	ratio	10-K	2025-02-14
Annual	2024-12-31	0.1274	+72.4%	ratio	10-K	2026-02-10
Annual	2025-12-31	0.0636	-50.1%	ratio	10-K	2026-02-10

ROA

Profitability Q: 30 | A: 10

Quarterly

Annual

Show Data Rows

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	0.0247	—	ratio	10-Q	2017-05-09
Quarterly	2016-06-30	0.0238	-3.7%	ratio	10-Q	2017-08-04
Quarterly	2016-09-30	0.0225	-5.6%	ratio	10-Q	2017-11-07
Quarterly	2017-03-31	0.0230	+2.2%	ratio	10-Q	2018-05-08
Quarterly	2017-06-30	0.0230	+0.0%	ratio	10-Q	2018-08-03
Quarterly	2017-09-30	0.0148	-35.5%	ratio	10-Q	2018-11-06
Quarterly	2018-03-31	0.0344	+131.7%	ratio	10-Q	2019-05-03
Quarterly	2018-06-30	0.0256	-25.5%	ratio	10-Q	2019-08-02
Quarterly	2018-09-30	0.0236	-8.0%	ratio	10-Q	2019-11-01
Quarterly	2019-03-31	0.0272	+15.6%	ratio	10-Q	2020-05-06
Quarterly	2019-06-30	0.0204	-25.1%	ratio	10-Q	2020-07-30
Quarterly	2019-09-30	0.0174	-14.7%	ratio	10-Q	2020-10-29
Quarterly	2020-03-31	0.0154	-11.7%	ratio	10-Q	2021-04-30
Quarterly	2020-06-30	0.0250	+62.5%	ratio	10-Q	2021-08-02
Quarterly	2020-09-30	0.0153	-38.8%	ratio	10-Q	2021-11-01
Quarterly	2021-03-31	0.0334	+118.9%	ratio	10-Q	2022-05-03
Quarterly	2021-06-30	0.0345	+3.4%	ratio	10-Q	2022-08-01
Quarterly	2021-09-30	0.0499	+44.4%	ratio	10-Q	2022-11-01
Quarterly	2022-03-31	0.0281	-43.7%	ratio	10-Q	2023-04-27
Quarterly	2022-06-30	0.0267	-4.7%	ratio	10-Q	2023-08-02
Quarterly	2022-09-30	0.0261	-2.3%	ratio	10-Q	2023-10-26
Quarterly	2023-03-31	0.0293	+12.1%	ratio	10-Q	2024-05-02
Quarterly	2023-06-30	0.0263	-10.0%	ratio	10-Q	2024-07-29
Quarterly	2023-09-30	0.0234	-11.3%	ratio	10-Q	2024-10-31
Quarterly	2024-03-31	0.0316	+35.4%	ratio	10-Q	2025-05-01
Quarterly	2024-06-30	0.0294	-7.1%	ratio	10-Q	2025-08-04
Quarterly	2024-09-30	0.0249	-15.2%	ratio	10-Q	2025-10-30
Quarterly	2025-03-31	0.0305	+22.4%	ratio	10-Q	2025-05-01
Quarterly	2025-06-30	0.0318	+4.1%	ratio	10-Q	2025-08-04
Quarterly	2025-09-30	0.0319	+0.3%	ratio	10-Q	2025-10-30
Annual	2016-12-31	0.1017	—	ratio	10-K	2019-02-21
Annual	2017-12-31	0.0750	-26.3%	ratio	10-K	2020-02-20
Annual	2018-12-31	0.1119	+49.3%	ratio	10-K	2021-02-19
Annual	2019-12-31	0.0920	-17.8%	ratio	10-K	2022-02-18
Annual	2020-12-31	0.0924	+0.4%	ratio	10-K	2023-02-17
Annual	2021-12-31	0.1522	+64.7%	ratio	10-K	2024-02-16
Annual	2022-12-31	0.1303	-14.4%	ratio	10-K	2025-02-14
Annual	2023-12-31	0.1084	-16.9%	ratio	10-K	2026-02-10
Annual	2024-12-31	0.1119	+3.2%	ratio	10-K	2026-02-10
Annual	2025-12-31	0.1282	+14.6%	ratio	10-K	2026-02-10

ROE

Profitability Q: 30 | A: 10

Quarterly

Annual

Show Data Rows

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	-0.1352	—	ratio	10-Q	2017-05-09
Quarterly	2016-06-30	-0.1217	+10.0%	ratio	10-Q	2017-08-04
Quarterly	2016-09-30	-0.1209	+0.7%	ratio	10-Q	2017-11-07
Quarterly	2017-03-31	-0.1450	-20.0%	ratio	10-Q	2018-05-08
Quarterly	2017-06-30	-0.1565	-7.9%	ratio	10-Q	2018-08-03
Quarterly	2017-09-30	-0.1046	+33.2%	ratio	10-Q	2018-11-06
Quarterly	2018-03-31	-0.2891	-176.4%	ratio	10-Q	2019-05-03
Quarterly	2018-06-30	-0.2342	+19.0%	ratio	10-Q	2019-08-02
Quarterly	2018-09-30	-0.2402	-2.6%	ratio	10-Q	2019-11-01
Quarterly	2019-03-31	-0.5237	-118.0%	ratio	10-Q	2020-05-06
Quarterly	2019-06-30	-0.5237	-0.0%	ratio	10-Q	2020-07-30
Quarterly	2019-09-30	-0.5280	-0.8%	ratio	10-Q	2020-10-29
Quarterly	2020-03-31	-0.9929	-88.1%	ratio	10-Q	2021-04-30
Quarterly	2020-06-30	2.1408	+315.6%	ratio	10-Q	2021-08-02
Quarterly	2020-09-30	0.5997	-72.0%	ratio	10-Q	2021-11-01
Quarterly	2021-03-31	0.6366	+6.2%	ratio	10-Q	2022-05-03
Quarterly	2021-06-30	0.9296	+46.0%	ratio	10-Q	2022-08-01
Quarterly	2021-09-30	1.3545	+45.7%	ratio	10-Q	2022-11-01
Quarterly	2022-03-31	3.5386	+161.2%	ratio	10-Q	2023-04-27
Quarterly	2022-06-30	-1.2075	-134.1%	ratio	10-Q	2023-08-02
Quarterly	2022-09-30	-1.7275	-43.1%	ratio	10-Q	2023-10-26
Quarterly	2023-03-31	6.6509	+485.0%	ratio	10-Q	2024-05-02
Quarterly	2023-06-30	3.0629	-53.9%	ratio	10-Q	2024-07-29
Quarterly	2023-09-30	3.5714	+16.6%	ratio	10-Q	2024-10-31
Quarterly	2024-03-31	1.4189	-60.3%	ratio	10-Q	2025-05-01
Quarterly	2024-06-30	1.2599	-11.2%	ratio	10-Q	2025-08-04
Quarterly	2024-09-30	1.8855	+49.7%	ratio	10-Q	2025-10-30
Quarterly	2025-03-31	-4.1667	-321.0%	ratio	10-Q	2025-05-01
Quarterly	2025-06-30	-1.5275	+63.3%	ratio	10-Q	2025-08-04
Quarterly	2025-09-30	-0.8814	+42.3%	ratio	10-Q	2025-10-30
Annual	2016-12-31	-0.6093	—	ratio	10-K	2019-02-21
Annual	2017-12-31	-0.5491	+9.9%	ratio	10-K	2020-02-20
Annual	2018-12-31	-1.5041	-173.9%	ratio	10-K	2021-02-19
Annual	2019-12-31	-7.3363	-387.7%	ratio	10-K	2022-02-18
Annual	2020-12-31	1.5169	+120.7%	ratio	10-K	2023-02-17
Annual	2021-12-31	5.1854	+241.8%	ratio	10-K	2024-02-16
Annual	2022-12-31	-93.6164	-1905.4%	ratio	10-K	2025-02-14
Annual	2023-12-31	5.7462	+106.1%	ratio	10-K	2026-02-10
Annual	2024-12-31	11.9946	+108.7%	ratio	10-K	2026-02-10
Annual	2025-12-31	-2.8084	-123.4%	ratio	10-K	2026-02-10

8-K Material Event Details

60 filings · 173 item records

This 8-K section tracks corporate event disclosures, not insider buy/sell sentiment. Insider trading direction is shown in the insider section below.

Event Type Distribution

Count per 8-K item

Insider Transaction History

652 transaction records

Net Insider Flow

Monthly open-market buy value minus open-market sell value

Monthly Insider Activity Mix

Share volume split between open-market trades, grants, and exercises

Transaction Value Timeline

Each circle = one priced transaction; size ∝ value X-axis date:

All Transactions

Date	Insider	Title	Type	Security	Shares	Price	Total Value	Post-Tx Shares
2026-02-18	McAlevey Michael R	EVP & Chief Legal & Admin Off.	Open-market sell S	Common Stock	1,694	$533.37	$903,537	8,853
2026-02-13	McAlevey Michael R	EVP & Chief Legal & Admin Off.	Exercise / conversion M · derivative	Stock Appreciation Right	5,000	$0.00	$0	8,860
2026-02-13	McAlevey Michael R	EVP & Chief Legal & Admin Off.	Other disposed transaction F	Common Stock	3,306	$540.29	$1,786,199	10,547
2026-02-13	McAlevey Michael R	EVP & Chief Legal & Admin Off.	Exercise / conversion M	Common Stock	5,000	$236.61	$1,183,050	13,853
2026-02-11	Wyatt Christopher F.	SVP & Controller	Open-market sell S	Common Stock	4,000	$505.00	$2,020,000	44,379
2026-02-10	Wyatt Christopher F.	SVP & Controller	Other disposed transaction F	Common Stock	1,034	$502.05	$519,120	48,379
2026-02-10	Wyatt Christopher F.	SVP & Controller	Equity grant / award A	Common Stock	3,350	$0.00	$0	49,413
2026-02-06	FRIST THOMAS F JR	—	Other acquired transaction J	Common Stock, par value $0.01 per share	36,557,141	—	—	36,557,141
2026-02-06	FRIST THOMAS F JR	—	Other disposed transaction J	Common Stock, par value $0.01 per share	36,629,188	—	—	0
2026-02-05	Wyatt Christopher F.	SVP & Controller	Exercise / conversion M · derivative	Stock Appreciation Right	10,670	$0.00	$0	0
2026-02-05	Wyatt Christopher F.	SVP & Controller	Other disposed transaction F	Common Stock	5,674	$513.76	$2,915,074	46,063
2026-02-05	Wyatt Christopher F.	SVP & Controller	Exercise / conversion M	Common Stock	10,670	$139.06	$1,483,770	51,737
2026-02-04	HAZEN SAMUEL N	CEO	Other acquired transaction J	Common Stock	1,045	$498.35	$520,776	16,024
2026-02-03	HAZEN SAMUEL N	CEO	Open-market sell S	Common Stock	120	$497.18	$59,661	32,276
2026-02-03	HAZEN SAMUEL N	CEO	Open-market sell S	Common Stock	4,293	$498.12	$2,138,442	32,396
2026-02-03	HAZEN SAMUEL N	CEO	Open-market sell S	Common Stock	5,162	$498.80	$2,574,794	36,689
2026-02-03	HAZEN SAMUEL N	CEO	Open-market sell S	Common Stock	6,189	$500.02	$3,094,609	41,851
2026-02-03	HAZEN SAMUEL N	CEO	Open-market sell S	Common Stock	7,395	$500.69	$3,702,626	48,040
2026-02-03	HAZEN SAMUEL N	CEO	Open-market sell S	Common Stock	5,002	$502.15	$2,511,757	55,435
2026-02-03	HAZEN SAMUEL N	CEO	Open-market sell S	Common Stock	14,716	$502.95	$7,401,386	60,437
2026-01-29	Wyatt Christopher F.	SVP & Controller	Equity grant / award A · derivative	Stock Appreciation Right	2,560	$0.00	$0	2,560
2025-11-14	HAZEN SAMUEL N	CEO	Equity grant / award G	Common Stock	14,830	$0.00	$0	32,276
2025-11-05	McAlevey Michael R	EVP & Chief Legal & Admin Off.	Open-market sell S	Common Stock	3,892	$473.79	$1,843,991	3,487
2025-11-03	McAlevey Michael R	EVP & Chief Legal & Admin Off.	Exercise / conversion M · derivative	Stock Appreciation Right	13,170	$0.00	$0	0
2025-11-03	McAlevey Michael R	EVP & Chief Legal & Admin Off.	Other disposed transaction F	Common Stock	9,278	$461.56	$4,282,354	7,379
2025-11-03	McAlevey Michael R	EVP & Chief Legal & Admin Off.	Exercise / conversion M	Common Stock	13,170	$236.61	$3,116,154	16,657
2025-10-31	HAZEN SAMUEL N	CEO	Exercise / conversion M · derivative	Stock Appreciation Right	58,050	$0.00	$0	0
2025-10-31	HAZEN SAMUEL N	CEO	Other disposed transaction F	Common Stock	28,173	$459.68	$12,950,565	47,106
2025-10-31	HAZEN SAMUEL N	CEO	Exercise / conversion M	Common Stock	58,050	$69.58	$4,039,119	75,279
2025-09-08	Cuffe Michael S.	EVP and Chief Clinical Officer	Open-market sell S	Common Stock	3,836	$418.84	$1,606,670	31,503
2025-09-04	Cuffe Michael S.	EVP and Chief Clinical Officer	Exercise / conversion M · derivative	Stock Appreciation Right	10,920	$0.00	$0	10,000
2025-09-04	Cuffe Michael S.	EVP and Chief Clinical Officer	Other disposed transaction F	Common Stock	7,084	$411.59	$2,915,704	35,339
2025-09-04	Cuffe Michael S.	EVP and Chief Clinical Officer	Exercise / conversion M	Common Stock	10,920	$173.12	$1,890,470	42,423
2025-07-29	CHIDSEY JOHN	—	Equity grant / award A	Common Stock	496	$0.00	$0	496
2025-05-13	HAZEN SAMUEL N	CEO	Equity grant / award G	Common Stock	90,076	$0.00	$0	93,088
2025-05-07	Marks Mike A	EVP and CFO	Equity grant / award G	Common Stock	144	$0.00	$0	0
2025-05-07	Marks Mike A	EVP and CFO	Other acquired transaction J	Common Stock	285	$356.84	$101,699	43,405
2025-05-07	Marks Mike A	EVP and CFO	Equity grant / award G	Common Stock	181	$0.00	$0	43,120
2025-05-06	Marks Mike A	EVP and CFO	Equity grant / award G	Common Stock	144	$0.00	$0	144
2025-05-06	Marks Mike A	EVP and CFO	Other acquired transaction J	Common Stock	288	$353.57	$101,830	288
2025-05-06	Marks Mike A	EVP and CFO	Equity grant / award G	Common Stock	466	$0.00	$0	466
2025-04-30	Frist William R	—	Other acquired transaction J	Common Stock, par value $0.01 per share	10,505	$340.60	$3,577,854	1,574,897
2025-04-29	Frist William R	—	Equity grant / award A	Common Stock, par value $0.01 per share	1,026	$0.00	$0	12,931
2025-02-13	Wyatt Christopher F.	SVP & Controller	Other disposed transaction F	Common Stock	227	$321.92	$73,076	41,067
2025-02-13	Wyatt Christopher F.	SVP & Controller	Equity grant / award A	Common Stock	845	$0.00	$0	41,294
2025-02-07	Berres Jennifer	SVP & Chief Human Res. Officer	Exercise / conversion M · derivative	Stock Appreciation Right	4,340	$0.00	$0	0
2025-02-07	Berres Jennifer	SVP & Chief Human Res. Officer	Exercise / conversion M · derivative	Stock Appreciation Right	7,440	$0.00	$0	0
2025-02-07	Berres Jennifer	SVP & Chief Human Res. Officer	Other disposed transaction F	Common Stock	6,747	$322.05	$2,172,871	23,764
2025-02-07	Berres Jennifer	SVP & Chief Human Res. Officer	Exercise / conversion M	Common Stock	4,340	$139.06	$603,520	30,511
2025-02-07	Berres Jennifer	SVP & Chief Human Res. Officer	Exercise / conversion M	Common Stock	7,440	$101.16	$752,630	26,171
2025-02-03	Mosier Sammie S	SVP & Chief Nurse Executive	Exercise / conversion M · derivative	Restricted Stock Units	138	$0.00	$0	0
2025-02-03	Mosier Sammie S	SVP & Chief Nurse Executive	Other disposed transaction F	Common Stock	41	$334.30	$13,706	10,495
2025-02-03	Mosier Sammie S	SVP & Chief Nurse Executive	Exercise / conversion M	Common Stock	138	—	—	10,536
2025-01-28	Wyatt Christopher F.	SVP & Controller	Equity grant / award A · derivative	Stock Appreciation Right	3,575	$0.00	$0	3,575
2024-11-14	Foster Jon M	EVP and COO	Exercise / conversion M · derivative	Stock Appreciation Right	36,600	$0.00	$0	0
2024-11-14	Foster Jon M	EVP and COO	Other disposed transaction F	Common Stock	20,902	$345.51	$7,221,850	26,278
2024-11-14	Foster Jon M	EVP and COO	Exercise / conversion M	Common Stock	36,600	$101.16	$3,702,456	47,180
2024-11-14	Foster Jon M	EVP and COO	Equity grant / award G	Common Stock	18,000	$0.00	$0	18,000
2024-11-14	Foster Jon M	EVP and COO	Equity grant / award G	Common Stock	1,955	$0.00	$0	66,515
2024-11-14	Foster Jon M	EVP and COO	Other acquired transaction J	Common Stock	9,502	$352.74	$3,351,735	64,560
2024-11-14	Billington Phillip G	SVP-Internal Audit Services	Open-market sell S	Common Stock	3,897	$350.00	$1,363,950	52,702
2024-11-14	Whalen Kathleen M	SVP & Chief Ethics Officer	Open-market sell S	Common Stock	1,474	$357.99	$527,677	9,454
2024-11-12	Billington Phillip G	SVP-Internal Audit Services	Exercise / conversion M · derivative	Stock Appreciation Right	8,000	$0.00	$0	0
2024-11-12	Billington Phillip G	SVP-Internal Audit Services	Other disposed transaction F	Common Stock	4,103	$350.53	$1,438,225	56,599
2024-11-12	Billington Phillip G	SVP-Internal Audit Services	Exercise / conversion M	Common Stock	8,000	$68.96	$551,680	60,702
2024-11-11	Whalen Kathleen M	SVP & Chief Ethics Officer	Exercise / conversion M · derivative	Stock Appreciation Right	4,710	$0.00	$0	1,570
2024-11-11	Whalen Kathleen M	SVP & Chief Ethics Officer	Other disposed transaction F	Common Stock	3,236	$357.99	$1,158,456	10,928
2024-11-11	Whalen Kathleen M	SVP & Chief Ethics Officer	Exercise / conversion M	Common Stock	4,710	$173.12	$815,395	14,164
2024-10-30	Elcan Patricia F	10%	Other acquired transaction J	Common Stock, par value $0.01 per share	638,574	$361.55	$230,876,417	9,668,536
2024-10-30	Elcan Patricia F	10%	Other acquired transaction J	Common Stock, par value $0.01 per share	138,000	$361.55	$49,893,900	264,217
2024-10-30	Elcan Patricia F	10%	Other acquired transaction J	Common Stock, par value $0.01 per share	244,626	$361.55	$88,444,543	9,029,962
2024-09-12	Cuffe Michael S.	EVP and Chief Clinical Officer	Open-market sell S	Common Stock	8,358	$385.42	$3,221,340	29,678
2024-09-10	Cuffe Michael S.	EVP and Chief Clinical Officer	Exercise / conversion M · derivative	Stock Appreciation Right	22,080	$0.00	$0	0
2024-09-10	Cuffe Michael S.	EVP and Chief Clinical Officer	Other disposed transaction F	Common Stock	13,722	$386.43	$5,302,592	38,036
2024-09-10	Cuffe Michael S.	EVP and Chief Clinical Officer	Exercise / conversion M	Common Stock	22,080	$145.24	$3,206,899	51,758
2024-08-08	HAZEN SAMUEL N	CEO	Equity grant / award G	Common Stock	7,115	$0.00	$0	14,979
2024-08-08	Marks Mike A	EVP and CFO	Equity grant / award G	Common Stock	2,237	$0.00	$0	43,227
2024-08-06	HAZEN SAMUEL N	CEO	Equity grant / award G	Common Stock	3,012	$0.00	$0	3,012
2024-08-06	HAZEN SAMUEL N	CEO	Equity grant / award G	Common Stock	12,084	$0.00	$0	16,731
2024-08-06	HAZEN SAMUEL N	CEO	Equity grant / award G	Common Stock	7,115	$0.00	$0	7,115
2024-08-05	Sowell Joseph A III	SVP; Chief Development Officer	Equity grant / award G	Common Stock	13,367	$0.00	$0	18,526
2024-07-31	Whalen Kathleen M	SVP & Chief Ethics Officer	Open-market sell S	Common Stock	2,987	$363.51	$1,085,804	9,454
2024-07-31	McManus Timothy M	Group President	Exercise / conversion M · derivative	Stock Appreciation Right	7,500	$0.00	$0	7,440
2024-07-31	McManus Timothy M	Group President	Other disposed transaction F	Common Stock	3,919	$363.05	$1,422,793	27,008
2024-07-31	McManus Timothy M	Group President	Exercise / conversion M	Common Stock	7,500	$77.13	$578,475	30,927
2024-07-29	Wyatt Christopher F.	SVP & Controller	Open-market sell S	Common Stock	4,000	$360.20	$1,440,782	40,449
2024-07-29	Whalen Kathleen M	SVP & Chief Ethics Officer	Exercise / conversion M · derivative	Stock Appreciation Right	8,280	$0.00	$0	0
2024-07-29	Whalen Kathleen M	SVP & Chief Ethics Officer	Open-market sell S	Common Stock	1,864	$359.92	$670,891	12,441
2024-07-29	Whalen Kathleen M	SVP & Chief Ethics Officer	Other disposed transaction F	Common Stock	5,293	$358.73	$1,898,758	14,305
2024-07-29	Whalen Kathleen M	SVP & Chief Ethics Officer	Exercise / conversion M	Common Stock	8,280	$145.24	$1,202,587	19,598
2024-07-25	Wyatt Christopher F.	SVP & Controller	Exercise / conversion M · derivative	Stock Appreciation Right	9,300	$0.00	$0	0
2024-07-25	Wyatt Christopher F.	SVP & Controller	Other disposed transaction F	Common Stock	5,278	$352.79	$1,862,026	44,449
2024-07-25	Wyatt Christopher F.	SVP & Controller	Exercise / conversion M	Common Stock	9,300	$101.16	$940,788	49,727
2024-05-17	Whalen Kathleen M	SVP & Chief Ethics Officer	Exercise / conversion M · derivative	Stock Appreciation Right	1,685	$0.00	$0	12,045
2024-05-17	Whalen Kathleen M	SVP & Chief Ethics Officer	Exercise / conversion M · derivative	Stock Appreciation Right	3,040	$0.00	$0	0
2024-05-17	Whalen Kathleen M	SVP & Chief Ethics Officer	Other disposed transaction F	Common Stock	2,861	$322.86	$923,702	11,318
2024-05-17	Whalen Kathleen M	SVP & Chief Ethics Officer	Exercise / conversion M	Common Stock	1,685	$133.53	$224,998	14,179
2024-05-17	Whalen Kathleen M	SVP & Chief Ethics Officer	Exercise / conversion M	Common Stock	3,040	$101.16	$307,526	12,494
2024-05-16	Whalen Kathleen M	SVP & Chief Ethics Officer	Open-market sell S	Common Stock	3,204	$326.30	$1,045,465	9,454
2024-05-15	Foster Jon M	EVP and COO	Equity grant / award G	Common Stock	5,350	$0.00	$0	54,308
2024-05-09	Cuffe Michael S.	EVP and Chief Clinical Officer	Open-market sell S	Common Stock	6,311	$316.88	$1,999,825	29,624
2024-05-08	Cuffe Michael S.	EVP and Chief Clinical Officer	Equity grant / award G	Common Stock	4,500	$0.00	$0	35,935
2024-05-07	Cuffe Michael S.	EVP and Chief Clinical Officer	Exercise / conversion M · derivative	Stock Appreciation Right	18,660	$0.00	$0	0
2024-05-07	Cuffe Michael S.	EVP and Chief Clinical Officer	Other disposed transaction F	Common Stock	12,349	$314.45	$3,883,143	40,435
2024-05-07	Cuffe Michael S.	EVP and Chief Clinical Officer	Exercise / conversion M	Common Stock	18,660	$139.06	$2,594,860	52,784
2024-05-06	Cuffe Michael S.	EVP and Chief Clinical Officer	Open-market sell S	Common Stock	1,600	$309.00	$494,400	34,124
2024-05-03	Torres Kathryn A.	SVP-Payer Contracting & Align.	Open-market sell S	Common Stock	890	$312.00	$277,680	21,475
2024-05-02	Torres Kathryn A.	SVP-Payer Contracting & Align.	Open-market sell S	Common Stock	973	$312.00	$303,576	22,365
2024-04-29	FRIST THOMAS F III	Dir	Equity grant / award A	Common Stock, par value $0.01 per share	1,284	$0.00	$0	13,497
2024-03-20	Wasserman Chad J	SVP and CIO	Open-market sell S	Common Stock	876	$330.25	$289,299	1,576
2024-03-18	Wasserman Chad J	SVP and CIO	Exercise / conversion M · derivative	Stock Appreciation Right	2,100	$0.00	$0	4,190
2024-03-18	Wasserman Chad J	SVP and CIO	Open-market sell S	Common Stock	344	$321.97	$110,758	2,452
2024-03-18	Wasserman Chad J	SVP and CIO	Other disposed transaction F	Common Stock	1,224	$327.17	$400,456	2,796
2024-03-18	Wasserman Chad J	SVP and CIO	Exercise / conversion M	Common Stock	2,100	$101.16	$212,436	4,020
2024-02-16	Wyatt Christopher F.	SVP & Controller	Other disposed transaction F	Common Stock	1,976	$308.55	$609,695	40,427
2024-02-16	Wyatt Christopher F.	SVP & Controller	Equity grant / award A	Common Stock	5,020	$0.00	$0	42,403
2024-02-14	Whalen Kathleen M	SVP & Chief Ethics Officer	Equity grant / award G	Common Stock	349	$0.00	$0	9,901
2024-02-09	Whalen Kathleen M	SVP & Chief Ethics Officer	Open-market sell S	Common Stock	4,262	$306.21	$1,305,074	10,250
2024-02-06	RUTHERFORD BILL B	CFO and EVP	Open-market sell S	Common Stock	6,000	$310.63	$1,863,780	8,448
2024-02-06	Torres Kathryn A.	SVP-Payer Contracting & Align.	Exercise / conversion M · derivative	Stock Appreciation Right	2,092	$0.00	$0	2,093
2024-02-06	Torres Kathryn A.	SVP-Payer Contracting & Align.	Other disposed transaction F	Common Stock	1,423	$306.82	$436,605	20,294
2024-02-06	Torres Kathryn A.	SVP-Payer Contracting & Align.	Exercise / conversion M	Common Stock	2,092	$173.12	$362,167	21,717
2024-02-05	RUTHERFORD BILL B	CFO and EVP	Equity grant / award G	Common Stock	1,194	$0.00	$0	19,834
2024-02-05	RUTHERFORD BILL B	CFO and EVP	Equity grant / award G	Common Stock	175	$0.00	$0	15,642
2024-02-05	Wyatt Christopher F.	SVP & Controller	Open-market sell S	Common Stock	4,000	$312.42	$1,249,680	37,383
2024-02-02	RUTHERFORD BILL B	CFO and EVP	Exercise / conversion M · derivative	Stock Appreciation Right	19,100	$0.00	$0	0
2024-02-02	RUTHERFORD BILL B	CFO and EVP	Other disposed transaction F	Common Stock	9,652	$309.42	$2,986,522	15,817
2024-02-02	RUTHERFORD BILL B	CFO and EVP	Exercise / conversion M	Common Stock	19,100	$69.58	$1,328,978	25,469
2024-01-31	Wyatt Christopher F.	SVP & Controller	Equity grant / award A · derivative	Stock Appreciation Right	4,402	$0.00	$0	4,402
2024-01-31	Wyatt Christopher F.	SVP & Controller	Exercise / conversion M · derivative	Stock Appreciation Right	9,000	$0.00	$0	9,300
2024-01-31	Wyatt Christopher F.	SVP & Controller	Exercise / conversion M · derivative	Stock Appreciation Right	2,680	$0.00	$0	0
2024-01-31	Wyatt Christopher F.	SVP & Controller	Other disposed transaction F	Common Stock	6,376	$304.90	$1,944,042	41,383
2024-01-31	Wyatt Christopher F.	SVP & Controller	Exercise / conversion M	Common Stock	9,000	$101.16	$910,440	47,759
2024-01-31	Wyatt Christopher F.	SVP & Controller	Exercise / conversion M	Common Stock	2,680	$81.96	$219,653	38,759
2024-01-29	Mosier Sammie S	SVP & Chief Nurse Executive	Exercise / conversion M · derivative	Restricted Stock Units	323	$0.00	$0	0
2024-01-29	Mosier Sammie S	SVP & Chief Nurse Executive	Other disposed transaction F	Common Stock	96	$286.73	$27,526	8,017
2024-01-29	Mosier Sammie S	SVP & Chief Nurse Executive	Exercise / conversion M	Common Stock	323	—	—	8,113
2024-01-28	McAlevey Michael R	SVP & Chief Legal Officer	Exercise / conversion M · derivative	Restricted Stock Units	1,940	$0.00	$0	0
2024-01-28	McAlevey Michael R	SVP & Chief Legal Officer	Other disposed transaction F	Common Stock	489	$283.43	$138,597	4,012
2024-01-28	McAlevey Michael R	SVP & Chief Legal Officer	Exercise / conversion M	Common Stock	1,940	—	—	4,501
2023-11-14	Sowell Joseph A III	SVP; Chief Development Officer	Equity grant / award G	Common Stock	5,159	$0.00	$0	5,159
2023-11-14	Sowell Joseph A III	SVP; Chief Development Officer	Equity grant / award G	Common Stock	29,771	$0.00	$0	29,771
2023-11-13	Akdamar Erol R	Group President	Exercise / conversion M · derivative	Stock Appreciation Right	12,325	$0.00	$0	0
2023-11-13	Akdamar Erol R	Group President	Exercise / conversion M · derivative	Stock Appreciation Right	14,500	$0.00	$0	0
2023-11-13	Akdamar Erol R	Group President	Other disposed transaction F	Common Stock	13,951	$229.99	$3,208,590	12,874
2023-11-13	Akdamar Erol R	Group President	Exercise / conversion M	Common Stock	26,825	$47.97	$1,286,795	26,825
2023-11-10	Sowell Joseph A III	SVP; Chief Development Officer	Equity grant / award G	Common Stock	29,771	$0.00	$0	29,771
2023-08-14	Torres Kathryn A.	SVP-Payer Contracting & Align.	Open-market sell S	Common Stock	5,204	$269.12	$1,400,516	19,760
2023-08-11	Cohen Jeffrey E.	SVP-Government Relations	Open-market sell S	Common Stock	1,500	$270.00	$405,000	4,414
2023-08-03	Whalen Kathleen M	SVP & Chief Ethics Officer	Open-market sell S	Common Stock	2,916	$270.00	$787,320	10,250
2023-08-02	RUTHERFORD BILL B	CFO and EVP	Equity grant / award G	Common Stock	49,500	$0.00	$0	49,500
2023-08-01	Foster Jon M	EVP and COO	Equity grant / award G	Common Stock	5,350	$0.00	$0	5,350
2023-08-01	Foster Jon M	EVP and COO	Equity grant / award G	Common Stock	6,100	$0.00	$0	55,058
2023-05-12	Hammett Richard A	Group President	Equity grant / award G	Common Stock	1,100	$0.00	$0	13,762
2023-05-04	HAZEN SAMUEL N	CEO	Equity grant / award G	Common Stock	4,647	$0.00	$0	4,647
2023-05-04	HAZEN SAMUEL N	CEO	Equity grant / award G	Common Stock	7,864	$0.00	$0	7,864
2023-04-28	Torres Kathryn A.	SVP-Payer Contracting & Align.	Exercise / conversion M · derivative	Stock Appreciation Right	3,509	$0.00	$0	4,771
2023-04-28	Torres Kathryn A.	SVP-Payer Contracting & Align.	Exercise / conversion M · derivative	Stock Appreciation Right	5,335	$0.00	$0	0
2023-04-28	Torres Kathryn A.	SVP-Payer Contracting & Align.	Other disposed transaction F	Common Stock	6,123	$287.33	$1,759,322	24,964
2023-04-28	Torres Kathryn A.	SVP-Payer Contracting & Align.	Exercise / conversion M	Common Stock	3,509	$145.24	$509,647	31,087
2023-04-28	Torres Kathryn A.	SVP-Payer Contracting & Align.	Exercise / conversion M	Common Stock	5,335	$139.06	$741,885	27,578
2023-04-24	Smith Andrea B	Dir	Equity grant / award A	Common Stock	663	$0.00	$0	2,902
2023-04-14	Paslick P. Martin	SVP and CIO	Open-market sell S	Common Stock	2,687	$275.00	$738,925	24,643
2023-04-12	Paslick P. Martin	SVP and CIO	Exercise / conversion M · derivative	Stock Appreciation Right	6,340	$0.00	$0	0
2023-04-12	Paslick P. Martin	SVP and CIO	Other disposed transaction F	Common Stock	3,653	$272.38	$995,004	27,330
2023-04-12	Paslick P. Martin	SVP and CIO	Exercise / conversion M	Common Stock	6,340	$81.96	$519,626	30,983
2023-04-10	Paslick P. Martin	SVP and CIO	Open-market sell S	Common Stock	2,539	$270.00	$685,530	24,643
2023-04-05	Paslick P. Martin	SVP and CIO	Exercise / conversion M · derivative	Stock Appreciation Right	6,000	$0.00	$0	6,340
2023-04-05	Paslick P. Martin	SVP and CIO	Other disposed transaction F	Common Stock	3,461	$271.31	$939,004	27,182
2023-04-05	Paslick P. Martin	SVP and CIO	Exercise / conversion M	Common Stock	6,000	$81.96	$491,760	30,643
2023-04-04	Paslick P. Martin	SVP and CIO	Open-market sell S	Common Stock	3,034	$265.00	$804,010	24,643
2023-02-17	Wyatt Christopher F.	SVP & Controller	Other disposed transaction F	Common Stock	2,393	$262.84	$628,976	36,079
2023-02-17	Wyatt Christopher F.	SVP & Controller	Equity grant / award A	Common Stock	6,080	$0.00	$0	38,472
2023-02-16	Torres Kathryn A.	SVP-Payer Contracting & Align.	Exercise / conversion M · derivative	Stock Appreciation Right	4,575	$0.00	$0	0
2023-02-16	Torres Kathryn A.	SVP-Payer Contracting & Align.	Other disposed transaction F	Common Stock	2,467	$263.15	$649,191	22,480
2023-02-16	Torres Kathryn A.	SVP-Payer Contracting & Align.	Exercise / conversion M	Common Stock	4,575	$101.16	$462,807	24,947
2023-02-07	Berres Jennifer	SVP & Chief Human Res. Officer	Open-market sell S	Common Stock	4,000	$255.23	$1,020,912	7,392
2023-02-03	RUTHERFORD BILL B	CFO and EVP	Open-market sell S	Common Stock	30,000	$258.19	$7,745,568	81,632
2023-02-03	Akdamar Erol R	Group President	Exercise / conversion M · derivative	Stock Appreciation Right	9,000	$0.00	$0	0
2023-02-03	Akdamar Erol R	Group President	Other disposed transaction F	Common Stock	3,932	$258.08	$1,014,771	39,794
2023-02-03	Akdamar Erol R	Group President	Exercise / conversion M	Common Stock	9,000	$45.30	$407,700	43,726
2023-02-03	Reiner Deborah M	SVP - Mktg. & Communications	Open-market sell S	Common Stock	7,941	$257.61	$2,045,699	0
2023-02-02	Akdamar Erol R	Group President	Open-market sell S	Common Stock	3,000	$258.63	$775,891	34,726
2023-02-01	Wyatt Christopher F.	SVP & Controller	Open-market sell S	Common Stock	4,900	$253.30	$1,241,170	32,392
2023-02-01	RUTHERFORD BILL B	CFO and EVP	Exercise / conversion M · derivative	Stock Appreciation Right	27,000	$0.00	$0	19,100
2023-02-01	RUTHERFORD BILL B	CFO and EVP	Exercise / conversion M · derivative	Stock Appreciation Right	37,000	$0.00	$0	0
2023-02-01	RUTHERFORD BILL B	CFO and EVP	Other disposed transaction F	Common Stock	34,895	$261.46	$9,123,647	111,632
2023-02-01	RUTHERFORD BILL B	CFO and EVP	Exercise / conversion M	Common Stock	27,000	$69.58	$1,878,660	146,527
2023-02-01	RUTHERFORD BILL B	CFO and EVP	Exercise / conversion M	Common Stock	37,000	$68.96	$2,551,520	119,527
2023-01-31	Wyatt Christopher F.	SVP & Controller	Equity grant / award G	Common Stock	379	$0.00	$0	37,292
2023-01-30	Mosier Sammie S	SVP & Chief Nurse Executive	Exercise / conversion M · derivative	Restricted Stock Units	273	$0.00	$0	0
2023-01-30	Mosier Sammie S	SVP & Chief Nurse Executive	Other disposed transaction F	Common Stock	74	$253.30	$18,744	6,846
2023-01-30	Mosier Sammie S	SVP & Chief Nurse Executive	Exercise / conversion M	Common Stock	273	—	—	6,920
2023-01-30	Wyatt Christopher F.	SVP & Controller	Equity grant / award A · derivative	Stock Appreciation Right	5,052	$0.00	$0	5,052
2023-01-30	Wyatt Christopher F.	SVP & Controller	Exercise / conversion M · derivative	Stock Appreciation Right	12,000	$0.00	$0	2,680
2023-01-30	Wyatt Christopher F.	SVP & Controller	Other disposed transaction F	Common Stock	6,513	$253.30	$1,649,743	37,671
2023-01-30	Wyatt Christopher F.	SVP & Controller	Exercise / conversion M	Common Stock	12,000	$81.96	$983,520	44,184
2023-01-29	Mosier Sammie S	SVP & Chief Nurse Executive	Exercise / conversion M · derivative	Restricted Stock Units	322	$0.00	$0	323
2023-01-29	Mosier Sammie S	SVP & Chief Nurse Executive	Other disposed transaction F	Common Stock	96	$254.77	$24,458	6,647
2023-01-29	Mosier Sammie S	SVP & Chief Nurse Executive	Exercise / conversion M	Common Stock	322	—	—	6,743
2023-01-28	McAlevey Michael R	SVP & Chief Legal Officer	Exercise / conversion M · derivative	Restricted Stock Units	1,940	$0.00	$0	1,940
2023-01-28	McAlevey Michael R	SVP & Chief Legal Officer	Other disposed transaction F	Common Stock	489	$254.77	$124,583	2,561
2023-01-28	McAlevey Michael R	SVP & Chief Legal Officer	Exercise / conversion M	Common Stock	1,940	—	—	3,050
2023-01-23	Paslick P. Martin	SVP and CIO	Exercise / conversion M · derivative	Stock Appreciation Right	6,000	$0.00	$0	12,340
2023-01-23	Paslick P. Martin	SVP and CIO	Other disposed transaction F	Common Stock	2,966	$263.81	$782,460	22,146
2023-01-23	Paslick P. Martin	SVP and CIO	Exercise / conversion M	Common Stock	6,000	$81.96	$491,760	25,112
2022-11-11	MOORE A BRUCE JR	Group President - Service Line	Open-market sell S	Common Stock	10,000	$224.07	$2,240,690	30,807
2022-10-28	Billington Phillip G	SVP-Internal Audit Services	Open-market sell S	Common Stock	8,332	$222.58	$1,854,518	40,652
2022-10-28	Hall Charles J	Group President	Exercise / conversion M · derivative	Stock Appreciation Right	21,997	$0.00	$0	7,333
2022-10-28	Hall Charles J	Group President	Exercise / conversion M · derivative	Stock Appreciation Right	9,150	$0.00	$0	0
2022-10-28	Hall Charles J	Group President	Open-market sell S	Common Stock	9,838	$223.50	$2,198,793	199,883
2022-10-28	Hall Charles J	Group President	Other disposed transaction F	Common Stock	23,064	$223.66	$5,158,494	209,721
2022-10-28	Hall Charles J	Group President	Exercise / conversion M	Common Stock	21,997	$139.06	$3,058,903	232,785
2022-10-28	Hall Charles J	Group President	Exercise / conversion M	Common Stock	9,150	$101.16	$925,614	210,788
2022-10-27	MOORE A BRUCE JR	Group President - Service Line	Exercise / conversion M · derivative	Stock Appreciation Right	35,625	$0.00	$0	0
2022-10-27	MOORE A BRUCE JR	Group President - Service Line	Other disposed transaction F	Common Stock	17,709	$217.77	$3,856,489	40,807
2022-10-27	MOORE A BRUCE JR	Group President - Service Line	Exercise / conversion M	Common Stock	35,625	$37.18	$1,324,538	58,516
2022-10-26	Billington Phillip G	SVP-Internal Audit Services	Exercise / conversion M · derivative	Stock Appreciation Right	8,075	$0.00	$0	0
2022-10-26	Billington Phillip G	SVP-Internal Audit Services	Exercise / conversion M · derivative	Stock Appreciation Right	8,500	$0.00	$0	0
2022-10-26	Billington Phillip G	SVP-Internal Audit Services	Other disposed transaction F	Common Stock	8,243	$217.48	$1,792,688	48,984
2022-10-26	Billington Phillip G	SVP-Internal Audit Services	Exercise / conversion M	Common Stock	16,575	$37.18	$616,258	57,227
2022-10-25	Sowell Joseph A III	SVP; Chief Development Officer	Exercise / conversion M · derivative	Stock Appreciation Right	27,500	$0.00	$0	0
2022-10-25	Sowell Joseph A III	SVP; Chief Development Officer	Other disposed transaction F	Common Stock	14,554	$214.40	$3,120,378	12,946
2022-10-25	Sowell Joseph A III	SVP; Chief Development Officer	Exercise / conversion M	Common Stock	27,500	$47.97	$1,319,175	27,500
2022-10-25	Sowell Joseph A III	SVP; Chief Development Officer	Equity grant / award G	Common Stock	3,600	$0.00	$0	29,771
2022-10-24	Torres Kathryn A.	SVP-Payer Contracting & Align.	Open-market sell S	Common Stock	300	$209.94	$62,982	20,372
2022-10-24	Torres Kathryn A.	SVP-Payer Contracting & Align.	Open-market sell S	Common Stock	1,700	$202.13	$343,623	20,672
2022-08-10	Sowell Joseph A III	SVP; Chief Development Officer	Equity grant / award G	Common Stock	17,051	$0.00	$0	33,371
2022-08-04	Sowell Joseph A III	SVP; Chief Development Officer	Equity grant / award G	Common Stock	5,000	$0.00	$0	16,320
2022-07-25	Elcan Patricia F	10%	Open-market buy P	Common Stock, par value $0.01 per share	325	$198.66	$64,564	89,337
2022-05-13	Berres Jennifer	SVP & Chief Human Res. Officer	Open-market sell S	Common Stock	2,358	$218.87	$516,086	11,392
2022-05-03	Whalen Kathleen M	SVP & Chief Ethics Officer	Open-market sell S	Common Stock	500	$215.38	$107,690	11,373
2022-05-02	FRIST THOMAS F JR	10%	Open-market buy P	Common Stock, par value $0.01 per share	7,577	$215.29	$1,631,279	478,955
2022-05-02	FRIST THOMAS F JR	10%	Open-market buy P	Common Stock, par value $0.01 per share	12,170	$214.48	$2,610,270	471,378
2022-05-02	FRIST THOMAS F JR	10%	Open-market buy P	Common Stock, par value $0.01 per share	7,683	$213.47	$1,640,067	459,208
2022-05-02	FRIST THOMAS F JR	10%	Open-market buy P	Common Stock, par value $0.01 per share	3,606	$212.60	$766,632	451,525
2022-05-02	FRIST THOMAS F JR	10%	Open-market buy P	Common Stock, par value $0.01 per share	16,313	$211.22	$3,445,589	447,919
2022-05-02	FRIST THOMAS F JR	10%	Open-market buy P	Common Stock, par value $0.01 per share	37,623	$210.60	$7,923,404	431,606
2022-05-02	FRIST THOMAS F JR	10%	Open-market buy P	Common Stock, par value $0.01 per share	4,128	$209.73	$865,760	393,983
2022-04-29	McAlevey Michael R	SVP & Chief Legal Officer	Open-market buy P	Common Stock	1,110	$218.56	$242,602	1,110
2022-04-28	Smith Andrea B	Dir	Open-market buy P	Common Stock	1,160	$213.63	$247,815	2,239
2022-04-25	Smith Andrea B	Dir	Equity grant / award A	Common Stock	902	$0.00	$0	1,079
2022-03-11	Sowell Joseph A III	SVP; Chief Development Officer	Open-market sell S	Common Stock	11,522	$269.00	$3,099,418	17,051
2022-02-18	Wyatt Christopher F.	SVP & Controller	Other disposed transaction F	Common Stock	1,836	$244.10	$448,168	32,184
2022-02-18	Wyatt Christopher F.	SVP & Controller	Equity grant / award A	Common Stock	6,200	$0.00	$0	34,020
2022-02-17	MOORE A BRUCE JR	Group President - Service Line	Open-market sell S	Common Stock	9,367	$253.18	$2,371,502	91,788
2022-02-16	MOORE A BRUCE JR	Group President - Service Line	Open-market sell S	Common Stock	20,633	$244.01	$5,034,685	101,155
2022-02-03	Mosier Sammie S	SVP & Chief Nurse Executive	Exercise / conversion M · derivative	Restricted Stock Units	137	$0.00	$0	413
2022-02-03	Mosier Sammie S	SVP & Chief Nurse Executive	Other disposed transaction F	Common Stock	34	$240.86	$8,189	5,710
2022-02-03	Mosier Sammie S	SVP & Chief Nurse Executive	Exercise / conversion M	Common Stock	137	—	—	5,744
2022-01-28	Smith Andrea B	Dir	Equity grant / award A	Common Stock	177	$0.00	$0	177
2022-01-05	Sowell Joseph A III	SVP; Chief Development Officer	Exercise / conversion M · derivative	Stock Appreciation Right	23,375	$0.00	$0	0
2022-01-05	Sowell Joseph A III	SVP; Chief Development Officer	Other disposed transaction F	Common Stock	11,853	$258.97	$3,069,571	23,879
2022-01-05	Sowell Joseph A III	SVP; Chief Development Officer	Exercise / conversion M	Common Stock	23,375	$47.97	$1,121,299	35,732
2022-01-04	Sowell Joseph A III	SVP; Chief Development Officer	Open-market sell S	Common Stock	22,198	$259.23	$5,754,390	12,357
2021-12-29	Sowell Joseph A III	SVP; Chief Development Officer	Exercise / conversion M · derivative	Stock Appreciation Right	42,750	$0.00	$0	0
2021-12-29	Sowell Joseph A III	SVP; Chief Development Officer	Other disposed transaction F	Common Stock	20,552	$258.49	$5,312,486	34,555
2021-12-29	Sowell Joseph A III	SVP; Chief Development Officer	Exercise / conversion M	Common Stock	42,750	$37.18	$1,589,445	55,107
2021-11-11	Foster Jon M	Group President	Open-market sell S	Common Stock	294	$242.79	$71,379	0
2021-11-11	Foster Jon M	Group President	Open-market sell S	Common Stock	7,000	$242.20	$1,695,394	294
2021-11-11	Foster Jon M	Group President	Open-market sell S	Common Stock	9,000	$241.17	$2,170,526	7,294
2021-11-10	Reiner Deborah M	SVP - Mktg. & Communications	Open-market sell S	Common Stock	2,052	$246.23	$505,261	4,524
2021-11-09	Foster Jon M	Group President	Exercise / conversion M · derivative	Stock Appreciation Right	31,875	$0.00	$0	0
2021-11-09	Foster Jon M	Group President	Exercise / conversion M · derivative	Stock Appreciation Right	1,500	$0.00	$0	0
2021-11-09	Foster Jon M	Group President	Other disposed transaction F	Common Stock	17,081	$246.14	$4,204,317	16,294
2021-11-09	Foster Jon M	Group President	Exercise / conversion M	Common Stock	33,375	$47.97	$1,600,999	33,375
2021-11-08	Torres Kathryn A.	SVP-Payer Contracting & Align.	Exercise / conversion M · derivative	Stock Appreciation Right	2,760	$0.00	$0	8,280
2021-11-08	Torres Kathryn A.	SVP-Payer Contracting & Align.	Exercise / conversion M · derivative	Stock Appreciation Right	5,335	$0.00	$0	5,335
2021-11-08	Torres Kathryn A.	SVP-Payer Contracting & Align.	Other disposed transaction F	Common Stock	5,986	$247.63	$1,482,313	18,008
2021-11-08	Torres Kathryn A.	SVP-Payer Contracting & Align.	Exercise / conversion M	Common Stock	2,760	$145.24	$400,862	23,994
2021-11-08	Torres Kathryn A.	SVP-Payer Contracting & Align.	Exercise / conversion M	Common Stock	5,335	$139.06	$741,885	21,234
2021-11-05	Wyatt Christopher F.	SVP & Controller	Open-market sell S	Common Stock	2,100	$252.94	$531,174	27,820
2021-11-04	Whalen Kathleen M	SVP & Chief Ethics Officer	Open-market sell S	Common Stock	3,815	$250.48	$955,598	8,877
2021-11-03	Englebright Jane D.	SVP and Chief Nursing Officer	Exercise / conversion M · derivative	Stock Appreciation Right	7,688	$0.00	$0	0
2021-11-03	Englebright Jane D.	SVP and Chief Nursing Officer	Other disposed transaction F	Common Stock	4,324	$250.00	$1,081,000	3,364
2021-11-03	Englebright Jane D.	SVP and Chief Nursing Officer	Exercise / conversion M	Common Stock	7,688	$69.58	$534,931	7,688
2021-11-02	Whalen Kathleen M	SVP & Chief Ethics Officer	Exercise / conversion M · derivative	Stock Appreciation Right	5,000	$0.00	$0	0
2021-11-02	Whalen Kathleen M	SVP & Chief Ethics Officer	Exercise / conversion M · derivative	Stock Appreciation Right	700	$0.00	$0	0
2021-11-02	Whalen Kathleen M	SVP & Chief Ethics Officer	Exercise / conversion M · derivative	Stock Appreciation Right	2,625	$0.00	$0	0
2021-11-02	Whalen Kathleen M	SVP & Chief Ethics Officer	Other disposed transaction F	Common Stock	4,510	$248.44	$1,120,464	12,692
2021-11-02	Whalen Kathleen M	SVP & Chief Ethics Officer	Exercise / conversion M	Common Stock	5,000	$68.96	$344,800	17,202
2021-11-02	Whalen Kathleen M	SVP & Chief Ethics Officer	Exercise / conversion M	Common Stock	3,325	$47.97	$159,500	12,202
2021-10-29	Wyatt Christopher F.	SVP & Controller	Exercise / conversion M · derivative	Stock Appreciation Right	5,260	$0.00	$0	0
2021-10-29	Wyatt Christopher F.	SVP & Controller	Other disposed transaction F	Common Stock	3,087	$250.46	$773,170	29,920
2021-10-29	Wyatt Christopher F.	SVP & Controller	Exercise / conversion M	Common Stock	5,260	$79.80	$419,748	33,007
2021-10-25	Cuffe Michael S.	President-Physician Services	Equity grant / award A · derivative	Stock Appreciation Right	7,350	$0.00	$0	7,350
2021-09-01	Johnston Hugh F	Dir	Equity grant / award A	Common Stock	455	$0.00	$0	465
2021-08-05	Englebright Jane D.	SVP and Chief Nursing Officer	Open-market sell S	Common Stock	4,018	$250.12	$1,004,997	0
2021-08-03	MOORE A BRUCE JR	Group President - Service Line	Exercise / conversion M · derivative	Stock Appreciation Right	37,500	$0.00	$0	0
2021-08-03	MOORE A BRUCE JR	Group President - Service Line	Other disposed transaction F	Common Stock	18,093	$253.51	$4,586,756	121,788
2021-08-03	MOORE A BRUCE JR	Group President - Service Line	Exercise / conversion M	Common Stock	37,500	$37.18	$1,394,250	139,881
2021-08-02	Englebright Jane D.	SVP and Chief Nursing Officer	Open-market sell S	Common Stock	409	$249.57	$102,073	4,018
2021-08-02	Perlin Jonathan B	Pres-Clinical Operations & CMO	Open-market sell S	Common Stock	8,631	$250.00	$2,157,750	44,348
2021-08-02	Perlin Jonathan B	Pres-Clinical Operations & CMO	Open-market sell S	Common Stock	100	$250.06	$25,006	34,729
2021-08-02	Perlin Jonathan B	Pres-Clinical Operations & CMO	Open-market sell S	Common Stock	11,269	$250.00	$2,817,250	34,829
2021-08-02	Perlin Jonathan B	Pres-Clinical Operations & CMO	Open-market sell S	Common Stock	20,000	$250.00	$5,000,000	0
2021-07-30	Englebright Jane D.	SVP and Chief Nursing Officer	Open-market sell S	Common Stock	2,900	$249.43	$723,352	4,427
2021-07-28	Perlin Jonathan B	Pres-Clinical Operations & CMO	Equity grant / award G	Common Stock	20,000	$0.00	$0	20,000
2021-07-28	Perlin Jonathan B	Pres-Clinical Operations & CMO	Equity grant / award G	Common Stock	3,268	$0.00	$0	22,085
2021-07-28	Perlin Jonathan B	Pres-Clinical Operations & CMO	Equity grant / award G	Common Stock	11,704	$0.00	$0	18,817
2021-07-28	Perlin Jonathan B	Pres-Clinical Operations & CMO	Equity grant / award G	Common Stock	1,182	$0.00	$0	7,113
2021-07-28	Perlin Jonathan B	Pres-Clinical Operations & CMO	Equity grant / award G	Common Stock	3,846	$0.00	$0	5,931
2021-07-27	Paslick P. Martin	SVP and CIO	Open-market sell S	Common Stock	7,466	$250.00	$1,866,500	12,878
2021-07-22	Whalen Kathleen M	SVP & Chief Ethics Officer	Open-market sell S	Common Stock	886	$246.90	$218,752	8,877
2021-07-21	Paslick P. Martin	SVP and CIO	Exercise / conversion M · derivative	Stock Appreciation Right	17,080	$0.00	$0	0
2021-07-21	Paslick P. Martin	SVP and CIO	Other disposed transaction F	Common Stock	9,614	$249.25	$2,396,290	20,344
2021-07-21	Paslick P. Martin	SVP and CIO	Exercise / conversion M	Common Stock	17,080	$69.58	$1,188,426	29,958
2021-05-13	Foster Jon M	Group President	Equity grant / award G	Common Stock	4,919	$0.00	$0	48,958
2021-05-12	Foster Jon M	Group President	Equity grant / award G	Common Stock	4,919	$0.00	$0	4,919
2021-05-11	Reiner Deborah M	SVP - Mktg. & Communications	Open-market sell S	Common Stock	3,432	$208.33	$714,989	6,576
2021-05-06	Paslick P. Martin	SVP and CIO	Open-market sell S	Common Stock	7,672	$207.55	$1,592,324	12,878
2021-05-05	WATERMAN ROBERT A	SVP & General Counsel	Open-market sell S	Common Stock	40,626	$207.19	$8,417,126	50,062
2021-05-04	Wyatt Christopher F.	SVP & Controller	Open-market sell S	Common Stock	4,604	$204.00	$939,216	27,747
2021-05-04	WATERMAN ROBERT A	SVP & General Counsel	Open-market sell S	Common Stock	19,043	$205.30	$3,909,591	90,688
2021-05-04	Paslick P. Martin	SVP and CIO	Exercise / conversion M · derivative	Stock Appreciation Right	19,000	$0.00	$0	0
2021-05-04	Paslick P. Martin	SVP and CIO	Other disposed transaction F	Common Stock	11,328	$206.34	$2,337,420	20,550
2021-05-04	Paslick P. Martin	SVP and CIO	Exercise / conversion M	Common Stock	19,000	$68.96	$1,310,240	31,878
2021-05-03	WATERMAN ROBERT A	SVP & General Counsel	Open-market sell S	Common Stock	21,584	$205.21	$4,429,151	109,731
2021-04-30	WATERMAN ROBERT A	SVP & General Counsel	Open-market sell S	Common Stock	1,843	$203.06	$374,235	131,315
2021-04-30	Wyatt Christopher F.	SVP & Controller	Exercise / conversion M · derivative	Stock Appreciation Right	4,990	$0.00	$0	5,260
2021-04-30	Wyatt Christopher F.	SVP & Controller	Exercise / conversion M · derivative	Stock Appreciation Right	7,010	$0.00	$0	0
2021-04-30	Wyatt Christopher F.	SVP & Controller	Other disposed transaction F	Common Stock	7,396	$201.06	$1,487,040	32,351
2021-04-30	Wyatt Christopher F.	SVP & Controller	Exercise / conversion M	Common Stock	4,990	$79.80	$398,202	39,747
2021-04-30	Wyatt Christopher F.	SVP & Controller	Exercise / conversion M	Common Stock	7,010	$69.58	$487,756	34,757
2021-04-30	Perlin Jonathan B	Pres-Clinical Operations & CMO	Equity grant / award G	Common Stock	23,445	$0.00	$0	56,247
2021-04-29	WATERMAN ROBERT A	SVP & General Counsel	Open-market sell S	Common Stock	7,230	$202.90	$1,466,969	133,158
2021-04-29	WATERMAN ROBERT A	SVP & General Counsel	Open-market sell S	Common Stock	19,623	$201.96	$3,962,987	140,388
2021-04-29	WATERMAN ROBERT A	SVP & General Counsel	Open-market sell S	Common Stock	41,352	$201.09	$8,315,680	160,011
2021-04-29	WATERMAN ROBERT A	SVP & General Counsel	Open-market sell S	Common Stock	4,641	$200.30	$929,584	201,363
2021-04-29	Cuffe Michael S.	President-Physician Services	Exercise / conversion M · derivative	Stock Appreciation Right	5,930	$0.00	$0	0
2021-04-29	Cuffe Michael S.	President-Physician Services	Open-market sell S	Common Stock	18,664	$201.53	$3,761,384	20,369
2021-04-29	Cuffe Michael S.	President-Physician Services	Other disposed transaction F	Common Stock	3,794	$201.94	$766,160	39,033
2021-04-29	Cuffe Michael S.	President-Physician Services	Exercise / conversion M	Common Stock	5,930	$81.96	$486,023	42,827
2021-04-28	WATERMAN ROBERT A	SVP & General Counsel	Open-market sell S	Common Stock	42,578	$200.24	$8,525,849	206,004
2021-04-28	WATERMAN ROBERT A	SVP & General Counsel	Open-market sell S	Common Stock	21,508	$199.53	$4,291,386	248,582
2021-04-28	WATERMAN ROBERT A	SVP & General Counsel	Open-market sell S	Common Stock	8,759	$198.75	$1,740,862	270,090
2021-04-27	Perlin Jonathan B	Pres-Clinical Operations & CMO	Open-market sell S	Common Stock	38,390	$199.91	$7,674,595	25,514
2021-04-27	Perlin Jonathan B	Pres-Clinical Operations & CMO	Open-market sell S	Common Stock	25,000	$200.08	$5,002,122	0
2021-04-27	Perlin Jonathan B	Pres-Clinical Operations & CMO	Equity grant / award G	Common Stock	25,000	$0.00	$0	25,000
2021-04-23	Perlin Jonathan B	Pres-Clinical Operations & CMO	Exercise / conversion M · derivative	Stock Appreciation Right	5,520	$0.00	$0	16,560
2021-04-23	Perlin Jonathan B	Pres-Clinical Operations & CMO	Exercise / conversion M · derivative	Stock Appreciation Right	9,330	$0.00	$0	9,330
2021-04-23	Perlin Jonathan B	Pres-Clinical Operations & CMO	Exercise / conversion M · derivative	Stock Appreciation Right	24,015	$0.00	$0	8,005
2021-04-23	Perlin Jonathan B	Pres-Clinical Operations & CMO	Exercise / conversion M · derivative	Stock Appreciation Right	25,680	$0.00	$0	0
2021-04-23	Perlin Jonathan B	Pres-Clinical Operations & CMO	Exercise / conversion M · derivative	Stock Appreciation Right	23,910	$0.00	$0	0
2021-04-23	Perlin Jonathan B	Pres-Clinical Operations & CMO	Exercise / conversion M · derivative	Stock Appreciation Right	24,000	$0.00	$0	0
2021-04-23	Perlin Jonathan B	Pres-Clinical Operations & CMO	Open-market sell S	Common Stock	37,305	$200.03	$7,462,130	63,904
2021-04-23	Perlin Jonathan B	Pres-Clinical Operations & CMO	Other disposed transaction F	Common Stock	74,065	$202.50	$14,998,162	101,209
2021-04-23	Perlin Jonathan B	Pres-Clinical Operations & CMO	Exercise / conversion M	Common Stock	5,520	$145.24	$801,725	175,274
2021-04-23	Perlin Jonathan B	Pres-Clinical Operations & CMO	Exercise / conversion M	Common Stock	9,330	$139.06	$1,297,430	169,754
2021-04-23	Perlin Jonathan B	Pres-Clinical Operations & CMO	Exercise / conversion M	Common Stock	24,015	$101.16	$2,429,357	160,424
2021-04-23	Perlin Jonathan B	Pres-Clinical Operations & CMO	Exercise / conversion M	Common Stock	25,680	$81.96	$2,104,733	136,409
2021-04-23	Perlin Jonathan B	Pres-Clinical Operations & CMO	Exercise / conversion M	Common Stock	23,910	$69.58	$1,663,658	110,729
2021-04-23	Perlin Jonathan B	Pres-Clinical Operations & CMO	Exercise / conversion M	Common Stock	24,000	$68.96	$1,655,040	86,819
2021-04-20	Foster Jon M	Group President	Open-market sell S	Common Stock	5,504	$194.90	$1,072,730	9,838
2021-04-16	Foster Jon M	Group President	Exercise / conversion M · derivative	Stock Appreciation Right	12,000	$0.00	$0	1,500
2021-04-16	Foster Jon M	Group President	Other disposed transaction F	Common Stock	6,496	$196.93	$1,279,257	15,342
2021-04-16	Foster Jon M	Group President	Exercise / conversion M	Common Stock	12,000	$47.97	$575,640	21,838
2021-03-08	Riley Wayne Joseph	Dir	Open-market sell S	Common Stock	1,650	$190.00	$313,500	10,819
2021-02-24	WATERMAN ROBERT A	SVP & General Counsel	Open-market sell S	Common Stock	4,100	$175.32	$718,809	278,849
2021-02-24	WATERMAN ROBERT A	SVP & General Counsel	Open-market sell S	Common Stock	43,990	$176.36	$7,758,288	282,949
2021-02-24	WATERMAN ROBERT A	SVP & General Counsel	Open-market sell S	Common Stock	12,266	$177.00	$2,171,056	326,939
2021-02-24	WATERMAN ROBERT A	SVP & General Counsel	Open-market sell S	Common Stock	13,497	$178.20	$2,405,182	339,205
2021-02-24	Wyatt Christopher F.	SVP & Controller	Equity grant / award G	Common Stock	433	$0.00	$0	27,747
2021-02-23	Englebright Jane D.	SVP and Chief Nursing Officer	Open-market sell S	Common Stock	2,090	$174.06	$363,792	3,509
2021-02-23	Englebright Jane D.	SVP and Chief Nursing Officer	Open-market sell S	Common Stock	3,061	$175.03	$535,774	5,599
2021-02-23	Englebright Jane D.	SVP and Chief Nursing Officer	Open-market sell S	Common Stock	600	$175.75	$105,448	8,660
2021-02-19	Wyatt Christopher F.	SVP & Controller	Open-market sell S	Common Stock	3,200	$177.06	$566,580	28,180
2021-02-18	Wyatt Christopher F.	SVP & Controller	Other disposed transaction F	Common Stock	2,360	$174.61	$412,080	31,380
2021-02-18	Wyatt Christopher F.	SVP & Controller	Equity grant / award A	Common Stock	8,111	$0.00	$0	33,740
2021-02-16	Berres Jennifer	SVP & Chief Human Res. Officer	Exercise / conversion M · derivative	Stock Appreciation Right	6,000	$0.00	$0	0
2021-02-16	Berres Jennifer	SVP & Chief Human Res. Officer	Exercise / conversion M · derivative	Stock Appreciation Right	3,825	$0.00	$0	0
2021-02-16	Berres Jennifer	SVP & Chief Human Res. Officer	Exercise / conversion M · derivative	Stock Appreciation Right	4,500	$0.00	$0	0
2021-02-16	Berres Jennifer	SVP & Chief Human Res. Officer	Other disposed transaction F	Common Stock	7,633	$174.00	$1,328,142	8,067
2021-02-16	Berres Jennifer	SVP & Chief Human Res. Officer	Exercise / conversion M	Common Stock	6,000	$68.96	$413,760	15,700
2021-02-16	Berres Jennifer	SVP & Chief Human Res. Officer	Exercise / conversion M	Common Stock	8,325	$47.97	$399,350	9,700
2021-02-08	Wyatt Christopher F.	SVP & Controller	Exercise / conversion M · derivative	Stock Appreciation Right	8,000	$0.00	$0	0
2021-02-08	Wyatt Christopher F.	SVP & Controller	Other disposed transaction F	Common Stock	4,308	$178.94	$770,874	25,629
2021-02-08	Wyatt Christopher F.	SVP & Controller	Exercise / conversion M	Common Stock	8,000	$68.96	$551,680	29,937
2021-02-04	Riley Wayne Joseph	Dir	Open-market sell S	Common Stock	1,650	$175.00	$288,750	12,469
2021-02-03	Riley Wayne Joseph	Dir	Open-market sell S	Common Stock	1,650	$166.19	$274,214	14,119
2020-11-24	Reiner Deborah M	SVP - Mktg. & Communications	Open-market sell S	Common Stock	1,266	$155.00	$196,230	5,484
2020-11-17	Reiner Deborah M	SVP - Mktg. & Communications	Exercise / conversion M · derivative	Stock Appreciation Right	2,000	$0.00	$0	6,000
2020-11-17	Reiner Deborah M	SVP - Mktg. & Communications	Exercise / conversion M · derivative	Stock Appreciation Right	3,432	$0.00	$0	6,865
2020-11-17	Reiner Deborah M	SVP - Mktg. & Communications	Exercise / conversion M · derivative	Stock Appreciation Right	1,605	$0.00	$0	1,605
2020-11-17	Reiner Deborah M	SVP - Mktg. & Communications	Other disposed transaction F	Common Stock	5,771	$153.03	$883,136	6,750
2020-11-17	Reiner Deborah M	SVP - Mktg. & Communications	Exercise / conversion M	Common Stock	2,000	$139.06	$278,120	12,521
2020-11-17	Reiner Deborah M	SVP - Mktg. & Communications	Exercise / conversion M	Common Stock	3,432	$101.16	$347,181	10,521
2020-11-17	Reiner Deborah M	SVP - Mktg. & Communications	Exercise / conversion M	Common Stock	1,605	$81.96	$131,546	7,089
2020-11-16	Perlin Jonathan B	Pres-Clinical Operations & CMO	Exercise / conversion M · derivative	Stock Appreciation Right	44,750	$0.00	$0	0
2020-11-16	Perlin Jonathan B	Pres-Clinical Operations & CMO	Other disposed transaction F	Common Stock	24,257	$151.82	$3,682,698	22,421
2020-11-16	Perlin Jonathan B	Pres-Clinical Operations & CMO	Exercise / conversion M	Common Stock	44,750	$37.18	$1,663,805	46,678
2020-11-16	Reiner Deborah M	SVP - Mktg. & Communications	Open-market sell S	Common Stock	5,078	$151.75	$770,586	5,484
2020-11-13	Perlin Jonathan B	Pres-Clinical Operations & CMO	Open-market sell S	Common Stock	17,002	$149.50	$2,541,799	1,928
2020-11-13	Perlin Jonathan B	Pres-Clinical Operations & CMO	Equity grant / award G	Common Stock	7,802	$0.00	$0	57,802
2020-11-11	Perlin Jonathan B	Pres-Clinical Operations & CMO	Equity grant / award G	Common Stock	7,802	$0.00	$0	57,802
2020-11-10	Hall Charles J	Group President	Open-market sell S	Common Stock	6,536	$154.46	$1,009,537	200,517
2020-11-09	Perlin Jonathan B	Pres-Clinical Operations & CMO	Open-market sell S	Common Stock	5,531	$147.36	$815,070	17,532
2020-11-09	Perlin Jonathan B	Pres-Clinical Operations & CMO	Exercise / conversion M · derivative	Stock Appreciation Right	7,500	$0.00	$0	44,750
2020-11-09	Perlin Jonathan B	Pres-Clinical Operations & CMO	Exercise / conversion M · derivative	Stock Appreciation Right	30,000	$0.00	$0	0
2020-11-09	Perlin Jonathan B	Pres-Clinical Operations & CMO	Other disposed transaction F	Common Stock	20,498	$147.32	$3,019,765	34,534
2020-11-09	Perlin Jonathan B	Pres-Clinical Operations & CMO	Exercise / conversion M	Common Stock	37,500	$37.18	$1,394,250	55,032
2020-11-05	Perlin Jonathan B	Pres-Clinical Operations & CMO	Exercise / conversion M · derivative	Stock Appreciation Right	12,500	$0.00	$0	30,000
2020-11-05	Perlin Jonathan B	Pres-Clinical Operations & CMO	Other disposed transaction F	Common Stock	6,969	$137.56	$958,656	23,063
2020-11-05	Perlin Jonathan B	Pres-Clinical Operations & CMO	Exercise / conversion M	Common Stock	12,500	$37.18	$464,750	30,032
2020-11-03	Paslick P. Martin	SVP and CIO	Open-market sell S	Common Stock	1,771	$133.50	$236,428	0
2020-11-02	Morgan Sandra L.	SVP-Provider Relations	Open-market sell S	Common Stock	5,030	$127.75	$642,564	5,598
2020-10-30	Hall Charles J	Group President	Equity grant / award G	Common Stock	8,150	$0.00	$0	207,053
2020-10-29	Whalen Kathleen M	SVP & Chief Ethics Officer	Open-market sell S	Common Stock	1,268	$124.41	$157,747	3,964
2020-10-27	Paslick P. Martin	SVP and CIO	Open-market sell S	Common Stock	850	$133.50	$113,475	1,771
2020-08-11	Paslick P. Martin	SVP and CIO	Open-market sell S	Common Stock	227	$134.97	$30,638	2,621
2020-08-07	Paslick P. Martin	SVP and CIO	Open-market sell S	Common Stock	2,594	$132.97	$344,924	2,848
2020-08-07	Perlin Jonathan B	Pres-Clinical Operations & CMO	Equity grant / award G	Common Stock	50,000	$0.00	$0	50,000
2020-08-06	Paslick P. Martin	SVP and CIO	Open-market sell S	Common Stock	254	$132.97	$33,774	5,442
2020-05-11	Perlin Jonathan B	Pres-Clinical Operations & CMO	Equity grant / award G	Common Stock	50,000	$0.00	$0	50,000
2020-05-06	Foster Jon M	Group President	Open-market sell S	Common Stock	2,700	$101.52	$274,096	40,203
2020-05-06	Foster Jon M	Group President	Open-market sell S	Common Stock	6,309	$100.80	$635,941	42,903
2020-05-06	Foster Jon M	Group President	Open-market sell S	Common Stock	15,211	$99.71	$1,516,617	49,212
2020-05-01	Frist William R	Dir	Equity grant / award A	Common Stock, par value $0.01 per share	1,668	$0.00	$0	7,036
2020-05-01	Perlin Jonathan B	Pres-Clinical Operations & CMO	Equity grant / award G	Common Stock	50,000	$0.00	$0	50,000
2020-02-19	Wyatt Christopher F.	SVP & Controller	Other disposed transaction F	Common Stock	1,548	$150.08	$232,324	21,937
2020-02-19	Wyatt Christopher F.	SVP & Controller	Equity grant / award A	Common Stock	6,234	$0.00	$0	23,485
2020-02-13	Hall Charles J	Group President	Exercise / conversion M · derivative	Stock Appreciation Right	20,000	$0.00	$0	4,000
2020-02-13	Hall Charles J	Group President	Exercise / conversion M · derivative	Stock Appreciation Right	37,500	$0.00	$0	0
2020-02-13	Hall Charles J	Group President	Exercise / conversion M · derivative	Stock Appreciation Right	17,875	$0.00	$0	0
2020-02-13	Hall Charles J	Group President	Other disposed transaction F	Common Stock	44,914	$150.88	$6,776,624	204,025
2020-02-13	Hall Charles J	Group President	Exercise / conversion M	Common Stock	20,000	$68.96	$1,379,200	248,939
2020-02-13	Hall Charles J	Group President	Exercise / conversion M	Common Stock	55,375	$47.97	$2,656,339	228,939
2020-02-12	Reiner Deborah M	SVP - Mktg. & Communications	Open-market sell S	Common Stock	2,050	$150.12	$307,746	5,484
2020-02-07	Whalen Kathleen M	SVP & Chief Ethics Officer	Open-market sell S	Common Stock	1,956	$146.46	$286,475	3,964
2020-02-07	Hall Charles J	Group President	Equity grant / award G	Common Stock	3,410	$0.00	$0	173,564
2020-02-05	Torres Kathryn A.	SVP-Payer Contracting & Align.	Open-market sell S	Common Stock	1,500	$149.16	$223,743	6,977
2020-02-04	Sowell Joseph A III	SVP; Chief Development Officer	Open-market sell S	Common Stock	21,309	$145.00	$3,089,805	646
2020-01-29	Morgan Sandra L.	SVP-Provider Relations	Equity grant / award A · derivative	Stock Appreciation Right	8,280	$0.00	$0	8,280
2019-12-23	Cuffe Michael S.	President-Physician Services	Open-market sell S	Common Stock	5,891	$147.04	$866,213	35,193
2019-12-20	Cuffe Michael S.	President-Physician Services	Exercise / conversion M · derivative	Stock Appreciation Right	20,000	$0.00	$0	0
2019-12-20	Cuffe Michael S.	President-Physician Services	Other disposed transaction F	Common Stock	13,541	$147.53	$1,997,704	41,084
2019-12-20	Cuffe Michael S.	President-Physician Services	Exercise / conversion M	Common Stock	20,000	$68.96	$1,379,200	54,625
2019-12-20	Sowell Joseph A III	SVP; Chief Development Officer	Exercise / conversion M · derivative	Stock Appreciation Right	60,654	$0.00	$0	0
2019-12-20	Sowell Joseph A III	SVP; Chief Development Officer	Other disposed transaction F	Common Stock	29,591	$147.53	$4,365,560	31,709
2019-12-20	Sowell Joseph A III	SVP; Chief Development Officer	Exercise / conversion M	Common Stock	60,654	$22.95	$1,392,009	61,300
2019-12-19	Cuffe Michael S.	President-Physician Services	Exercise / conversion M · derivative	Stock Appreciation Right	14,500	$0.00	$0	0
2019-12-19	Cuffe Michael S.	President-Physician Services	Other disposed transaction F	Common Stock	8,609	$145.39	$1,251,663	34,625
2019-12-19	Cuffe Michael S.	President-Physician Services	Exercise / conversion M	Common Stock	14,500	$47.97	$695,565	43,234
2019-12-11	Englebright Jane D.	SVP and Chief Nursing Officer	Open-market sell S	Common Stock	2,049	$143.50	$294,032	10,480
2019-12-06	Englebright Jane D.	SVP and Chief Nursing Officer	Exercise / conversion M · derivative	Stock Appreciation Right	2,100	$0.00	$0	4,550
2019-12-06	Englebright Jane D.	SVP and Chief Nursing Officer	Exercise / conversion M · derivative	Stock Appreciation Right	2,450	$0.00	$0	0
2019-12-06	Englebright Jane D.	SVP and Chief Nursing Officer	Other disposed transaction F	Common Stock	2,501	$144.61	$361,670	12,529
2019-12-06	Englebright Jane D.	SVP and Chief Nursing Officer	Exercise / conversion M	Common Stock	4,550	$37.18	$169,169	15,030
2019-11-15	Hall Charles J	Group President	Exercise / conversion M · derivative	Stock Appreciation Right	14,000	$0.00	$0	17,875
2019-11-15	Hall Charles J	Group President	Exercise / conversion M · derivative	Stock Appreciation Right	52,250	$0.00	$0	0
2019-11-15	Hall Charles J	Group President	Exercise / conversion M · derivative	Stock Appreciation Right	55,000	$0.00	$0	0
2019-11-15	Hall Charles J	Group President	Other disposed transaction F	Common Stock	68,184	$138.05	$9,412,801	184,879
2019-11-15	Hall Charles J	Group President	Exercise / conversion M	Common Stock	14,000	$47.97	$671,580	253,063
2019-11-15	Hall Charles J	Group President	Exercise / conversion M	Common Stock	107,250	$37.18	$3,987,555	239,063
2019-11-08	Englebright Jane D.	SVP and Chief Nursing Officer	Open-market sell S	Common Stock	1,995	$137.50	$274,312	10,480
2019-11-05	Reiner Deborah M	SVP - Mktg. & Communications	Open-market sell S	Common Stock	749	$136.67	$102,366	5,484
2019-11-05	Englebright Jane D.	SVP and Chief Nursing Officer	Exercise / conversion M · derivative	Stock Appreciation Right	4,550	$0.00	$0	2,450
2019-11-05	Englebright Jane D.	SVP and Chief Nursing Officer	Other disposed transaction F	Common Stock	2,555	$134.34	$343,239	12,475
2019-11-05	Englebright Jane D.	SVP and Chief Nursing Officer	Exercise / conversion M	Common Stock	4,550	$37.18	$169,169	15,030
2019-11-04	Whalen Kathleen M	SVP & Chief Ethics Officer	Open-market sell S	Common Stock	2,540	$135.21	$343,438	5,920
2019-11-01	Reiner Deborah M	SVP - Mktg. & Communications	Exercise / conversion M · derivative	Stock Appreciation Right	2,753	$0.00	$0	5,505
2019-11-01	Reiner Deborah M	SVP - Mktg. & Communications	Other disposed transaction F	Common Stock	2,004	$133.65	$267,835	6,233
2019-11-01	Reiner Deborah M	SVP - Mktg. & Communications	Exercise / conversion M	Common Stock	2,753	$76.83	$211,513	8,237
2019-10-31	Foster Jon M	Group President	Open-market sell S	Common Stock	19,477	$132.35	$2,577,707	10,015
2019-10-30	Wyatt Christopher F.	SVP & Controller	Exercise / conversion M · derivative	Stock Appreciation Right	4,675	$0.00	$0	0
2019-10-30	Wyatt Christopher F.	SVP & Controller	Exercise / conversion M · derivative	Stock Appreciation Right	5,500	$0.00	$0	0
2019-10-30	Wyatt Christopher F.	SVP & Controller	Open-market sell S	Common Stock	3,900	$134.74	$525,487	17,251
2019-10-30	Wyatt Christopher F.	SVP & Controller	Other disposed transaction F	Common Stock	6,202	$134.77	$835,844	21,151
2019-10-30	Wyatt Christopher F.	SVP & Controller	Exercise / conversion M	Common Stock	10,175	$47.97	$488,095	27,353
2019-08-13	Whalen Kathleen M	SVP & Chief Ethics Officer	Exercise / conversion M · derivative	Stock Appreciation Right	2,250	$0.00	$0	0
2019-08-13	Whalen Kathleen M	SVP & Chief Ethics Officer	Exercise / conversion M · derivative	Stock Appreciation Right	1,750	$0.00	$0	0
2019-08-13	Whalen Kathleen M	SVP & Chief Ethics Officer	Open-market sell S	Common Stock	977	$127.56	$124,626	8,460
2019-08-13	Whalen Kathleen M	SVP & Chief Ethics Officer	Other disposed transaction F	Common Stock	2,047	$127.90	$261,811	9,437
2019-08-13	Whalen Kathleen M	SVP & Chief Ethics Officer	Exercise / conversion M	Common Stock	4,000	$45.30	$181,200	11,484
2019-08-06	Elcan Patricia F	10%	Open-market buy P	Common Stock, par value $0.01 per share	250	$124.10	$31,024	997,017
2019-07-31	WATERMAN ROBERT A	SVP & General Counsel	Exercise / conversion M · derivative	Non-Qualified Stock Option (right to buy)	6,756	$0.00	$0	0
2019-07-31	WATERMAN ROBERT A	SVP & General Counsel	Exercise / conversion M · derivative	Non-Qualified Stock Option (right to buy)	3,378	$0.00	$0	0
2019-07-31	WATERMAN ROBERT A	SVP & General Counsel	Exercise / conversion M · derivative	Non-Qualified Stock Option (right to buy)	6,759	$0.00	$0	0
2019-07-31	WATERMAN ROBERT A	SVP & General Counsel	Exercise / conversion M · derivative	Non-Qualified Stock Option (right to buy)	10,137	$0.00	$0	0
2019-07-31	WATERMAN ROBERT A	SVP & General Counsel	Open-market sell S	Common Stock	4,208	$135.85	$571,656	262,655
2019-07-31	WATERMAN ROBERT A	SVP & General Counsel	Open-market sell S	Common Stock	29,578	$134.86	$3,988,922	266,863
2019-07-31	WATERMAN ROBERT A	SVP & General Counsel	Exercise / conversion M	Common Stock	3,378	$15.91	$53,748	296,441
2019-07-31	WATERMAN ROBERT A	SVP & General Counsel	Exercise / conversion M	Common Stock	10,134	$6.48	$65,640	289,685
2019-07-31	WATERMAN ROBERT A	SVP & General Counsel	Exercise / conversion M	Common Stock	16,896	$5.98	$101,074	279,551
2019-05-21	Elcan Patricia F	10%	Equity grant / award G	Common Stock, par value $0.01 per share	20,841	$0.00	$0	797,415
2019-05-17	Sowell Joseph A III	SVP; Chief Development Officer	Equity grant / award G	Common Stock	21,320	$0.00	$0	21,320
2019-05-10	Foster Jon M	Group President	Equity grant / award G	Common Stock	4,000	$0.00	$0	13,344
2019-05-10	Foster Jon M	Group President	Open-market sell S	Common Stock	1,458	$122.92	$179,213	17,344
2019-05-10	Foster Jon M	Group President	Open-market sell S	Common Stock	42,823	$122.26	$5,235,480	18,802
2019-05-08	Foster Jon M	Group President	Exercise / conversion M · derivative	Stock Appreciation Right	60,000	$0.00	$0	2,500
2019-05-08	Foster Jon M	Group President	Other disposed transaction F	Common Stock	34,427	$125.09	$4,306,473	61,625
2019-05-08	Foster Jon M	Group President	Exercise / conversion M	Common Stock	60,000	$37.18	$2,230,800	96,052
2019-05-01	ROWE JOHN W	Dir	Equity grant / award A	Common Stock	1,410	$0.00	$0	30,388
2019-03-01	CROFTON MEG	Dir	Equity grant / award A	Common Stock	197	$0.00	$0	197
2019-02-25	WATERMAN ROBERT A	SVP & General Counsel	Exercise / conversion M · derivative	Restricted Stock Units	1,802	$0.00	$0	0
2019-02-25	WATERMAN ROBERT A	SVP & General Counsel	Other disposed transaction F	Common Stock	667	$143.26	$95,554	262,655
2019-02-25	WATERMAN ROBERT A	SVP & General Counsel	Exercise / conversion M	Common Stock	1,802	—	—	263,322
2019-02-21	Wyatt Christopher F.	SVP & Controller	Other disposed transaction F	Common Stock	2,054	$142.01	$291,689	17,178
2019-02-21	Wyatt Christopher F.	SVP & Controller	Equity grant / award A	Common Stock	7,823	$0.00	$0	19,232
2019-02-13	Foster Jon M	Group President	Open-market sell S	Common Stock	21,304	$140.89	$3,001,435	32,852
2019-02-12	Foster Jon M	Group President	Open-market sell S	Common Stock	11,640	$139.68	$1,625,874	54,156
2019-02-12	RUTHERFORD BILL B	CFO and EVP	Exercise / conversion M · derivative	Non-Qualified Stock Option (right to buy)	18,750	$0.00	$0	0
2019-02-12	RUTHERFORD BILL B	CFO and EVP	Open-market sell S	Common Stock	37,500	$139.65	$5,236,691	21,472
2019-02-12	RUTHERFORD BILL B	CFO and EVP	Exercise / conversion M	Common Stock	37,500	$17.33	$649,875	58,972
2019-02-11	Foster Jon M	Group President	Exercise / conversion M · derivative	Stock Appreciation Right	40,000	$0.00	$0	0
2019-02-11	Foster Jon M	Group President	Other disposed transaction F	Common Stock	18,696	$138.66	$2,592,387	65,796
2019-02-11	Foster Jon M	Group President	Exercise / conversion M	Common Stock	40,000	$22.95	$918,000	84,492
2019-02-11	Foster Jon M	Group President	Equity grant / award G	Common Stock	19,985	$0.00	$0	19,985
2019-02-07	STEELE JOHN M	SVP & Chief Human Res. Officer	Exercise / conversion M · derivative	Stock Appreciation Right	35,625	$0.00	$0	0
2019-02-07	STEELE JOHN M	SVP & Chief Human Res. Officer	Exercise / conversion M · derivative	Stock Appreciation Right	37,500	$0.00	$0	0
2019-02-07	STEELE JOHN M	SVP & Chief Human Res. Officer	Other disposed transaction F	Common Stock	39,455	$140.62	$5,548,162	111,404
2019-02-07	STEELE JOHN M	SVP & Chief Human Res. Officer	Exercise / conversion M	Common Stock	73,125	$37.18	$2,718,788	150,859
2019-02-06	Whalen Kathleen M	SVP & Chief Ethics Officer	Open-market sell S	Common Stock	200	$139.48	$27,896	6,231
2019-02-06	Whalen Kathleen M	SVP & Chief Ethics Officer	Equity grant / award G	Common Stock	440	$0.00	$0	6,431
2019-02-05	Reiner Deborah M	SVP - Mktg. & Communications	Open-market sell S	Common Stock	466	$139.07	$64,807	3,432
2019-02-05	Torres Kathryn A.	SVP-Payer Contracting & Align.	Exercise / conversion M · derivative	Stock Appreciation Right	4,575	$0.00	$0	13,725
2019-02-05	Torres Kathryn A.	SVP-Payer Contracting & Align.	Exercise / conversion M · derivative	Stock Appreciation Right	7,340	$0.00	$0	7,340
2019-02-05	Torres Kathryn A.	SVP-Payer Contracting & Align.	Exercise / conversion M · derivative	Stock Appreciation Right	5,125	$0.00	$0	5,125
2019-02-05	Torres Kathryn A.	SVP-Payer Contracting & Align.	Exercise / conversion M · derivative	Stock Appreciation Right	3,877	$0.00	$0	1,293
2019-02-05	Torres Kathryn A.	SVP-Payer Contracting & Align.	Exercise / conversion M · derivative	Stock Appreciation Right	7,000	$0.00	$0	0
2019-02-05	Torres Kathryn A.	SVP-Payer Contracting & Align.	Other disposed transaction F	Common Stock	19,549	$139.72	$2,731,386	12,605
2019-02-05	Torres Kathryn A.	SVP-Payer Contracting & Align.	Exercise / conversion M	Common Stock	4,575	$101.16	$462,807	32,154
2019-02-05	Torres Kathryn A.	SVP-Payer Contracting & Align.	Exercise / conversion M	Common Stock	7,340	$81.96	$601,586	27,579
2019-02-05	Torres Kathryn A.	SVP-Payer Contracting & Align.	Exercise / conversion M	Common Stock	5,125	$77.13	$395,291	20,239
2019-02-05	Torres Kathryn A.	SVP-Payer Contracting & Align.	Exercise / conversion M	Common Stock	3,877	$69.58	$269,762	15,114
2019-02-05	Torres Kathryn A.	SVP-Payer Contracting & Align.	Exercise / conversion M	Common Stock	7,000	$68.96	$482,720	11,237
2019-02-01	Reiner Deborah M	SVP - Mktg. & Communications	Exercise / conversion M · derivative	Stock Appreciation Right	1,605	$0.00	$0	3,210
2019-02-01	Reiner Deborah M	SVP - Mktg. & Communications	Other disposed transaction F	Common Stock	1,139	$139.71	$159,130	3,898
2019-02-01	Reiner Deborah M	SVP - Mktg. & Communications	Exercise / conversion M	Common Stock	1,605	$81.96	$131,546	5,037
2019-01-31	Reiner Deborah M	SVP - Mktg. & Communications	Open-market sell S	Common Stock	523	$138.89	$72,639	3,432
2019-01-30	Morgan Sandra L.	SVP-Provider Relations	Equity grant / award A · derivative	Stock Appreciation Right	8,000	$0.00	$0	8,000
2019-01-30	Wyatt Christopher F.	SVP & Controller	Equity grant / award A · derivative	Stock Appreciation Right	10,670	$0.00	$0	10,670
2019-01-29	Reiner Deborah M	SVP - Mktg. & Communications	Exercise / conversion M · derivative	Stock Appreciation Right	1,495	$0.00	$0	1,495
2019-01-29	Reiner Deborah M	SVP - Mktg. & Communications	Other disposed transaction F	Common Stock	972	$138.03	$134,165	3,955
2019-01-29	Reiner Deborah M	SVP - Mktg. & Communications	Exercise / conversion M	Common Stock	1,495	$69.58	$104,022	4,927
2018-11-13	Torres Kathryn A.	SVP-Payer Contracting & Align.	Open-market sell S	Common Stock	820	$142.36	$116,732	4,237
2018-11-07	Perlin Jonathan B	Pres-Clinical Services & CMO	Exercise / conversion M · derivative	Stock Appreciation Right	12,500	$0.00	$0	42,500
2018-11-07	Perlin Jonathan B	Pres-Clinical Services & CMO	Other disposed transaction F	Common Stock	6,909	$141.65	$978,660	100,716
2018-11-07	Perlin Jonathan B	Pres-Clinical Services & CMO	Exercise / conversion M	Common Stock	12,500	$37.18	$464,750	107,625
2018-11-05	Reiner Deborah M	SVP - Mktg. & Communications	Open-market sell S	Common Stock	723	$135.06	$97,648	3,432
2018-11-02	Cuffe Michael S.	President-Physician Services	Open-market sell S	Common Stock	5,196	$136.52	$709,358	20,915
2018-11-01	Reiner Deborah M	SVP - Mktg. & Communications	Exercise / conversion M · derivative	Stock Appreciation Right	2,752	$0.00	$0	8,258
2018-11-01	Reiner Deborah M	SVP - Mktg. & Communications	Other disposed transaction F	Common Stock	2,029	$135.69	$275,315	4,155
2018-11-01	Reiner Deborah M	SVP - Mktg. & Communications	Exercise / conversion M	Common Stock	2,752	$76.83	$211,436	6,184
2018-10-31	Cuffe Michael S.	President-Physician Services	Exercise / conversion M · derivative	Stock Appreciation Right	11,875	$0.00	$0	0
2018-10-31	Cuffe Michael S.	President-Physician Services	Other disposed transaction F	Common Stock	6,679	$133.53	$891,847	26,111
2018-10-31	Cuffe Michael S.	President-Physician Services	Exercise / conversion M	Common Stock	11,875	$37.18	$441,512	32,790
2018-08-15	Englebright Jane D.	SVP and Chief Nursing Officer	Equity grant / award G	Common Stock	939	$0.00	$0	6,504
2018-08-15	Englebright Jane D.	SVP and Chief Nursing Officer	Open-market sell S	Common Stock	6,543	$129.86	$849,688	7,443
2018-08-03	MOORE A BRUCE JR	Group President - Service Line	Exercise / conversion M · derivative	Stock Appreciation Right	50,000	$0.00	$0	0
2018-08-03	MOORE A BRUCE JR	Group President - Service Line	Other disposed transaction F	Common Stock	25,023	$130.16	$3,256,994	152,903
2018-08-03	MOORE A BRUCE JR	Group President - Service Line	Exercise / conversion M	Common Stock	50,000	$22.95	$1,147,500	177,926
2018-07-31	Wyatt Christopher F.	SVP & Controller	Equity grant / award G	Common Stock	800	$0.00	$0	11,409
2018-07-27	Perlin Jonathan B	Pres-Clinical Services & CMO	Open-market sell S	Common Stock	3,300	$124.47	$410,751	95,394
2018-07-27	Perlin Jonathan B	Pres-Clinical Services & CMO	Open-market sell S	Common Stock	37,152	$123.52	$4,588,970	98,694
2018-07-27	Perlin Jonathan B	Pres-Clinical Services & CMO	Open-market sell S	Common Stock	32,846	$122.92	$4,037,351	135,846
2018-07-27	Paslick P. Martin	SVP and CIO	Exercise / conversion M · derivative	Stock Appreciation Right	35,625	$0.00	$0	0
2018-07-27	Paslick P. Martin	SVP and CIO	Exercise / conversion M · derivative	Stock Appreciation Right	37,500	$0.00	$0	0
2018-07-27	Paslick P. Martin	SVP and CIO	Other disposed transaction F	Common Stock	42,059	$124.15	$5,221,625	41,263
2018-07-27	Paslick P. Martin	SVP and CIO	Exercise / conversion M	Common Stock	73,125	$37.18	$2,718,788	83,322
2018-07-26	Morgan Sandra L.	SVP-Provider Relations	Open-market sell S	Common Stock	1,913	$122.29	$233,942	6,593
2018-07-25	Reiner Deborah M	SVP - Mktg. & Communications	Open-market sell S	Common Stock	237	$112.53	$26,670	3,432
2018-07-25	Perlin Jonathan B	Pres-Clinical Services & CMO	Exercise / conversion M · derivative	Stock Appreciation Right	75,000	$0.00	$0	0
2018-07-25	Perlin Jonathan B	Pres-Clinical Services & CMO	Exercise / conversion M · derivative	Non-Qualified Stock Option (right to buy)	10,000	$0.00	$0	0
2018-07-25	Perlin Jonathan B	Pres-Clinical Services & CMO	Other disposed transaction F	Common Stock	76,702	$118.13	$9,060,807	168,692
2018-07-25	Perlin Jonathan B	Pres-Clinical Services & CMO	Exercise / conversion M	Common Stock	150,000	$22.95	$3,442,500	245,394
2018-07-25	Perlin Jonathan B	Pres-Clinical Services & CMO	Open-market sell S	Common Stock	10,000	$112.53	$1,125,300	95,394
2018-07-25	Perlin Jonathan B	Pres-Clinical Services & CMO	Exercise / conversion M	Common Stock	10,000	$22.10	$221,000	105,394
2018-07-23	Reiner Deborah M	SVP - Mktg. & Communications	Exercise / conversion M · derivative	Stock Appreciation Right	1,605	$0.00	$0	4,815
2018-07-23	Reiner Deborah M	SVP - Mktg. & Communications	Other disposed transaction F	Common Stock	1,368	$108.36	$148,236	3,669
2018-07-23	Reiner Deborah M	SVP - Mktg. & Communications	Exercise / conversion M	Common Stock	1,605	$81.96	$131,546	5,037
2018-06-21	Perlin Jonathan B	Pres-Clinical Services & CMO	Exercise / conversion M · derivative	Non-Qualified Stock Option (right to buy)	12,500	$0.00	$0	0
2018-06-21	Perlin Jonathan B	Pres-Clinical Services & CMO	Open-market sell S	Common Stock	12,500	$108.00	$1,350,000	95,394
2018-06-21	Perlin Jonathan B	Pres-Clinical Services & CMO	Exercise / conversion M	Common Stock	12,500	$21.35	$266,875	107,894
2018-06-11	Perlin Jonathan B	Pres-Clinical Services & CMO	Exercise / conversion M · derivative	Non-Qualified Stock Option (right to buy)	25,000	$0.00	$0	0
2018-06-11	Perlin Jonathan B	Pres-Clinical Services & CMO	Open-market sell S	Common Stock	25,000	$106.00	$2,650,000	95,394
2018-06-11	Perlin Jonathan B	Pres-Clinical Services & CMO	Exercise / conversion M	Common Stock	25,000	$17.33	$433,250	120,394
2018-06-05	Reiner Deborah M	SVP - Mktg. & Communications	Open-market sell S	Common Stock	1,204	$105.00	$126,420	3,432
2018-05-30	Reiner Deborah M	SVP - Mktg. & Communications	Exercise / conversion M · derivative	Stock Appreciation Right	1,495	$0.00	$0	2,990
2018-05-30	Reiner Deborah M	SVP - Mktg. & Communications	Exercise / conversion M · derivative	Stock Appreciation Right	1,500	$0.00	$0	1,500
2018-05-30	Reiner Deborah M	SVP - Mktg. & Communications	Exercise / conversion M · derivative	Stock Appreciation Right	1,125	$0.00	$0	0
2018-05-30	Reiner Deborah M	SVP - Mktg. & Communications	Exercise / conversion M · derivative	Stock Appreciation Right	675	$0.00	$0	0
2018-05-30	Reiner Deborah M	SVP - Mktg. & Communications	Other disposed transaction F	Common Stock	3,591	$104.90	$376,696	4,636
2018-05-30	Reiner Deborah M	SVP - Mktg. & Communications	Exercise / conversion M	Common Stock	1,495	$69.58	$104,022	8,227
2018-05-30	Reiner Deborah M	SVP - Mktg. & Communications	Exercise / conversion M	Common Stock	1,500	$68.96	$103,440	6,732
2018-05-30	Reiner Deborah M	SVP - Mktg. & Communications	Exercise / conversion M	Common Stock	1,800	$47.97	$86,346	5,232
2018-05-17	Perlin Jonathan B	Pres-Clinical Services & CMO	Exercise / conversion M · derivative	Non-Qualified Stock Option (right to buy)	11,520	$0.00	$0	25,000
2018-05-17	Perlin Jonathan B	Pres-Clinical Services & CMO	Open-market sell S	Common Stock	11,520	$104.00	$1,198,080	95,346
2018-05-17	Perlin Jonathan B	Pres-Clinical Services & CMO	Exercise / conversion M	Common Stock	11,520	$17.33	$199,642	106,866
2018-05-14	Englebright Jane D.	SVP and Chief Nursing Officer	Open-market sell S	Common Stock	5,822	$102.47	$596,580	13,986
2018-05-02	Frist William R	Dir	Equity grant / award A	Common Stock, par value $0.01 per share	1,790	$0.00	$0	3,958
2018-02-25	YUSPEH ALAN R	SVP & Chief Ethics Officer	Exercise / conversion M · derivative	Restricted Stock Units	922	$0.00	$0	923
2018-02-25	YUSPEH ALAN R	SVP & Chief Ethics Officer	Exercise / conversion M · derivative	Restricted Stock Units	825	$0.00	$0	0
2018-02-25	YUSPEH ALAN R	SVP & Chief Ethics Officer	Other disposed transaction F	Common Stock	385	$100.84	$38,823	35,546
2018-02-25	YUSPEH ALAN R	SVP & Chief Ethics Officer	Exercise / conversion M	Common Stock	1,747	—	—	35,931
2018-02-22	YUSPEH ALAN R	SVP & Chief Ethics Officer	Equity grant / award A · derivative	Stock Appreciation Right	2,625	$0.00	$0	2,625
2018-02-22	YUSPEH ALAN R	SVP & Chief Ethics Officer	Other disposed transaction F	Common Stock	3,150	$100.54	$316,701	34,184
2018-02-22	YUSPEH ALAN R	SVP & Chief Ethics Officer	Equity grant / award A	Common Stock	8,800	$0.00	$0	37,334
2018-02-21	Hall Charles J	Group President	Exercise / conversion M · derivative	Non-Qualified Stock Option (right to buy)	10,000	$0.00	$0	0
2018-02-21	Hall Charles J	Group President	Exercise / conversion M · derivative	Non-Qualified Stock Option (right to buy)	12,500	$0.00	$0	0
2018-02-21	Hall Charles J	Group President	Exercise / conversion M · derivative	Non-Qualified Stock Option (right to buy)	16,996	$0.00	$0	0
2018-02-21	Hall Charles J	Group President	Exercise / conversion M · derivative	Non-Qualified Stock Option (right to buy)	3,375	$0.00	$0	34,125
2018-02-21	Hall Charles J	Group President	Equity grant / award G	Common Stock	4,950	$0.00	$0	50,087
2018-02-21	Hall Charles J	Group President	Open-market sell S	Common Stock	15,757	$101.07	$1,592,500	55,037
2018-02-21	Hall Charles J	Group President	Open-market sell S	Common Stock	13,621	$101.40	$1,381,169	70,794
2018-02-21	Hall Charles J	Group President	Exercise / conversion M	Common Stock	10,000	$22.10	$221,000	84,415
2018-02-21	Hall Charles J	Group President	Exercise / conversion M	Common Stock	12,500	$21.35	$266,875	74,415
2018-02-21	Hall Charles J	Group President	Exercise / conversion M	Common Stock	20,371	$17.33	$353,029	61,915
2018-02-20	Hall Charles J	Group President	Exercise / conversion M · derivative	Non-Qualified Stock Option (right to buy)	20,504	$0.00	$0	16,996
2018-02-20	Hall Charles J	Group President	Open-market sell S	Common Stock	20,504	$101.40	$2,079,106	41,544
2018-02-20	Hall Charles J	Group President	Exercise / conversion M	Common Stock	20,504	$17.33	$355,334	62,048
2018-02-20	Frist William R	Dir	Equity grant / award G	Common Stock, par value $0.01 per share	22,168	$0.00	$0	416,421
2018-02-16	YUSPEH ALAN R	SVP & Chief Ethics Officer	Exercise / conversion M · derivative	Stock Appreciation Right	5,500	$0.00	$0	0
2018-02-16	YUSPEH ALAN R	SVP & Chief Ethics Officer	Exercise / conversion M · derivative	Stock Appreciation Right	6,875	$0.00	$0	0
2018-02-16	YUSPEH ALAN R	SVP & Chief Ethics Officer	Other disposed transaction F	Common Stock	6,497	$101.00	$656,197	28,534
2018-02-16	YUSPEH ALAN R	SVP & Chief Ethics Officer	Exercise / conversion M	Common Stock	12,375	$37.18	$460,102	35,031
2018-02-14	Hall Charles J	Group President	Exercise / conversion M · derivative	Non-Qualified Stock Option (right to buy)	119,637	$0.00	$0	0
2018-02-14	Hall Charles J	Group President	Open-market sell S	Common Stock	95,293	$100.19	$9,547,568	41,544
2018-02-14	Hall Charles J	Group President	Open-market sell S	Common Stock	24,344	$99.96	$2,433,446	136,837
2018-02-14	Hall Charles J	Group President	Exercise / conversion M	Common Stock	119,637	$22.64	$2,708,761	161,181
2018-02-13	CAMPBELL VICTOR L	SVP	Exercise / conversion M · derivative	Stock Appreciation Right	37,500	$0.00	$0	0
2018-02-13	CAMPBELL VICTOR L	SVP	Exercise / conversion M · derivative	Non-Qualified Stock Option (right to buy)	4,504	$0.00	$0	0
2018-02-13	CAMPBELL VICTOR L	SVP	Exercise / conversion M · derivative	Non-Qualified Stock Option (right to buy)	2,252	$0.00	$0	0
2018-02-13	CAMPBELL VICTOR L	SVP	Exercise / conversion M · derivative	Non-Qualified Stock Option (right to buy)	4,506	$0.00	$0	0
2018-02-13	CAMPBELL VICTOR L	SVP	Exercise / conversion M · derivative	Non-Qualified Stock Option (right to buy)	1,158	$0.00	$0	0
2018-02-13	CAMPBELL VICTOR L	SVP	Other disposed transaction F	Common Stock	44,535	$98.92	$4,405,402	180,264
2018-02-13	CAMPBELL VICTOR L	SVP	Exercise / conversion M	Common Stock	75,000	$22.95	$1,721,250	224,799
2018-02-13	CAMPBELL VICTOR L	SVP	Exercise / conversion M	Common Stock	2,252	$15.91	$35,832	149,799
2018-02-13	CAMPBELL VICTOR L	SVP	Exercise / conversion M	Common Stock	6,756	$6.48	$43,760	145,295
2018-02-13	CAMPBELL VICTOR L	SVP	Exercise / conversion M	Common Stock	5,664	$5.98	$33,883	138,539
2018-02-09	Cuffe Michael S.	President-Physician Services	Open-market sell S	Common Stock	8,335	$97.26	$810,680	11,089
2018-02-07	Cuffe Michael S.	President-Physician Services	Exercise / conversion M · derivative	Stock Appreciation Right	7,500	$0.00	$0	0
2018-02-07	Cuffe Michael S.	President-Physician Services	Other disposed transaction F	Common Stock	6,665	$98.40	$655,836	19,424
2018-02-07	Cuffe Michael S.	President-Physician Services	Exercise / conversion M	Common Stock	15,000	$22.95	$344,250	26,089
2018-02-05	Wyatt Christopher F.	SVP & Controller	Exercise / conversion M · derivative	Restricted Stock Units	375	$0.00	$0	0
2018-02-05	Wyatt Christopher F.	SVP & Controller	Other disposed transaction F	Common Stock	112	$95.89	$10,740	6,420
2018-02-05	Wyatt Christopher F.	SVP & Controller	Exercise / conversion M	Common Stock	375	—	—	6,532
2018-01-31	YUSPEH ALAN R	SVP & Chief Ethics Officer	Equity grant / award A · derivative	Stock Appreciation Right	13,730	$0.00	$0	13,730
2018-01-31	YUSPEH ALAN R	SVP & Chief Ethics Officer	Open-market sell S	Common Stock	15,000	$100.61	$1,509,152	22,656
2018-01-30	Sowell Joseph A III	SVP; Chief Development Officer	Exercise / conversion M · derivative	Stock Appreciation Right	1,846	$0.00	$0	60,654
2018-01-30	Sowell Joseph A III	SVP; Chief Development Officer	Exercise / conversion M · derivative	Stock Appreciation Right	62,500	$0.00	$0	0
2018-01-30	Sowell Joseph A III	SVP; Chief Development Officer	Exercise / conversion M · derivative	Non-Qualified Stock Option (right to buy)	22,025	$0.00	$0	0
2018-01-30	Sowell Joseph A III	SVP; Chief Development Officer	Other disposed transaction F	Common Stock	32,751	$101.45	$3,322,589	36,981
2018-01-30	Sowell Joseph A III	SVP; Chief Development Officer	Open-market sell S	Common Stock	22,025	$101.86	$2,243,466	69,732
2018-01-30	Sowell Joseph A III	SVP; Chief Development Officer	Exercise / conversion M	Common Stock	64,346	$22.95	$1,476,741	91,757
2018-01-30	Sowell Joseph A III	SVP; Chief Development Officer	Exercise / conversion M	Common Stock	22,025	$13.25	$291,924	27,411
2018-01-30	Sowell Joseph A III	SVP; Chief Development Officer	Other disposed transaction F	Common Stock	34,151	$101.45	$3,464,619	35,581
2018-01-26	Sowell Joseph A III	SVP; Chief Development Officer	Exercise / conversion M · derivative	Non-Qualified Stock Option (right to buy)	23,025	$0.00	$0	22,025
2018-01-26	Sowell Joseph A III	SVP; Chief Development Officer	Exercise / conversion M · derivative	Non-Qualified Stock Option (right to buy)	35,150	$0.00	$0	0
2018-01-26	Sowell Joseph A III	SVP; Chief Development Officer	Open-market sell S	Common Stock	58,175	$95.00	$5,526,625	5,386
2018-01-26	Sowell Joseph A III	SVP; Chief Development Officer	Exercise / conversion M	Common Stock	23,025	$13.25	$305,178	63,561
2018-01-26	Sowell Joseph A III	SVP; Chief Development Officer	Exercise / conversion M	Common Stock	35,150	$7.70	$270,655	40,536

Regulatory Activity

Last 12 months to 2025-04-29

Insider Filings (Forms 3/4/5) — 12 months

Material Event Filings (8-K) — 12 months

8-K Material Event Filing Activity

Monthly count

Insider Trading Activity (Forms 3/4/5)

Monthly count